Publikationen UKH-HZL (1989-2019)

2019

  • Tichelli A, Peffault de Latour R, Passweg J, Knol-Bout C, Socié G, Marsh J, Schrezenmeier H, Höchsmann B, Bacigalupo A, Samarasinghe S, Rovó A, Kulasekararaj A, Röth A, Eikema DJ, Bosman P, Bader P, Risitano A, Dufour C. Long-term Outcome of a reandomized controlled study in patients with newly diagnosed severe aplastic anemia treated with antithymocyte globuline, cyclosporie, with or without G-CSF: a Severe Aplastic Anemia Working Party Trial from the European Group of Blood and Marrow Transplantation.
    Haematologica. 2019 Oct 3. [Epub ahead of print]
  • Lazaryan A, Dolan M, Zhang MJ, Wang HL, Kharfan-Dabaja MA, Marks DI, Bejanyan N, Copelan E, Maijhail N, Waller EK, Chao N, Prestidge T, Nishihori T, Kebriaei P, Inamoto Y, Hamilton B, Hashmi SK, Kamble RT, Bacher U, Hildebrandt GC, Stiff PJ, McGuirk J, Aldoss I, Beitinjaneh AM, Muffly L, Vij R, Olsson RF, Byrne M, Schultz KR, Aljurf M, Seftel M, Savoie ML, Savani BN, Verdonck LF, Cairo MS, Hossain N, Bhatt VR, Frangoul HA, Abdel-Azim H, Al Malki M, Munker R, Rizzieri D, Khera N, Nakamura R, Ringdén O, van der Poel M, Murthy HS, Liu H, Mori S, De Oliveira S, Bolaños-Meade J, Elsawy M, Barba P, Nathan S, George B, Pawarode A, Grunwald M, Agrawal V, Wang Y, Assal A, Castillo Caro P, Kuwatsuka Y, Seo S, Ustun C, Politikos J, Lazarus HM, Saber W, Sandmaier BM, de Lima M, Litzow M, Bachanova V, Weisdorf D, Acute Leukemia Committee of the CIBMTR. Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research.
    Haematologica 2019 Sep 26. [Epub ahead of print]
  • Yang J, van Engelen TSR, Haak BW, Bonta PI, Majoor CJ, van 't Veer C, de Vos AF, Kemper EM, Lutter R, van Mierlo G, Zeerleder SS, Bel EH, van der Poll T. Effect of C1-Inhibitor in adults with mild asthma: a randomised controlled trial.
    Allergy. 2019 Sept 19. [Epub ahead of print]
  • Angelillo-Scherrer A, Mansouri Taleghani B, Förger F, Baerlocher GM, Pabst T, Pöllinger A, Banz Y, Geiser T, Kremer Hovinga JA, Rovó A. Immunoadsorption and autologous transplantation for life-threatening primary antiphospholipid syndrome.
    Blood Adv. 2019 Sep 10; 3(17):2664-2667
  • Moser S, Bacher U, Jeker B, Mansouri Taleghani B, Betticher D, Ruefer A, Egger T, Novak U, Pabst T. Autologous stem cell transfusions on multiple days in patients with multiple myeloma - does it matter?
    Hematol Oncol 2019 Sep 4 [Epub ahead of print]
  • Van Avondt K, Nur E, Zeerleder SS. Mechanisms of haemolysis-induced kidney injury.
    Nat Rev Nephrol. 2019 Aug 27. [Epub ahead of print]
  • de Jong G, Janssen JJWM, Biemond BJ, Zeerleder SS, Ossenkoppele GJ, Visser O, Nur E, Meijer E, Hazenberg MD. Survival of early post-hematopoietic stem cell transplantation relapse of myeloid malignancies.
    Eur J Haematol. 2019 Aug 14. [Epub ahead of print]
  • Rudin D, Spoendlin J, Cismaru AL, Liakoni E, Bonadies N, Amstutz U, Meier CR, Krähenbühl S, Haschke M. Metamizole-associated neutropenia: Comparison of patients with neutropenia and metamizole-tolerant patients.
    Eur J Intern Med. 2019 Aug 2. [Epub ahead of print]
  • Garcia Garrido HM, van Aalst M, Schinkel J, Koen G, Defoer JM, Hazenberg MD, Nur E, Grobusch MP, Zeerleder SS, Goorhuis A, de Bree GJ. Early loss of immunity against measles following allogeneic hematopoietic stem cell transplantation.
    Am J Hematol. 2019 Juli 24. [Epub ahead of print]
  • Robertz J, Andres M, Mansouri Taleghani B, Koneth I, Binet I, Kremer Hovinga JA. Obinutuzumab in two patients suffering from immune-mediated thrombotic thrombocytopenic purpurea intolerant to rituximab.
    Am J Hematol. 2019 Jul 18. [Epub ahead of print]
  • Kim HT, Ahn KW, Hu ZH, Davids MS, Volpe V, Antin JH, Sorror M, Shadman M, Press OW, Pidala J, Hogan W, Negrin R, Devine S, Uberti J, Agura E, Nash R, Mehta J, McGuirk JP, Forman S, Langston A, Giralt S, Perales MA, Battiwalla M, Hale G, Gale RP, Marks DI, Hamadani M, Ganguly S, Bacher U, Lazarus H, Reshef R, Hildebrandt GC, Inamoto Y, Cahn JY, Solh M, Kharfan-Dabaja MA, Ghosh N, Saad A, Aljurf M, Schouten HC, Hill BT, Pawarode A, Kindwall-Keller T, Saba NS, Copelan E, Nathan S, Beitinjaneh AM, Savani B, Cerny J, Grunwald MR, Yared J, Wirk B, Nishihori T, Chhabra S, Olsson R, Bashey A, Gergis U, Popat U, Sobecks RM, Alyea EP, Saber W, Brown JR.
    Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report.
    Clin Cancer Res. 2019 Jun 28. [Epub ahead of print]
  • Nowak A, Angelillo-Scherrer A, Betticher D, Dickenmann M, Guessous I, Juillerat P, Korte W, Neuner-Jehle S, Pfister O, Surbek D, Battegay E. Steurer J. Swiss Delphi study on iron deficiency.
    Swiss Med Wkly. 2019 Jul 3.
  • Tiefenbacher S, Albisetti M, Baker P, Kappert G, Kitchen S, Kremer Hovinga JA, Pouplard C, Scholz U, Ternisien C, Borgvall C, Vicente T, Belyanskaya , Walter O, Oldenburg J, Nuwiq Field Study Participating Laboratories. Estimation of Nuwiq® (simoctocog alfa) activity using one-stage and chromogenic assays-Results from an international comparative field study.
    Haemophilia. 2019 May 20. [Epub ahead of print]
  • Klingenberg R, Schlager O, Limacher A, Méan M, Veuilleumier N, Beer JH, Staub D, Frauchiger B, Aschwanden M, Lämmle B, Righini M, Egloff M, Osterwalder J, Angelillo-Scherrer A, Kucher N, Banyai M, Rodondi N, von Eckardstein A, Aujesky D, Husmann M, Matter CM. Risk stratification of elderly patients with acute pulmonary embolism.
    Eur J Clin Invest. 2019 Jun 27 [Epub ahead of print]
  • Shouval R, Labopin M, Gorin NC, Bomze D, Houhou M, Blaise D, Zuckerman T, Baerlocher GM, Capria S, Forcade E, Huynh A, Saccardi R, Martino M, Schaap M, Wu D, Mohty M, Nagler A. Individualized prediction of leukemia-free surival after autologous stem cell transplantation in acute myeloid leukemia.
    Cancer. 2019 Juni 21. [Epub ahead of print]
  • Baas I, Delvasto-Nuñez l, Ligthart P, Brouwer C, Folman C, Reis ES, Ricklin D, Lambris JD, Wouters D, de Haas M, Jongerius I, Zeerleder SS.
    Complement C3 inhibition by compstatin Cp40 prevents intra- and extravascular hemolysis of reed blood cells.
    Haematologica. 2019, Juni 6. pii: haematol.2019.216028. [Epub ahead of print]
  • De Santiago de Benito A, Jeker B, Gfeller E, Porret N, Banz Y, Novak U, Bacher U, Pabst T. Molecular minimal residual disease negativity and decreased stem cell mobilization potential predict excellent outcome after autologous transplant in NPM1 mutant acute myeloid leukemia.
    Haematologica. 2019 May 23; [Epub ahead of print]
  • Ahmed S, Kanakry JA, Ahn KW, Litovich C, Abdel-Azim H, Aljurf M, Bacher VU, Bejanyan N, Cohen JB, Fuchs EJ, Bolaños-Meade J, Ghosh N, Herrera A, Hossain NM, Inwards D, Kanate AS, Martino R, Munshi PN, Murthy H, Mussetti A, Nieto Y, Perales MA, Romee R, Savani BN, Seo S, Wirk B, Yared JA, Sureda A, Fenske TS, Hamadani M. Lower GVHD and relapse risk in PTCy-based Haploidentical vs Matched Sibling Donor RIC Transplant for Hodgkin Lymphoma.
    Biol Blood Marrow Transplant. 2019 May 24. pii: S1083-8791(19)30336-2. [Epub ahead of print]
  • Ecsedi M, Lengline É, Knol-Bout C, Bosman P, Eikema DJ, Afanasyev B, Maschan A, Dreger P, Halkes CJM, Drexler B, Cortelezzi A, Drénou B, Patriarca A, Bruno B, Onofrillo D, Lanino E, Pulanic D, Serventi-Seiwerth R, Garnier A, Ljungman P, Bonifazi F, Giammarco S, Tournilhac O, Pioltelli P, Rovó A, Risitano AM, de Latour RP, Dufour C, Passweg J, EBMT SAA Working Party. Use of eltrombopag in aplastic anemia in Europe.
    Ann Hematol. 2019 Jun;98(6):1341-1350
  • Wieland Greguare-Sander A, Wuillemin WA, Nagler M. Thromboelastometry as a diagnostic tool in mild bleeding disorders: A prospective cohort study.
    Eur J Anaesthesiol. 2019 Jun;36(6):457-465
  • Inamoto Y, Petriček I, Burns L, Chhabra S, DeFilipp Z, Hematti P, Rovó A, Schears R, Shah A, Agrawal V, Al-Khinji A, Ahmed I, Ali A, Aljurf M, Alkhateeb H, Beitinjaneh A, Bhatt N, Buchbinder D, Byrne M, Callander N, Fahnehjelm K, Farhadfar N, Gale RP, Ganguly S, Hildebrandt GC, Horn E, Jakubowski A, Kamble RT, Law J, Lee C, Nathan S, Penack O, Pingali R, Prasad P. Pulanic D, Roth S, Shreenivas A, Steinberg A, Tabbara K, Tichelli A, Wirk B, Yared J, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Valdös-Sanz N. Correction: Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.
    Bone Marrow Transplant. 2019 May;54(5):782-783
  • Heestermans M, Salloum-Asfar S, Streef T, Laghmani EH, Salvatori D, Luken BM, Zeerleder SS, Spronk HMH, Korporaal SJ, Kirchhofer D, Wagenaar GTM, Versteeg HH, Reitsma PH, Renné T, van Vlijmen BJM. Mouse venous thrombosis upon silencing of anticoagulants depends on tissue factor and platelets, not FXII or neutrophils.
    Blood. 2019 May 9;133(19):2090-2099.
  • Haas Q, Frias Boligan K, Jandus C, Schneider C, Simillion C, Stanczak MA, Haubitz M, Seyed Jafari SM, Zippelius A, Baerlocher GM, Läubli H, Hunger RE, Romero P, Simon HU, von Gunten S. Siglec-9 regulates an effector memory CD8+ T-cell subset that congregates in the melanoma tumor microenvironment.
    Cancer Immunol Res. 2019 May;7(5):707-718
  • Bonadies N, Bacher VU, What role can next-generation sequencing play in myelodysplastic syndrome care?
    Expert Rev Hematol. 2019 May 7:1-4. [Epub ahead of print]
  • Affentranger L, Bohlius J, Hallal M, Bonadies N. Efficacy of granulocyte colony stimulating factor in combination with erythropoiesis stimulating agents for treatment of anemia in patients with lower risk myelodysplastic syndromes: A systematic review.
    Crit Rev Oncol Hematol 2019 Apr; 136:37-47
  • Müller M, Eastline J, Nagler M, Exadaktylos AK, Sauter TC.
    Application of prothrombin complex concentrate for reversal of direct anticoagulants in clinical practice: indications, patient characteristics and clinical outcomes compared to reversal of vitamin K antagonists.
    Scand J Trauma Resusc Emerg Med. 2019 Apr 23;27(1):48
  • Adler M, Kaufmann J, Alberio l, Nagler M. Diagnostic utility of the ISTH bleeding assessment tool in patients with suspected platelet function disorders.
    J Thromb Haemost. 2019 Apr 15; [Epub ahead of print]
  • Cohn DM, Zeerleder SS, Meijers JCM, Stroes ESG, Levi M. Albumin plasma exchange for life-threatening angioedema with normal C1-inhibitor.
    J Allergy Clin Immunol Pract. 2019 Apr; 7(4) 1360-1361
  • Fassbind P, Jeker B, Mueller BU, Bacher U, Zimmerli S, Endrich O, Gahl B, Novak U, Pabst T. Improved survival rates of AML patients following admission to the intensive care unit.
    Leuk Lymphoma. 2019 Apr 3: 1-9. [Epub ahead of print]
  • Schneider C, Stutz-Grunder E, Lüer S, Keller P. Kremer Hovinga JA, Ammann RA, Karow A. Fulminant Essential Thrombocythemia Associated with Acquired Von Willebrand Syndrome and Bleeding Episodes in a 14-year-old Girl.
    Hamostaseologie. 2019 Mar 20. [Epub ahead of print]
  • Prediletto I, Farag SA, Bacher U, Jeker B, Mansouri Taleghani B, Brégy R, Zander T, Betticher D, Egger T, Novak U, Pabst T. High incidence of reversible renal toxicity  of dose-intensified bendamustine-based high-dose chemotherapy in lymphoma and myeloma patients.
    Bone Marrow Transplant. 2019 Mar 19. [Epub ahead of print]
  • Shumilov E, Flach J, Joncourt R, Porret N, Wiedemann G, Angelillo-Scherrer A, Trümper L, Fieder M, Jeker B, Amstutz U, Pabst T, Bacher U. Critical evaluation of current molecular MRD strategies including NGS for the management of AML patients with multiple mutations.
    Hematol Oncol. 2019 Mar 6. [Epub ahead of print]
  • van Dorland HA, Mansori Taleghani M, Sakai K, Friedmann KD, George JN, Hrachovinova I, Knöbl PN, von Krogh AS, Schneppenheim R, Aebi-Huber I, Büttikofer L, Largiadèr CR, Cermakova Z, Kokame K, Miyata T, Yagi H, Terrell DR, Vesely SK, Matsumoto M, Lämmle B, Fujimura Y, Kremer Hovinga JA. Hereditary TTP Registry. The Intenational Hereditary Thrombotic Thrombocytopenic Purpura Registry: Key findings at enrolment until 2017.
    Haematologica. 2019 Feb 21. [Epub ahead of print]
  • Reiner MF, Müller D, Gobbato S, Stalder O, Limacher A, Bonetti N, Pasterk L, Méan M, Rodondi N, Aujesky D, Angelillo-Scherrer A, Matter Ch, Lüscher TF, Camici GG, von Eckardstein A, Beer JH. Gut microbiota-dependent trimethylamine-N-oxide (TMAO) shows a U-shaped association with mortality but not with recurrent venous thromboembolism.
    Thromb Res. 2019 Feb; 174:40-47
  • Schnegg-Kaufmann A, Calzavarini S, Limacher A, Mean M, Righini M, Staub D, Bee Jh, Frauchiger B, Osterwalder J, Kucher N, Matter CM, Husmann M, Banyai M, Aschwanden M, Mazzolai L, Hugli O, Nagler M, Daskalakis m, Rodondi N, Aujesky D, Angelillo-Scherrer A. A high Gas6 level in plasma predicts venous thromboemolism recurrence, major bleeding and mortality in the elderly: a prospective multicenter cohort study.
    J Thromb Haemost. 2019 Feb; 17(2):306-318
  • Rijkers M, Schmidt D, Lu N, Kramer CSM, Heidt S, Mulder A, Porcelijn L, Claas FHJ, Leebeek FWG, Jansen AJG, Jongerius I, Zeerleder SS, Vidarsson G, Voorberg J, de Haas M. Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets.
    Haematologica. 2019 Feb;104(2):403-416
  • Ouahchi I, Zhang L, Benitez Brito R, Benz R, Müller R, Bonadies N, Tchinda J. Microarray-based comparative genomic hybridisation reveals additional recurrent aberrations in adult patients evaluated for myelodysplastic syndrome with normal karyotype.
    BR J Haematol. 2019 Jan; 184(2):282-287
  • Bonadies N. Myelodysplastische Syndrome: nur kleine Fortschritte in Richtung Präzisionsmedizin
    Leading Opinions, Hämatologie & Onkologie 1/2019
  • Inamoto Y, Valdés-Sanz N, Oqawa Y, Alves M, Berchicci L, Galvin J, Greinix H, Hale GA, Horn B, Kelly D, Liu H, Rowley S, Schoemans H, Shah A, Stanghellini MTL, Agrawal V, Ahmed I, Ali A, Bhatt N, Byrne M, Chhabra S. DeFilipp Z, Fahnehjelm K, Farhadfar N, Horn E, Lee C, Nathan S, Penack O, Prasad P, Rotz S, Rovó A, Yared J, Pavletic S, Basak GW, Battiwalla M, Duarte R, Svani BN, Flowers ME, Shaw BE, Petriček I. Ocular graft-versus-host disease after hematopoietic cell transplantation; expert reviw from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.
    Biol Blood marrow Transplant. 2019 Feb(2):e46-e54 
  • Poiré X, Labopin M, Polge E, Blaise D, Chevallier P, Maertens J, Deconinck E, Forcade E, Rambaldi A, Baerlocher GM, Zuckermann T, Volin L, Schouten HC, Ifrah N, Mohty M, Esteve J, Nagler A. Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myleoid leukemia in first remission.
    Am J Hematol. 2019 Feb;94(2):231-239
  • Benzarti S, Daskalakis M, Feller A, Bacher U, Schnegg-Kaumfann A, Rüfer A, Holbro A, Schmidt A, Benz R, Solenthaler M, Stuss G, Arndt V, Bonadies N, the NICER Working Group. Trends of incidence and survival of patients with chronic myelomonocytic leukemia betwenn 1999 and 2014. A comparison between Swiss and American population-based cancer registries.
    Cancer Epidemiol. 2019 Jan 25;59:51-57 [Epub ahead of print]
  • Langedijk AC, van Aalst M, Meek B, van Leeuwen EMM, Zeerleder S, Meijer E, Hazenberg MD, Grobusch MP, Goorhuis A. Long-term pneumococcal vaccine immunogenicity following allogeneic hematopoietic stem cell transplantation.
    Vaccine. 2019 Jan 14;37(3):510-515
  • Scully M, Cataland SR, Peyvandi F, Coppo , Knöbl P, Kremer Hovinga JA, de la Rubia J, Pavenski K, Callewaert F, Biswas D, De Winter H, Zeldin RK, HERCULES Investigators. Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura.
    N Engl J Med. 2019 Jan 9. [Epub ahead of print]
  • Amsler IG, Jeker B, Mansouri Taleghani B, Bacher U, Betticher D, Egger T, Zander T, Luethi JM, Novak U, Pabst T. Prolonged survival with increasing duration of lenalidomide maintenance after autologous transplant for multiple myeloma.
    Leuk Lymphoma. 2019 Jan 8: 1-4 [Epub ahead of print]
  • Rovó A, Kulasekararaj A, Medinger M, Chevallier P, Ribera JM, Peffault de Latour R, Knol C, Iacobelli S, Kanfer E, Bruno B, Maury S, Quarello P, Koh MBC, Schouten H, Blau IW, Tichelli A, Hill A, Risitano A, Passweg J, Marsh J, Dreger P. Dufour C. Association of aplastic anaemia and lymphoma: a report from the severe aplastic anaemia working party of the European Society of Blood and Bone Marrow Transplantation.
    Br J Haematol. 2019 Jan; 184(2):294-298

 

 

2018

  • Griesshammer M, Baerlocher GM, Döhner K, Gisslinger H. Koschmiede S, Petrides PE, Lengfelder E. Primäre Myelofibrose (PFM).
    Onkopedia Leitlinien, ICD-10 D47.1, 2018 Dec
  • Petrides PE, Baerlocher GM, Döhner K, Gisslinger H, Griesshammer M, Koschmieder S, Lengfelder E. Essentielle (oder primäre) Thrombozythämie (ET).
    Onkopedia Leitlinien, ICD-10 D47.3, 2018 Dec.
  • Engel R, Delvasto-Nuñez L, Roem D, van Mierlo G, Holst S, Hipgrave Ederveen AL, van Buul JD, Whrer M, Wouters D, Zeerleder S. α1-Antichymotrypsin Present in Therapeutic C1-Inhibitor Products Competes with Selectin-Sialyl LewisX Interaction.
    Thromb Haemost. 2018 Dec;118(12):2134-2144
  • Moor I, Bacher VU, Jeker B, Mansouri Taleghani B, Mueller BU, Keller P, Betticher D, Egger T, Novak U, Pabst T. Peripheral flow-MRD status at the time of autologous stem cell collection predicts outcome in multiple myeloma.
    Bone Marrow Transplantant. 2018 Dec;53(12):1599-1602
  • Caversaccio NI, Reina Caro MD, Prince R, Müller M, Lewis CS, Bogdanov VY, Dufour JF, Angelillo-Scherrer A. Alternatively spliced tissue factor levels are elevated in the plasma of patients with chronic liver diseases.
    Eur J Gastroenterol Hepatol. 2018 Dec;30(12):1470-1475
  • Erdoes G, Schloer H, Eberle B, Nagler M. Next generation viscoelasticity assays in cardiothoracic surgery: Feasibility of the TEG6s system.
    PLoS One. 2018 Dec 20;13(12):e0209360
  • Asp J, Skov V, Bellosillo B, Kristensen T, Lippert E, Dicker F, Schwarz J, Wojtaszewska M, Palmqvist L, Akiki S, Aggerholm A, Tolstrup Andersen M, Girodon F, Kjaer L, Oppliger Leibundgut E, Pancrazzi A, Vorland M, Andrikovics H, Kralovics R, Cassinat B, Coucelo M, Eftimov A, Haslam K, Kusec R, Link-Lenczowska D, Lodé L, Matiakowska K, Naguib D, Navaglia F, Novotny GW, Percy MJ, Sudarikov A, Hermouet S, Pallisgaard N. International external quality assurance of JAK2 V617 F quantification.
    Ann Hematol. 2018 Dec 8 [Epub ahead of print]
  • Inamoto Y, Valdés-Sanz N, Oqawa Y, Alves M, Berchicci L, Galvin J, Greinix H, Hale GA, Horn B, Kelly D, Liu H, Rowley S, Schoemans H, Shah A, Lupo Stanghellini MT, Agrawal V, Ahmed I, Ali A, Bhatt N, Byrne M, Chhabra S. DeFilipp Z, Fahnehjelm K, Farhadfar N, Horn E, Lee C, Nathan S, Penack O, Prasad P, Rotz S, Rovó A, Yared J, Pavletic S, Basak GW, Battiwalla M, Duarte R, Svani BN, Flowers ME, Shaw BE, Petriček I. Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert reviw from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.
    Bone Marrow Transplant. 2018 Dec 7 [Epub ahead of print]
  • Inamoto Y, Petriček I, Burns L, Chhabra S, DeFilipp Z, Hematti P, Rovó A, Schaers R, Shah A, Agrawal V, Ahmed A, Ahmed I, Ali A, Aljurf M, Alkhateeb H, Beitinjaneh A, Bhatt N, Buchbinder D, Byrne M, Callander N, Fahnehjelm K, Farhadfar N, Gale RP, Ganguly S, Hildebrandt GC, Horn E, Jakubowski A, Kamble RT, Lawq J, Lee C, Nathan S, Penack O, Pingali R, Prasad P, Pulanic D, Rotz S, Shreenivas A, Steinberg A, Tabbara K, Tichelli A, Wirk B, Yared J, Basak GW Batiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Valdés-Sanz N. Non-GVHD ocular complications after hematopoietic cell transplantation; expert reviw from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.
    Bone Marrow Transplant. 2018 Dec 7 [Epub ahead of print]
  • Michel C, Burchert A, Hochhaus A, Saussele S, Neubauer A, Lauseker M, Krause SW, Kolb HJ, Hossfeld DK, Nerl C, Baerlocher GM, Heim D, Brümmendorf TH, Fabarius A, Haferlach C, Schlegelberger B, Balleisen L, Goebeler ME, Hänel M, Ho A, Dengler J, Falge C, Möhle R, Kremers S, Kneba M, Stegelmann F, Köhne CH, Lindemann HW, Waller CF, Spiekermann K, Berdel WE, Müller L, Edinger M, Mayer J, Beelen DW, Bentz M, Link H, Hertenstein B, Fuchs R, Wernli M, Schlegel F, Schlag R, de Wit M, Trümper L, Hebart H, hahn M, Thomalla J, Scheid C, Schafhausen P, Verbeek W, Eckart MJ, Gassmann W, Schenk M, Brossart P, Wündisch T, Geer T, Bildat S, Schäfer E, Hasford J, Hehlmann R, Pfirrmann M. Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.
    Haematologica. 2018 Dec 4 [Epub ahead of print]
  • Levi M, Cohn D, Zeerleder S, Dziadzio M, Longhurst H. Long term effects upon rituximab treatment of acquired angio-edema due to c1-inhibitor deficiency.
    Allergy. 2018 Nov 29 [Epub ahead of print
  • Nagler M. Schwierigkeiten bei der Diagnose der Heparin-induzierten Thrombozytopeni (HIT).
    Leading Opinions Hämatologie & Onkologie 6/2018:70-73
  • Chigrinova E, Andres M, Bacher U, Rovó A, Angelillo-Scherrer A. La maladie de Waldenström.
    Swiss Medical Forum 2018;18(48):1006-1013
  • Shumilov E, Flach J, Kohlmann A, Ban Y, Bonadies N, Fiedler M, Pabst T, Bacher U. Current status and trends in the diagnostics of AML and MDS.
    Blood rev. 2018 Nov;32(6):508-519
  • van der Meer AJ, Ding C, Hoogendijk AJ, de Vos AF, Bood L, Zeerleder SS, van der Poll T. Neutrophils mitigate the systemic host response during endotoxemia in mice.
    Immunology. 2018 Nov 25 [Epub ahead of print]
  • Tichelli A, Beohou E, Labopin M, Socié G, Rovó A, Badoglio M, van Biezen A, Bader P. Duarte RF, Basak G, Salooja N, Transplant Complications Working Party of the EBMT. Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European Patients.
    JAMA Oncol. 2018 Nov 21 [Epub ahead of print]
  • Bacher U, Shumilov E, Flach J, Porret N, Joncourt R, Wiedemann G, Fiedler M, Novak U, Amstutz U, Pabst T. Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use.
    Blood Cancer J. 2018 Nov 12;8(11):113
  • Thielen Astrid J F, Meulenbroek EM, Baas I, Bruggen R, Zeerleder SS, Wouters D. Complement Deposition and IgG Binding on Stored Red Blood Cells Are Independent of Storage Time.
    Transfus Med hemother. 2018 Nov;45(6):378-384
  • Moiseev IS, Tsvetkova T, Aljurf M, Alnounou RM, Bogardt J, Chalandon Y, Drokov MY, Dvirnyk V, Faraci M, Friis LS, Giglio F, Greinix HT, Kornblit BT, Koelper C, Koenecke C, Lewandowski K, Niederwieser D, Passweg JR, Peczynski C, Penack O, Peric Z, Piekarska A, Ronchi PE, Rovo A, Rzepecki P, Scuderi F, Sigrist D, Siitonen SM, Stoelzel F, Sulek K, Tsakiris DA, Wilkowojska U, Duarte RF, Ruutu T, Basak GW. Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT.
    Bone Marrow Transplant. 2018 Oct 25. [Epub ahead of print]
  • Karow A, Wilhelm A, Ammann RA, Baerlocher GM, Pabst T, Mansouri Taleghani B, Roessler J, Leibundgut K. Peripheral blood progenitor cell collection in pediatric patients optimized by high pre-apheresis count of circulating CD34+ cells and high blood flow.
    Bone Marrow Transplant. 2018 Oct 23. [Epub ahead of print] 
  • Schmid M, Spichiger E, Kremer Hovinga JA. Aufbau einer interprofessionellen Betreuung für Patientinnen/Patienten mit angeborenen Hämostasestörungen.
    Pflegewissenschaft 2019; 21(3-4):110-117
  • Müller M, Schlittler F, Schaller B, Nagler M, Exadaktylos AK, Sauter TC. Characteristics, treatment and outcome of bleeding after tooth extraction in patients on DOAC and phenprocoumon compared to non-anticoagulated patients-a retrospective study of emergency department consultations.
    Clin Oral Investig. 2018 Oct 5. [Epub ahead of print]
  • Farag S, Jeker B, Bacher U, Taleghani BM, Mueller BU, Novak U, Pabst T, Dose-intensified bendamustine and melphalan (BenMel) conditioning before second autologous transplantation in myeloma patients.
    Hematol Oncol. 2018 Oct;36(4):671-678
  • Bacher UPorret N, Joncourt R, Sanz J, Aliu N, Wiedemann G, Jeker B, Banz Y, Pabst T. Pitfalls in the molecular follow-up of NPM1 mutant acute myeloid leukemia.
    Haematologica. 2018 Oct;103(10):e486-e488
  • Alva LC, Bacher U, Seipel K, Mansouri Taleghani B, Mueller BU, Novak U, Pabst T. Iron overload is correlated with impaired atologous stem cell mobilization and survival in acute myeloid leukemia.
    Transfusion. 2018 Oct;58(10):2365-2373
  • Anastasiou M, Baerlocher GM. Acute myeloid leukemia: Highlights from the annual meeting of the EHA.
    Leading Opinions Hämatologie & Onkologie 5/2018: 34-39 
  • Bellwald S, Balasubramaniam R, Nagler M, Burri MS, Fischer SDA, Hakim A, Dobrocky T, YU Y, Scalzo F, Heldner MR, Wiest R, Mono ML, Sarikya H, El-Koussy M, Mordasini P, Fischer U, Schroth G, Gralla J, Mattle HP, Arnold M, Liebeskind D, Jung S. Association of anemia and hemoglobin decrease during acute stroke treatment with infarct growth and clinical outcome.
    PLoS One. 2018 Sep 26;13(9):e0203535
  • Mueller BU, Seipel K, Bacher U, Pabst T. Autologous Transplantation for Older Adults with AML.
    Cancers 2018 Sep 19;10(9)
  • Bürki S, Shumilov E, Bonadies N, Flach J, Legros M, Banz Y, Oppliger Leibundgut E, Fiedler M, Angelillo-Scherrer A, Rovo A, Bacher U. Coincidence of 5q deletion and the JAK2V617F mutation: report of two patients with overlapping myelodysplastic and myeloproliferative features and review of the literature.
    Leuk Lymphoma. 2018 Sep;59(9):2233-2237
  • Erdoes G, Dietrich W, Stucki MP, Merz TM, Angelillo-Scherrer A, Nagler M, Carrel T, Eberle B. Short-term recovery pattern of plasma fibrinogen after cardiac surgery: A prospective observational study.
    PLoS One. 2018 Aug 3;13(8):e0201647
  • Lengfelder E, Baerlocher GM, Döhner K, Disslinger H, Griesshammer M, Koschmieder S, Petrides PE. Polycythaemia Vera (PV).
    Onkopedia Leitlinien, ICD10: D45, August 2018
  • Massenblutung nach Knochenmarksbiopsie
    SGAIM Bulletin 38/2018 Komplikationenliste; Juli bis Dezember 2017; 13-14
  • Engel N, Rovo A, Badoglio M, Labopin M, Basak GW, Beguin Y, Guyotat D, Ljungman P, Nagler A, Schattenberg A, Schroeder T, Schroyens W, Tischer J, Socie G, Kolb HJ, Tichelli A, Salooja N, Duarte RF; Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation. European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantation.
    Leukemia. 2018 Jul 26. [Epub ahead of print]
  • Smith SM, Godfrey J, Ahn KW, DiGilio A, Ahmed S, Agrawal V, Bachanova V, Bacher U, Bashey A, Bolaños-Meade J, Cairo M, Chen A, Chhabra S, Copelan E, Dahi PB, Aljurf M, Farooq U, Ganguly S, Hertzberg M, Holmberg L, Inwards D, Kanate AS, Karmali R, Kenkre VP, Kharfan-Dabaja MA, Klein A, Lazarus HM, Mei M, Mussetti A, Nishihori T, Ramakrishnan Geethakumari P, Saad A, Savani BN, Schouten HC, Shah N, Urbano-Ispizua A, Vij R, Vose J, Sureda A, Hamadani M. Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure.
    Cancer. 2018 Jun 15;124(12):2541-2551
  • Kipfer B, Daikeler T, Kuchen S, Hallal M, Andina N, Allam R, Bonadies N. Increased cardiovascular comorbidities in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia presenting with systemic inflammatory and autoimmune manifestations.
    Semin Hematol. 2018 Oct;55(4):242-247
  • Bürki S, Brand B, Escher R, Wuillemin WA, Nagler M. Accuracy, reproducibility and costs of different laboratory assays for the monitoring of unfractionated heparin in clinical practice: a prospective evaluation study and survey among Swiss institutions.
    BMJ Open. 2018 Jun 9;8(6):e022943
  • Junge A, Bacher U, Mueller BU, Keller P, Solenthaler M, Pabst T. Adverse outcome of AML with aberrant CD16 and CD56 NK cell marker expression.
    Hematol Oncol. 2018 Jun 3. [Epub ahead of print]
  • Shumilov E, Flach J, Pabst T, Fiedler M, Angelillo-Scherrer A, Trümper L, Joncourt R, Kohlmann A, Bacher U. Genetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors: Diagnostic challenges in  the era of high-throughput sequencing in hemato-oncology.
    Crit Rev Oncol Hematol. 2018 Jun;126:64-79
  • Lauber S, Limacher A, Tritschler T, Stalder O, Méan M, Righini M, Aschwanden M, Beer JH, Frauchiger B, Osterwalder J, Kucher N, Lämmle B, Cornuz J, Angelillo-Scherrer A, Matter CM, Husmann M, Banyai M, Staub D, Mazzolai L, Hugli O, Rodondi N, Aujesky D. Predictors and Outcomes of Recurrent Venous Thromboembolism in Elderly Patients.
    Am J Med. 2018 Jun;131(6):703.e7-703.e16
  • Porret N, Wiedemann G, Rovó A. NGS-Analysen für Patienten mit Knochenmarksversagen.
    Leading Opinions Hämatologie & Onkologie 6/2018: 9-10
  • Jutzi M, Mansouri Taleghani B, Rueesch M, Amsler l, Buser A. Nationwide Implementation of Pathogen Inactivation for All Platelet Concentrates in Switzerland
    Transfus Med Hemother. 2018 May;45(3)151-156
  • Bacher U, Pabst T. Aktuelle Entwicklungen in der hämato-onkologischen Diagnostik
    JATROS Hämatologie & Onkologie 5/2018
  • Reckhaus J, Jutzi M, Fontana S, Bacher VU, Vogt M, Daskalakis M, Mansouri Taleghani B. Platelet Transfusion Induces Alloimmunization to D and Non-D Rhesus Antigens.
    Transfus Med Hemother. 2018 May;45(3):167-172
  • Floriani C, Feller M, Aubert CE, M'Rabet-Bensalah K, Collet TH, den Elzen WPJ, Bauer DC, Angelillo-Scherrer A, Aujesky D, Rodondi N. Thyroid Dysfunction and Anemia: A Prospective Cohort Study and a Systematic Review.
    Thyroid. 2018 May;28(5):575-582
  • Silzle T, Bonadies N. WHO-Klassifikation und Einsatz
    der «Next-Generation»-Sequenzierung.
    PPM MEDIC 2018 Mai; 22-27
  • Frauchiger DA, Heeb SR, May RD, Wöltje M, Benneker LM, Gantenbein B. Differentiation of MSC and annulus fibrosus cells on genetically engineered silk fleece-membrane-composites enriched for GDF-6 or TGF-β3.
    J Orthop Res. 2018 May;36(5):1324-1333
  • Saussele S, Hehlmann R, Fabarius A, Jeromin S, Proetel U, Rinaldetti S, Kohlbrenner K, Einsele H, Falge C, Kanz L, Neubauer A, Kneba M, Stegelmann F, Pfreundschuh M, Waller CF, Oppliger Leibundgut E, Heim D, Krause SW, Hofmann WK, Hasford J, Pfirrmann M, Müller MC, Hochhaus A, Lauseker M. Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV.
    Leukemia. 2018 May;32(5):1222-1228
  • Shumilov E, Flach J, Kohlmann A, Ban Y, Bonadies N, Fiedler M, Pabst T, Bacher U. Current status and trends in the diagnostics of AML and MDS.
    Blood Rev. 2018 Apr 27. [Epub ahead of print]
  • Shumilov E, Bacher U, Perske C, Mohr A, Eiffert H, Hasenkamp J, Trümper L, Wulf GG, Ströbel P, Ibrahim AS, Venkataramani V. In Situ Validation of the Endothelial Cell Receptor GRP78 in a Case of Rhinocerebral Mucormycosis.
    Antimicrob Agents Chemother. 2018 Apr 26;62(5)
  • Kebriaei P, Anasetti C, Zhang MJ, Wang HL, Aldoss I, de Lima M, Khoury HJ, Sandmaier BM, Horowitz MM, Artz A, Bejanyan N, Ciurea S, Lazarus HM, Gale RP, Litzow M, Bredeson C, Seftel MD, Pulsipher MA, Boelens JJ, Alvarnas J, Champlin R, Forman S, Pullarkat V, Weisdorf D, Marks DI; Acute Leukemia Committee of the CIBMTR (Collaborators: Hogan W, Battiwalla M, Copelan E, Hildebrandt G, Ganguly S, Majhail N, Woolfrey A, Nivison-Smith I, Hertzberg M, Diaz MA, Jakubowski A, Ustun C, Yong A, Freytes C, DeFilipp Z, Inamoto Y, Cahn JY, Savani B, Yared J, Bajel A, Bacher U, Uy G, Rizzieri D, Wieduwilt M, Schultz K, Grunwald M, Kamble R, Qayed M, Brammer J, Ballen K, Khera N, Schouten H, Bierings M, Kanakry C, Wood WA, Saad A, Savoie L, Hamilton BK, Aljurf M, Vij R, Pawarode A, Olsson R, Wirk BM, Beitinjaneh A, Seo S, Cerny J, Akpek G, Norkin M, Nishihori T, Lazaryan A, Sabloff M.). Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia.
    Biol Blood Marrow Transplant. 2018 Apr;24(4):726-733
  • Chennupati V, Veiga DF, Maslowski KM, Andina N, Tardivel A, Yu EC, Stilinovic M, Simillion C, Duchosal MA, Quadroni M, Roberts I, Sankaran VG, MacDonald HR, Fasel N, Angelillo-Scherrer A, Schneider P, Hoang T, Allam R. Ribonuclease inhibitor 1 regulates erythropoiesis by controlling GATA1 translation.
    J Clin Invest. 2018 Apr 2;128(4):1597-1614
  • Gössi U, Jeker B, Mansouri Taleghani B, Bacher U, Novak U, Betticher D, Egger T, Zander T, Pabst T. Prolonged survival after second autologous transplantation and lenalidomide maintenance for salvage treatment of myeloma patients at first relapse after prior autograft.
    Hematol Oncol. 2018 Apr;36(2):436-444
  • Kremer Hovinga JA, Heeb SR, Skowronska M, Schaller M. Pathophysiology of thrombotic thrombocytopenic purpura and hemolytic uremic Syndrome.
    J Thromb Haemost. 2018 Apr;16(4):618-629
  • Andres M, Feller A, Arndt V; NICER Working Group. Trends of incidence, mortality, and survival of multiple myeloma in Switzerland between 1994 and 2013.
    Cancer Epidemiol. 2018 Apr;53:105-110
  • Andres M. Die Ablösung der klassischen Zytostatika durch BCL-2- und BCR-Inhibitoren geht in die nächste Runde.
    Leading Opinions 1/2018: 28-30
  • Bonadies N. Myelodysplastische Syndrome
    info@onkologie_04_2018: 8-14
  • Bonadies N, Bacher U. Implementierung einer Präzisionsmedizin bei Patienten mit MDS und unklaren Zytopenien.
    Leading Opinions 1/2018:18-22
  • Prince R, Bologna L, Manetti M, Melchiorre D, Rosa I, Dewarrat N, Suardi S, Amini P, Fernández JA, Burnier L, Quarroz C, Reina Caro MD, Matsumura Y, Kremer Hovinga JA, Griffin JH, Simon HU, Ibba-Manneschi L, Saller F, Calzavarini S, Angelillo-Scherrer A. Targeting anticoagulant protein S to improve hemostasis in hemophilia.
    Blood. 2018 Mar 22;131(12):1360-1371
  • Njue L, Baerlocher GM. Medikamentös-induzierte Neutropenien/Agranulozytosen.
    der informierte Arzt_02_2018
  • Sauter TC, Eberle B, Wuillemin WA, Thiele T, Angelillo-Scherrer A, Exadaktylos AK, Erdös G, Cuker A, Nagler M. How I manage patients with anticoagulation-associated bleeding or urgent surgery.
    Swiss Med Wkly. 2018 Mar 14;148:w14598
  • Schanz J, Cevik N, Fonatsch C, Braulke F, Shirneshan K, Bacher U, Haase D. Detailed analysis of clonal evolution and cytogenetic evolution patterns in patients with myelodysplastic syndromes (MDS) and related myeloid disorders.
    Blood Cancer J. 2018 Mar 7;8(3):28
  • Passweg JR, Baldomero H, Ansari M, Baerlocher GM, Bargetzi M, Chalandon Y, Duchosal MA, Gerull S, Güngör T, Halter JP, Heim D, Hess U, Leibundgut K, Masouridi-Levrat S, Müller A, Nair G, Pabst T, Renner C, Schmidt A, Stussi G, Nicoloso de Faveri G, Schanz U, For The Swiss Blood Stem Cell Transplantation Group Sbst. Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997-2016.
    Swiss Med Wkly. 2018 Mar 1;148:w14589
  • Nagy M, Mastenbroek TG, Mattheij NJA, de Witt S, Clemetson KJ, Kirschner J, Schulz AS, Vraetz T, Speckmann C, Braun A, Cosemans JMEM, Zieger B, Heemskerk JWM. Variable impairment of platelet functions in patients with severe, genetically linked immune deficiencies.
    Haematologica. 2018 Mar;103(3):540-549
  • Jiménez-Alcazar M, Limacher A, Panda R, Méan M, Bitterling J, Peine S, renné T. Beer JH, Aujesky D, Lämmle B, Fuchs TA. Circulating extracellular DNA is an independent predictor of mortality in elderly patients with venous thromboembolism.
    PLoS One. 2018 Feb 23; 12(2):e0191150
  • Nagler M, Ten Cate H, Prins MH, Ten Cate-Hoek AJ. Risk factors for recurrence in deep vein thrombosis patients following a tailored anticoagulant treatment incorporating residual vein obstruction.
    Res Pract Thromb Haemost. 2018 Feb 3;2(2):299-309
  • Jeker B, Novak U, Mansouri Taleghani B, Baerlocher GM, Seipel K, Mueller BU, Bigler M, Betticher D, Luethi JM, Farese S, Ruefer A, Pabst T. NSAID treatment with meloxicam enhances peripheral stem cell mobilization in myeloma.
    Bone Marrow Transplant. 2018 Feb;53(2):175-179
  • Rovó R. Anämie bei Krebserkrankungen.
    Leading Opinions Hämatologie & Onkologie 2/2018:16-18
  • Sauter TC, Hegazy K, Hautz WE, Krummrey G, Riklin ME, Nagler M, Borner U, Exadaktylos AK. Epistaxis in anticoagulated patients: Fewer hospital admissions and shorter hospital stays on rivaroxaban compared to phenprocoumon.
    Clin Otolaryngol. 2018 Feb;43(1):103-108
  • Oyekunle A, Shumilov E, Kostrewa P, Burchert A, Trümper L, Wuchter P, Wulf G, Bacher U, Kröger N. Chemotherapy-Based Stem Cell Mobilisation Does Not Result in Significant Paraprotein Reduction in Myeloma Patients in the Era of Novel Induction Regimens.
    Biol Blood Marrow Transplant. 2018 Feb;24(2):276-281
  • Schnegg-Kaufmann A, Feller A, Baldomero H, Rovó A, Manz MG, Gregor M, Efthymiou A, Bargetzi M, Hess U, Spertini O, Chalandon Y, Passweg JR, Stussi G, Arndt V, Bonadies N, NICER Working Group. Improvement of relative survival in elderly ptients with acute myeloid leukaemia emerging from population-based cancer registries in Switzerland between 2001 and 2013.
    Cancer Epidemiol. 2018 Feb;52:55-62
  • Volken T, Buser A, Castelli D, Fontana S, Frey BM, Rüsges-Wolter I, Sarraj A, Sigle J, Thierbach J, Weingand T, Taleghani BM. Red blood cell use in Switzerland: trends and demographic challenges.
    Blood Transfus. 2018 Jan;16(1):73-82

2017

  • Berger MD, Heini AD, Seipel K, Mueller B, Angelillo-Scherrer A, Pabst T. Increased fibrinogen levels at diagnosis are associated with adverse outcome in patients with acute myeloid leukemia.
    Hematol Oncol. 2017 Dec;35(4):789-796
  • Mansouri Taleghani B. Kommentar zu Stivala et al.
    Transfusionsmedizin 2017;7:212 (Publikation auf Anfrage verfügbar)
  • Hehlmann R, Lauseker M, Saussele S, Pfirrmann M, Krause S, Kolb HJ, Neubauer A, Hossfeld DK, Nerl C, Gratwohl A, Baerlocher GM, Heim D, Brümmendorf TH, Fabarius A, Haferlach C, Schlegelberger B, Müller MC, Jeromin S, Proetel U, Kohlbrenner K, Voskanyan A, Rinaldetti S, Seifarth W, Spieß B, Balleisen L, Goebeler MC, Hänel M, Ho A, Dengler J, Falge C, Kanz L, Kremers S, Burchert A, Kneba M, Stegelmann F, Köhne CA, Lindemann HW, Waller CF, Pfreundschuh M, Spiekermann K, Berdel WE, Müller L, Edinger M, Mayer J, Beelen DW, Bentz M, Link H, Hertenstein B, Fuchs R, Wernli M, Schlegel F, Schlag R, de Wit M, Trümper L, Hebart H, Hahn M, Thomalla J, Scheid C, Schafhausen P, Verbeek W, Eckart MJ, Gassmann W, Pezzutto A, Schenk M, Brossart P, Geer T, Bildat S, Schäfer E, Hochhaus A, Hasford J. Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.
    Leukemia. 2017 Nov;31(11):2398-2406
  • Hammouda MB, Riahi-Chebbi I, Souid S, Othman H, Aloui Z, Srairi-Abid N, Karoui H, Gasmi A, Magnenat EM, Wells TNC, Clemetson KJ, Rodríguez-López JN, Essafi-Benkhadir K. Macrovipecetin, a C-type lectin from Macrovipera lebetina venom, inhibits proliferation migration and invasion of SK-MEL-28 human melanoma cells and enhances their sensitivity to cisplatin.
    Biochim Biophys Acta. 2017 Nov 28;1862(3):600-614
  • Nagler M, Angelillo-Scherrer A, Méan M, Limacher A, Abbal C, Righini M, Beer JH, Osterwalder J, Frauchiger B, Aschwanden M, Matter CM, Kucher N, Cornuz J, Banyai M, Husmann M, Staub D, Mazzolai L, Hugli O, Rodondi N, Aujesky D. Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists.
    J Thromb Haemost. 2017 Nov;15(11):2165-2175
  • Scully M, Knöbl P, Kentouche K3 Rice L, Windyga J, Schneppenheim R, Kremer Hovinga JA, Kajiwara M, Fujimura Y, Maggiore C, Doralt J, Hibbard C, Martell L, Ewenstein B. A recombinant human ADAMTS-13: first-in-human study evaluating pharmacokinetics, safety and tolerability in cTTP patients.
    Blood. 2017 Nov 9;130(19):2055-2063
  • Oberson JS, Novak U, Mansouri Taleghani B, Baerlocher GM, Seipel K3, Mueller BU, Leibundgut K, Zimmerli S, Pabst T. Revisiting G-CSF Support for Hematologic Recovery after Autologous Transplantation in AML Patients.
    Ann Hematol Oncol. 2017; 4(5): 1148.
  • Méan M, Limacher A, Stalder O, Angelillo-Scherrer A, Alberio L, Fontana P, Beer HJ, Rodondi N, Lämmle B, Aujesky D. Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients?
    Am J Med. 2017 Oct;130(10):1220.e17-1220.e22
  • Trabanelli S, Chevalier MF, Martinez-Usatorre A, Gomez-Cadena A, Salomé B, Lecciso M, Salvestrini V, Verdeil G, Racle J, Papayannidis C, Morita H, Pizzitola I, Grandclément C, Bohner P, Bruni E, Girotra M, Pallavi R, Falvo P, Oppliger Leibundgut  E, Baerlocher GM, Carlo-Stella C, Taurino D, Santoro A, Spinelli O, Rambaldi A, Giarin E, Basso G, Tresoldi C, Ciceri F, Gfeller D, Akdis CA, Mazzarella L, Minucci S, Pelicci PG, Marcenaro E, McKenzie ANJ, Vanhecke D, Coukos G, Mavilio D, Curti A, Derré L, Jandus C. Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis.
    Nat Commun. 2017 Sep 19;8(1):593
  • Bonadies N. Management of Adult Patients with Myelodysplastic Syndromes.
    EMJ Hematol. 2017;5(1):104-112
  • Studt JD, Alberio L, Angelillo-Scherrer A, Asmis LM, Fontana P, Korte W, Mendez A, Schmid P, Stricker H, Tsakiris DA, Wuillemin WA, Nagler M. Accuracy and consistency of anti-Xa activity measurement for determination of rivaroxaban plasma Levels.
    J Thromb Haemost. 2017 Aug;15(8):1576-1583
  • Volken T, Crawford RJ, Amar S, Mosimann E, Tschaggelar A, Mansouri Taleghani B. Blood Group Distribution in Switzerland - a Historical Comparison.
    Transfus Med Hemother. 2017 Aug;44(4):210-216
  • Tichelli A1, Rovó A. Does centre experience matter?
    Br J Haematol. 2017 Aug;178(4):497-498
  • Bulla O, Poncet A, Alberio L, Asmis LM, Gähler A, Graf L, Nagler M, Studt JD, Tsakiris DA, Fontana P. Impact of a product-specific reference standard for the measurement of a PEGylated rFVIII activity: the Swiss Multicentre Field Study.
    Haemophilia. 2017 Jul;23(4):e335-e339
  • Peyvandi F, Scully M, Kremer Hovinga JA, Knöbl P, Cataland S, De Beuf K, Callewaert F, De Winter H, Zeldin RK. Caplacizumab reduces the frequency of major thromboembolic events, exacerbations, and death in patients with acquired thrombotic thrombocytopenic Purpura.
    J Thromb Haemost. 2017 Jul;15(7):1448-1452
  • Diesch T, Rovo A, von der Weid N, Faraci M, Pillon M, Dalissier A, Dalle JH, Bader P. Fertility preservation practices in pediatric and adolescent cancer patients undergoing HSCT in Europe: a population-based Survey.
    Bone Marrow Transplant. 2017 Jul;52(7):1022-1028
  • Hudák R, Vincze J, Csernoch L, Beke Debreceni I, Oláh T, Erdődi F, Clemetson KJ, Kappelmayer J. The Phosphatase Inhibitor Calyculin-A Impairs Clot Retraction, Platelet Activation, and Thrombin Generation.
    Biomed Res Int. 2017;2017:9795271. [Epub 2017 Jun 7]
  • Heuft HG, Fischer E, Weingand T, Burkhardt T, Leitner G, Baume H, Schmidt JP, Buser A, Fauchald G, Reinicke Voigt U, Mansouri-Taleghani B. Donor Safety in Haemapheresis: Development of an Internet-Based Registry for Comprehensive Assessment of Adverse Events from Healthy Donors.
    Transfus Med Hemother. 2017 Jun;44(3):188-200
  • Bankova A, Andres Y, Horn MP, Alberio L, Nagler M. Rapid immunoassays for diagnosis of heparin-induced thrombocytopenia: Comparison of diagnostic accuracy, reproducibility, and costs in clinical practice.
    PLoS One. 2017 Jun 8;12(6):e0178289
  • Ridger VC, Boulanger CM, Angelillo-Scherrer A, Badimon L, Blanc-Brude O, Bochaton-Piallat ML, Boilard E, Buzas EI, Caporali A, Dignat-George F, Evans PC, Lacroix R, Lutgens E, Ketelhuth DFJ, Nieuwland R, Toti F, Tunon J, Weber C. Microvesicles in vascular homeostasis and diseases. Position Paper of the European Society of Cardiology (ESC) Working Group on Atherosclerosis and Vascular Biology.
    Thromb Haemost. 2017 Jun 28;117(7):1296-1316
  • Fontana P, Alberio L, Angelillo-Scherrer A, Asmis LM, Korte W, Mendez A, Schmid P, Stricker H, Studt JD, Tsakiris DA, Wuillemin WA, Nagler M. Impact of rivaroxaban on point-of-care assays.
    Thromb Res. 2017 May;153:65-70
  • Stettler J, Novak U, Baerlocher GM, Seipel K, Mansouri Taleghani B, Pabst T. Autologous stem cell transplantation in elderly patients with multiple myeloma: evaluation of its safety and efficacy.
    Leuk Lymphoma. 2017 May;58(5):1076-1083
  • Blum V, Heini AD, Novak U, Mansouri Taleghani B, Baerlocher GM, Leibundgut K, Seipel K, Banz Y, Bargetzi M, Pabst T. Hematopoietic stem cell remobilization with vinorelbineand filgrastim in AML.
    Bone Marrow Transplant. 2017 May;52(5):786-788
  • Nagler M, Cuker AC. Profile of Instrumentation Laboratory's HemosIL® AcuStar HIT-Ab(PF4-H) assay for diagnosis of heparin-induced thrombocytopenia.
    Expert Rev Mol Diagn. 2017 May;17(5):419-426
  • Adler M, Ivic S, Bodmer NS, Ten Cate H, Bachmann LM, Wuillemin WA, Nagler M. Thromboelastometry and Thrombelastography Analysis under Normal Physiological Conditions - Systematic Review.
    Transfus Med Hemother. 2017 Apr;44(2):78-83
  • Thoennissen GB, Görlich D, Bacher U, Aufenberg T, Hüsken AC, Hansmeier AA, Evers G, Mikesch JH, Fritz F, Bokemeyer C, Müller-Tidow C, Stelljes M, Mesters RM, Krug U, Kropff MH, Thoennissen NH, Berdel WE. Autologous Stem Cell Transplantation in Multiple Myeloma in the Era of Novel Drug Induction: A Retrospective Single-Center Analysis.
    Acta Haematol. 2017;137(3):163-172
  • Page EE, Kremer Hovinga JA, Terrell DR, Vesely SK, George JN. Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015.
    Blood Adv. 2017 Apr 6;1(10):590-600
  • Kremer Hovinga JA, Coppo P, Lämmle B, Moake JL, Miyata T, Vanhoorelbeke K. Thrombotic thromocytopenic Purpura.
  • Gilli S, Novak U, Mansouri Taleghani B, Baerlocher GM, Leibundgut K, Banz Y, Zander T, Betticher D, Egger T, Rauch D, Pabst T. BeEAM conditioning with bendamustine-replacing BCNU before autologous transplantation is safe and effective in lymphoma patients.
    Ann Hematol. 2017 Mar;96(3):421-429
  • Baerlocher GM. Chronische Myeloische Leukämie.
    Hematology Notes 02/2017 Seite 2
  • Heini AD, Berger MD, Seipel K, Mansouri Taleghani B, Baerlocher GM, Leibundgut K, Banz Y, Novak U, Pabst T. Consolidation with autologous stem cell transplantation in first remission is safe and effective in AML patients above 65 years.
  • Armenian SH, Chemaitilly W, Chen M, Chow EJ, Duncan CN, Jones LW, Pulsipher MA, Remaley AT, Rovo A, Salooja N, Battiwalla M. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Cardiovascular Disease and Associated Risk Factors Working Group Report.
    Biol Blood Marrow Transplant. 2017 Feb;23(2):201-210
  • Scully M, Cataland S, Coppo P, de la Rubia J, Friedman KD, Kremer Hovinga J, Lämmle B, Matsumoto M, Pavenski K, Sadler E, Sarode R, Wu H; International Working Group for Thrombotic Thrombocytopenic Purpura. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies.
    J Thromb Haemost. 2017 Feb;15(2):312-322
  • Middendorp SJ, Wilbs J, Quarroz C, Calzavarini S, Angelillo-Scherrer A, Heinis C. Peptide macrocycle inhibitor of coagulation factor XII with subnanomolar affinity and high target selectivity.
    J Med Chem. 2017 Feb 9;60(3):1151-1158
  • Nita I, Hostettler K, Tamo L, Medová M, Bombaci G, Zhong J, Allam R, Zimmer Y, Roth M, Geiser T, Gazdhar A. Hepatocyte growth factor secreted by bone marrow stem cell reduce ER stress and improves repair in alveolar epithelial II cells.
    Sci Rep. 2017 Feb 3;7:41901
  • Faller N, Limacher A, Méan M, Righini M, Aschwanden M, Beer JH, Frauchiger B, Osterwalder J, Kucher N, Lämmle B, Cornuz J, Angelillo-Scherrer A, Matter CM, Husmann M, Banyai M, Staub D, Mazzolai L, Hugli O, Rodondi N, Aujesky D. Predictors and causes of long-term mortality in elderly patients with acute venous thromboembolism: a prospective cohort study.
    Am J Med. 2017 Feb;130(2):198-206
  • Kremer Hovinga JA, Scharf RE. Progress in Haemostasis. From individual patients to pathophysiological insights.
    Hamostaseologie. 2017 Jan 31;37(1):9-11
  • Jenkinson EM, Rodero MP, Kasher PR, Uggenti C, Oojageer A, Goosey LC, Rose Y, Kershaw CJ, Urquhart JE, Williams SG, Bhaskar SS, O'Sullivan J, Baerlocher GM, Haubitz M, Aubert G, Barañano KW, Barnicoat AJ, Battini R, Berger A, Blair EM, Brunstrom-Hernandez JE, Buckard JA, Cassiman DM, Caumes R, Cordelli DM, De Waele LM, Fay AJ, Ferreira P, Fletcher NA, Fryer AE, Goel H, Hemingway CA, Henneke M, Hughes I, Jefferson RJ, Kumar R, Lagae L, Landrieu PG, Lourenço CM, Malpas TJ, Mehta SG, Metz I, Naidu S, Õunap K, Panzer A, Prabhakar P, Quaghebeur G, Schiffmann R, Sherr EH, Sinnathuray KR, Soh C, Stewart HS, Stone J, Van Esch H, Van Mol CE, Vanderver A, Wakeling EL, Whitney A, Pavitt GD, Griffiths-Jones S, Rice GI, Revy P, van der Knaap MS, Livingston JH, O'Keefe RT, Crow YJ. Corrigendum: Mutations in SNORD118 cause the cerebral microangiopathy leukoencephalopathy with calcifications and cysts.
    Nat Genet. 2017 Jan 31;49(2):317
  • Clemetson KJ. The origins of major platelet receptor nomenclature.
    Platelets. 2017 Jan;28(1):40-42
  • Bonadies N, Feller A, Rovo A, Ruefer A, Blum S, Gerber B, Stuessi G, Benz R, Cantoni N, Holbro A, Schmidt A, Lehmann T, Wilk CM, Arndt V; NICER Working Group. Trends of classification, incidence, mortality, and survival of MDS patients in Switzerland between 2001 and 2012.
    Cancer Epidemiol. 2017 Jan 2;46:85-92
  • Mauramo M, Rohde L, Ramseier AM, Rovó A, Waltimo T. Determinants of stimulated salivary flow among haematopoietic stem cell transplantation recipients.
    Clin Oral Investig. 2017 Jan;21(1):121-126

2016

  • Angelillo-Scherrer A, Nagler M. Thrombophilieabklärung.
    Ther Umsch. 2016;73(10):626-634
  • Bonadies N, Rüfer A. Diagnostik und Therapie myelodysplastischer Syndrome.
    Schweizer Zeitschrift für Onkologie 2016/4:28-36
  • Volken T, Bänziger A, Buser A, Castelli D, Fontana S, Frey BM, Sarraj A, Sigle J, Thierbach J, Weingand T, Mansouri Taleghani B. Too Many Blood Donors - Response Bias in the Swiss Health Survey 2012.
    Transfus Med Hemother. 2016 Nov;43(6):400-406
  • Kölm R, Schaller M, Roumenina LT, Niemiec I, Kremer Hovinga JA, Khanicheh E, Kaufmann BA, Hopfer H, Trendelenburg M. Von Willebrand Factor Interacts with Surface-Bound C1q and Induces Platelet Rolling.
    J Immunol. 2016 Nov 1;197(9):3669-3679
  • Keller P, Rufener J, Schild C, Fedosov SN, Nissen PH, Nexo E. False low holotranscobalamin levels in a patient with a novel TCN2 mutation.
    Clin Chem Lab Med. 2016 Nov 1;54(11):1739-1743
  • Schaefer C, Wuillemin WA, Kessels A, Jacobson A, Nagler M. Predictors of anticoagulation quality in 15 834 patients performing patient self-management of oral anticoagulation with vitamin K antagonists in real-life practice: a survey of the International Self-Monitoring Association of Orally Anticoagulated Patients.
  • Jenkinson EM, Rodero MP, Kasher PR, Uggenti C, Oojageer A, Goosey LC, Rose Y, Kershaw CJ, Urquhart JE, Williams SG, Bhaskar SS, O'Sullivan J, Baerlocher GM, Haubitz M, Aubert G, Barañano KW, Barnicoat AJ, Battini R, Berger A, Blair EM, Brunstrom-Hernandez JE, Buckard JA, Cassiman DM, Caumes R, Cordelli DM, De Waele LM, Fay AJ, Ferreira P, Fletcher NA, Fryer AE, Goel H, Hemingway CA, Henneke M, Hughes I, Jefferson RJ, Kumar R, Lagae L, Landrieu PG, Lourenço CM, Malpas TJ, Mehta SG, Metz I, Naidu S, Õunap K, Panzer A, Prabhakar P, Quaghebeur G, Schiffmann R, Sherr EH, Sinnathuray KR, Soh C, Stewart HS, Stone J, Van Esch H, Van Mol CE, Vanderver A, Wakeling EL, Whitney A, Pavitt GD, Griffiths-Jones S, Rice GI, Revy P, van der Knaap MS, Livingston JH, O'Keefe RT, Crow YJ. Mutations in SNORD118 cause the cerebral microangiopathy leukoencephalopathy with calcifications and cysts.
    Nat Genet. 2016 Oct;48(10):1185-92
  • Diesch T, von der Weid NX, Szinnai G, Schaedelin S, De Geyter C, Rovó A; Swiss Pediatric Oncology Group SPOG. Fertility preservation in pediatric and adolescent cancer patients in Switzerland: A qualitative cross-sectional Survey.
    Cancer Epidemiol. 2016 Oct;44:141-146
  • Nagler M, Bakchoul T. Clinical and laboratory tests for the diagnosis of heparin-induced thrombocytopenia.
    Thromb Haemost. 2016 Oct 28;116(5):823-834
  • Page EE, Kremer Hovinga JA, Terrell DR, Vesely SK, George JN. Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic Purpura.
    Blood. 2016 Oct 27;128(17):2175-2178
  • Stalder G, Que YA, Calzavarini S, Burnier L, Kosinski C, Ballabeni P, Roger T, Calandra T, Duchosal MA, Liaudet L, Eggimann P, Angelillo-Scherrer A. Study of Early Elevated Gas6 Plasma Level as a Predictor of Mortality in a Prospective Cohort of Patients with Sepsis.
    PLoS One. 2016 Oct 27;11(10):e0163542
  • Volken T, Buser A, Castelli D, Fontana S, Frey BM, Rüsges-Wolter I, Sarraj A, Sigle J, Thierbach J, Weingand T, Mansouri Taleghani B. Red blood cell use in Switzerland: trends and demographic challenges.
    Blood Transfus. 2016 Sep 30:1-10
  • Nagler M, Kremer Hovinga JA, Alberio L, Peter-Salonen K, von Tengg-Kobligk H, Lottaz D, Neerman-Arbez M, Lämmle B. Thromboembolism in patients with congenital afibrinogenaemia. Long-term observational data and systematic review.
    Thromb Haemost. 2016 Sep 27;116(4):722-32
  • Nagler M, Angelillo-Scherrer A. Thromboembolien und Thrombophilie in der Schwangerschaft.
    Therapeutische Umschau 2016;73(7):377-383
  • Berger MD, Branger G, Klaeser B, Mansouri Taleghani B, Novak U, Banz Y, Mueller BU, Pabst T. Zevalin and BEAM (Z-BEAM) versus rituximab and BEAM (R-BEAM) conditioning chemotherapy prior to autologous stem cell transplantation in patients with mantle cell lymphoma.
    Hematol Oncol. 2016 Sep;34(3):133-9
  • Pavenski K, Cataland S, Kremer Hovinga JA, Thomas M, Vanhoorelbeke K. Thrombotic Thrombocytopenic Pupura (TTP) Dinner Symposium Proceedings.
    Expert Rev Hematol. 2016 Aug;9(8):733-5
  • Sauter TC, Blum S, Nagler M, Schlittler FL, Ricklin ME, Exadaktylos AK. Reversal of Dabigatran Using Idarucizumab in a Septic Patient with Impaired Kidney Function in Real-Life Practice.
    Case Rep Emerg Med. 2016;2016:1393057. [Epub 2016 Jul 27]
  • Schneider-Gold C, Krenzer M, Klinker E, Mansouri Taleghani B, Müllges W, Toyka KV, Gold R. Immunoadsorption versus plasma exchange versus combination for treatment of myasthenic Deterioration.
    Ther Adv Neurol Disord. 2016 Jul;9(4):297-303
  • Wagner AM, Krenger W, Stettler S, Beutler E, Herbst J, Surbek DV, Baerlocher GM. A novel, bedside technique to rapidly identify umbilical cord blood units with high total nucleated cell numbers.
    Transfusion. 2016 Jun;56(6):1406-12
  • Page EE, Kremer Hovinga JA, Terrell DR, Vesely SK, George JN. Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura.
    Blood. 2016 Jun 16;127(24):3092-4
  • Pedrazzini G, Biasco L, Sulzer I, Anesini A, Moccetti T, Kremer Hovinga JA, Alberio L. Acquired intracoronary ADAMTS13 deficiency and VWF retention at sites of critical coronary stenosis in patients with STEMI.
    Blood. 2016 Jun 9;127(23):2934-6
  • Rovó A, Tichelli A. Current approach for the diagnosis of Aplastic Anemia.
    Curr Drug Targets. 2016 Jun 6. [Epub ahead of print]
  • Miranda MB, Lauseker M, Kraus MP, Proetel U, Hanfstein B, Fabarius A, Baerlocher GM, Heim D, Hossfeld DK, Kolb HJ, Krause SW, Nerl C, Brümmendorf TH, Verbeek W, Fauser AA, Prümmer O, Neben K, Hess U, Mahlberg R, Plöger C, Flasshove M, Rendenbach B, Hofmann WK, Müller MC, Pfirrmann M, Hochhaus A, Hasford J, Hehlmann R, Saußele S. Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV.
    Leukemia. 2016 Jun;30(6):1255-62
  • Happonen KE, Tran S, Morgelin M, Prince R, Calzavarini S, Angelillo-Scherrer A, Dahlback B. The Gas6-Axl Interaction Mediates Endothelial Uptake of Platelet Microparticles.
    J Biol Chem. 2016 May 13;291(20):10586-601
  • Gowland P, Fontana S, Stolz M, Andina N, Niederhauser C. Parvovirus B19 Passive Transmission by Transfusion of Intercept® Blood System-Treated Platelet Concentrate.
    Transfus Med Hemother. 2016 May;43(3):198-202
  • Mueller BU, Keller S, Seipel K, Mansouri Taleghani B, Rauch D, Betticher D, Egger T, Pabst T. Stem cell mobilization chemotherapy with gemcitabine is effective and safe in myeloma patients with bortezomib induced neurotoxicity.
    Leuk Lymphoma. 2016 May;57(5):1122-9
  • Segna D, Méan M, Limacher A, Baumgartner C, Blum MR, Beer JH, Kucher N, Righini M, Matter CM, Frauchiger B, Cornuz J, Aschwanden M, Banyai M, Osterwalder J, Husmann M, Egloff M, Staub D, Lämmle B, Angelillo-Scherrer A, Aujesky D, Rodondi N. Association between thyroid dysfunction and venous thromboembolism in the elderly: a prospective cohort study.
    J Thromb Haemost. 2016 Apr;14(4):685-94
  • Michel P, Angelillo-Scherrer A, Maeder P,  Binaghi S,  Meyer IA, Correia P. Stenting as a treatment for exercise-induced intracranial hypertension from bilateral jugular vein obstruction.
    Neurol Clin Pract. 2016 Apr;6(2):e10-e13
  • M'Rabet-Bensalah K, Aubert CE, Coslovsky M, Collet TH, Baumgartner C, den Elzen WP, Luben R, Angelillo-Scherrer A, Aujesky D, Khaw KT, Rodondi N. Thyroid dysfunction and anaemia in a large population-based study.
    Clin Endocrinol (Oxf). 2016 Apr;84(4):627-31
  • Gratwohl A, Pfirrmann M, Zander A, Kröger N, Beelen D, Novotny J, Nerl C, Scheid C, Spiekermann K, Mayer J, Sayer HG, Falge C, Bunjes D, Döhner H, Ganser A, Schmidt-Wolf I, Schwerdtfeger R, Baurmann H, Kuse R, Schmitz N, Wehmeier A, Fischer JT, Ho AD, Wilhelm M, Goebeler ME, Lindemann HW, Bormann M, Hertenstein B, Schlimok G, Baerlocher GM, Aul C, Pfreundschuh M, Fabian M, Staib P, Edinger M, Schatz M, Fauser A, Arnold R, Kindler T, Wulf G, Rosselet A, Hellmann A, Schäfer E, Prümmer O, Schenk M, Hasford J, Heimpel H, Hossfeld DK, Kolb HJ, Büsche G, Haferlach C, Schnittger S, Müller MC, Reiter A, Berger U, Saußele S, Hochhaus A, Hehlmann R. Long-term outcome of patients with newly diagnosed chronic myeloid leukemia-A randomized comparison of stem cell transplantation with drug treatment.
    Leukemia. 2016 Mar;30(3):562-9
  • Sellmann L, Scholtysik R, de Beer D, Eisele L, Klein-Hitpass L, Nückel H, Dührsen U, Dürig J, Röth A, Baerlocher GM. Shorter telomeres correlate with an increase in the number of uniparental disomies in patients with chronic lymphocytic leukemia.
    Leuk Lymphoma. 2016 Mar;57(3):590-5
  • Fan X, Kremer Hovinga JA, Shirotani-Ikejima H, Eura Y, Hirai H, Honda S, Kokame K, Taleghani MM, von Krogh AS, Yoshida Y, Fujimura Y, Lämmle B, Miyata T. Genetic variations in complement factors in patients with congenital thrombotic thrombocytopenic purpura with renal insufficiency.
    Int J Hematol. 2016 Mar;103(3):283-91
  • Insam C, Méan M, Limacher A, Angelillo-Scherrer A, Aschwanden M, Banyai M, Beer JH, Bounameaux H, Egloff M, Frauchiger B, Husmann M, Kucher N, Lämmle B, Matter C, Osterwalder J, Righini M, Staub D, Rodondi N, Aujesky D. Anticoagulation Management Practices and Outcomes in Elderly Patients with Acute Venous Thromboembolism: A Clinical Research Study.
    PLoS One. 2016 Feb 23;11(2):e0148348
  • Peyvandi F, Scully M, Kremer Hovinga JA, Cataland S, Knöbl P, Wu H, Artoni A, Westwood JP, Mansouri Taleghani M, Jilma B, Callewaert F, Ulrichts H, Duby C, Tersago D; TITAN Investigators. Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.
    N Engl J Med. 2016 Feb 11;374(6):511-22
  • Nagler M, Bachmann LM, Ten Cate H, Ten Cate-Hoek A. Diagnostic value of immunoassays for heparin-induced thrombocytopenia: a systematic review and meta-analysis.
    Blood. 2016 Feb 4;127(5):546-57
  • Engert A, Balduini C, Brand A, Coiffier B, Cordonnier C, Döhner H, Duyvené de Wit T, Eichinger S, Fibbe W, Green T, de Haas F, Iolascon A, Jaffredo T, Rodeghiero F, Salles G, Schuringa JJ and the other authors of the EHA Roadmap for European Hematology Research (including Kremer Hovinga JA). The European Hematology Association Roadmap for European Hematology Research: a consensus document.
    Haematologica. 2016 Feb;101(2):115-208
  • von Krogh AS, Quist-Paulsen P, Waage A, Langseth ØO, Thorstensen K, Brudevold R, Tjønnfjord GE, Largiadèr CR, Lämmle B, Kremer Hovinga JA. High prevalence of hereditary thrombotic thrombocytopenic purpura in central Norway: from clinical observation to evidence.
    J Thromb Haemost. 2016 Jan;14(1):73-82
  • Kremer Hovinga JA. Schlaglicht Hämatologie 2015: 111 Jahre nach Alexei Nikolajewitsch Romanow – Heilung für schwere Hämophilie B in Sicht.
    Swiss Med Forum 2016;1:9-11
  • Kremer Hovinga JA. Highlights Hématologie 2015: 111 années après Alexis Nikolaïevitch Romanov, guérison de l’hémophilie B sévère en perspective.
    Swiss Med Forum 2016;1:9-11

    2015

    • Bertuch AA, Baerlocher GM, Alter BP. Chapter 3: Diagnosing Dyskeratosis and Related Telomere Biology Disorders in the Book Dyskeratosis Congenita and Telomere Biology Disorders.
      Diagnosis and Management Guidelines, First Edition 2015, Editors Sharon Savage, MD, and Elisabeth Cook, MD
    • Li Z, Mewawalla P, Stratton P, Yong AS, Shaw BE, Hashmi S, Jagasia M, Mohty M, Majhail NS, Savani BN, Rovó A. Sexual health in hematopoietic stem cell transplant recipients.
      Cancer. 2015 Dec 1;121(23):4124-31
    • Baerlocher GM, Burington B, Snyder DS. Telomerase Inhibitor Imetelstat in Essential Thrombocythemia and Myelofibrosis.
      N Engl J Med. 2015 Dec 24;373(26):2580
    • Dufour C, Veys P, Carraro E, Bhatnagar N, Pillon M, Wynn R, Gibson B, Vora AJ, Steward CG, Ewins AM, Hough RE, de la Fuente J, Velangi M, Amrolia PJ, Skinner R, Bacigalupo A, Risitano AM, Socie G, Peffault de Latour R, Passweg J, Rovo A, Tichelli A, Schrezenmeier H, Hochsmann B, Bader P, van Biezen A, Aljurf MD, Kulesekararaj A, Marsh JC, Samarasinghe S. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.
      Br J Haematol. 2015 Nov;171(4):585-94
    • Alberio L. Do we need antiplatelet therapy in thrombocytosis? Pro. Diagnostic and pathophysiologic considerations for a treatment choice.
      Hamostaseologie. 2016 Nov 7;36(4):227-240
    • Langabeer SE, Andrikovics H, Asp J, Bellosillo B, Carillo S, Haslam K, Kjaer L, Lippert E, Mansier O, Oppliger Leibundgut E, Percy MJ, Porret N, Palmqvist L, Schwarz J, McMullin MF, Schnittger S, Pallisgaard N, Hermouet S; MPN&MPNr-EuroNet. Molecular diagnostics of myeloproliferative neoplasms.
      Eur J Haematol. 2015 Oct;95(4):270-9
    • Stuehler C, Stüssi G, Halter J, Nowakowska J, Schibli A, Battegay M, Dirks J, Passweg J, Heim D, Rovo A, Kalberer C, Bucher C, Weisser M, Dumoulin A, Hirsch HH, Khanna N. Combination therapy for multidrug-resistant cytomegalovirus disease.
      Transpl Infect Dis. 2015 Oct;17(5):751-5
    • Gautschi O, Mach N, Rothschild SI, Li Q, Stahel RA, Zippelius A, Cathomas R, Früh M, Betticher DC, Peters S, Rauch D, Feilchenfeldt J, Bubendorf L, Savic S, Jaggi R, Oppgliger Leibundgut E, Largiadèr C, Brutsche M, Pilop C, Stalder L, Pless M, Ochsenbein AF; Swiss Group for Clinical Cancer Research. Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non-Small-Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation: Phase II Trial SAKK19/09.
      Clin Lung Cancer. 2015 Sep;16(5):358-65
    • Baerlocher GM, Oppliger Leibundgut E, Ottmann OG, Spitzer G, Odenike O, McDevitt MA, Röth A, Daskalakis M, Burington B, Stuart M, Snyder DS. Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia.
      N Engl J Med. 2015 Sep 3;373(10):920-8
    • Armanios M, Greider CW. Treating Myeloproliferation--On Target or Off?
      N Engl J Med. 2015 Sep 3;373(10):965-6
      Editorial zu Publikation
      N Engl J Med. 2015 Sep 3;373(10):920-8
    • von Krogh AS, Kremer Hovinga JA, Romundstad PR, Roten LT, Lämmle B, Waage A, Quist-Paulsen P. ADAMTS13 gene variants and function in women with preeclampsia: a population- based nested case- control study from the HUNT Study.
      Thromb Res. 2015 Aug;136(2):282-8
    • Baeriswyl V, Calzavarini S, Chen S, Zorzi A, Bologna L, Angelillo-Scherrer A, Heinis C. A Synthetic Factor XIIa Inhibitor Blocks Selectively Intrinsic Coagulation Initiation.
      ACS Chem Biol. 2015 Aug 21;10(8):1861-70
    • Adler M, Nagler M. Adherence to treatment with non-vitamin K antagonist anticoagulants: once- vs. twice-daily regimens.
      Europace. 2015 Aug;17(8):1316
    • Riether C, Schürch CM, Flury C, Hinterbrandner M, Drück L, Huguenin AL, Baerlocher GM, Radpour R, Ochsenbein AF. Tyrosine kinase inhibitor-induced CD70 expression mediates drug resistance in leukemia stem cells by activating Wnt signaling.
      Sci Transl Med. 2015 Jul 29;7(298):298ra119
    • Bonadies N, Göttgens B, Calero-Nieto FJ. The LMO2 -25 Region Harbours GATA2-Dependent Myeloid Enhancer and RUNX-Dependent T-Lymphoid Repressor Activity.
      PLoS One. 2015 Jul 10;10(7):e0131577
    • Keller S, Seipel K, Novak U, Mueller BU, Mansouri Taleghani B, Leibundgut K, Pabst T. Neurotoxicity of stem cell mobilization chemotherapy with vinorelbine in myeloma patients after bortezomib treatment.
      Leuk Res. 2015 Jul;39(7):786-92
    • Saussele S, Krauss MP, Hehlmann R, Lauseker M, Proetel U, Kalmanti L, Hanfstein B, Fabarius A, Kraemer D, Berdel WE, Bentz M, Staib P, de Wit M, Wernli M, Zettl F, Hebart HF, Hahn M, Heymanns J, Schmidt-Wolf I, Schmitz N, Eckart MJ, Gassmann W, Bartholomäus A, Pezzutto A, Oppliger Leibundgut E, Heim D, Krause SW, Burchert A, Hofmann WK, Hasford J, Hochhaus A, Pfirrmann M, Müller MC; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung and the German CML Study Group. Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV.
      Blood. 2015 Jul 2;126(1):42-9
    • Haaß W, Kleiner H, Weiß C, Haferlach C, Schlegelberger B, Müller MC, Hehlmann R, Hofmann WK, Fabarius A, Seifarth W; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung; German CML Study Group (including Lämmle B, Baerlocher G, Oppliger Leibundgut E, Tobler A). Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy.
      PLoS One. 2015 Jun 18;10(6):e0129648
    • Hubbard AR, Heath AB, Kremer Hovinga JA; Subcommittee on von Willebrand Factor. Establishment of the WHO 1st International StandardADAMTS13, plasma (12/252): communication from the SSC of the ISTH.
      J Thromb Haemost. 2015 Jun;13(6):1151-3
    • Jenny L, Dobó J, Gál P, Schroeder V. MASP-1 of the complement system promotes clotting via prothrombin activation.
      Mol Immunol. 2015 Jun;65(2):398-405
    • Cross NC, White HE, Colomer D, Ehrencrona H, Foroni L, Gottardi E, Lange T, Lion T, Machova Polakova K, Dulucq S, Martinelli G, Oppliger Leibundgut E, Pallisgaard N, Barbany G, Sacha T, Talmaci R, Izzo B, Saglio G, Pane F, Müller MC, Hochhaus A. Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia.
      Leukemia. 2015 May;29(5):999-1003
    • Kalmanti L, Saussele S, Lauseker M, Müller MC, Dietz CT, Heinrich L, Hanfstein B, Proetel U, Fabarius A, Krause SW, Rinaldetti S, Dengler J, Falge C, Oppliger Leibundgut E, Burchert A, Neubauer A, Kanz L, Stegelmann F, Pfreundschuh M, Spiekermann K, Scheid C, Pfirrmann M, Hochhaus A, Hasford J, Hehlmann R. Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV.
      Leukemia. 2015 May;29(5):1123-32
    • Eggimann L, Girsberger S, Halter J, Gerull S, Tichelli A, Baldomero H, Heim D, Passweg J, Rovó A. Kinetics of peripheral blood chimerism for surveillance of patients with leukemia and chronic myeloid malignancies after reduced-intensity conditioning allogeneic hematopoietic SCT.
      Bone Marrow Transplant. 2015 May;50(5):743-5
    • Clemetson KJ. Platelet receptors and patient responses: The contributions of Professor Stan Heptinstall to platelet research.
      Platelets. 2015;26(5):382-5
    • Dufour C, Pillon M, Sociè G, Rovó A, Carraro E, Bacigalupo A, Oneto R, Passweg J, Risitano A, Tichelli A, Peffault de Latour R, Schrezenmeier H, Hocshmann B, Peters C, Kulasekararaj A, Van Biezen A, Samarasinghe S, Hussein AA, Ayas M, Aljurf M, Marsh J. Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant.
      Br J Haematol. 2015 May;169(4):565-73
    • Nurden AT, Pillois X, Fiore M, Alessi MC, Bonduel M, Dreyfus M, Goudemand J, Gruel Y, Benabdallah-Guerida S, Latger-Cannard V, Négrier C, Nugent D, d'Oiron R, Rand ML, Sié P, Trossaert M, Alberio L, Martins N, Sirvain-Trukniewicz P, Couloux A, Canault M, Fronthroth JP, Fretigny M, Nurden P, Heilig R, Vinciguerra C. Expanding the Mutation Spectrum Affecting alphaIIbbeta3 Integrin in Glanzmann Thrombasthenia: Screening of the ITGA2B and ITGB3 Genes in a Large International Cohort.
      Hum Mutat. 2015 May;36(5):548-61
    • Jiménez-Alcázar M, Napirei M, Panda R, Köhler EC, Kremer-Hovinga JA, Mannherz HG, Peine S, Renné T, Lämmle B, Fuchs TA. Impaired DNase1-mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies.
      J Thromb Haemost. 2015 May;13(5):732-42
    • Arni D, Gumy-Pause F, Ansari M, Kremer Hovinga JA, McLin VA. Successful liver transplantation in a child with acute-on-chronic liver failure and acquired thrombotic thrombocytopenic purpura.
      Liver Transpl. 2015 May;21(5):704-6
    • Mathivanan I, Trepp C, Brunold C, Baerlocher G, Enzmann V. Retinal differentiation of human bone marrow-derived stem cells by co-culture with retinal pigment epithelium in vitro.
      Exp Cell Res. 2015 Apr 10;333(1):11-20
    • Kamber C, Zimmerli S, Suter-Riniker F, Mueller BU, Mansouri Taleghani B, Betticher D, Zander T, Pabst T. Varicella zoster virus reactivation after autologous SCT is a frequent event and associated with favorable outcome in myeloma patients.
      Bone Marrow Transplant. 2015 Apr;50(4):573-8
    • Nagler M, Surbek D, Angelillo-Scherrer A. Thrombophilie in Schwangerschaft und Wochenbett.
      Gynäkologie 2/2015:6-13
    • Priovolos A, Neerman-Arbez M, Morris M, Angelillo-Scherrer A, Nötzli J. Dysfibrinogenaemia associated with a novel heterozygous mutation in FGB (c.680delG) and a mild clinical history of bleeding.
      Blood Coagul Fibrinolysis. 2015 Mar;26(2):231-2
    • Allam R, Maillard MH, Tardivel A, Chennupati V, Bega H, Yu CW, Velin D, Schneider P, Maslowski KM. Epithelial NAIPs protect against colonic tumorigenesis.
      J Exp Med. 2015 Mar 9;212(3):369-83
    • van Geffen JP, Kleinegris MC, Verdoold R, Baaten CC, Cosemans JM, Clemetson KJ, Ten Cate H, Roest M, de Laat B, Heemskerk JW. Normal platelet activation profile in patients with peripheral arterial disease on aspirin.
      Thromb Res. 2015 Mar;135(3):513-20
    • Schmid A, Friess D, Mansouri Taleghani B, Keller P, Mueller BU, Baerlocher GM, Leibundgut K, Pabst T. Role of plerixafor in autologous stem cell mobilization with vinorelbine chemotherapy and granulocyte-colony stimulating factor in patients with myeloma: a phase II study (PAV-trial).
      Leuk Lymphoma. 2015 Mar;56(3):608-14
    • Schroeder V, Handrková H, Dodt J, Kohler HP. Free factor XIII activation peptide affects factor XIII function.
      Br J Haematol. 2015 Mar;168(5):757-9
    • de Beer D, Völzmann J, Kalka C, Baerlocher GM. Longitudinal Telomere Erosion in Lymphocyte Subsets of Patients with Atherosclerotic Peripheral Arterial Disease (PAD).
      J Clin Diagn Res. 2015 Mar;9(3):OM01-3
    • White H, Deprez L, Corbisier P, Hall V, Lin F, Mazoua S, Trapmann S, Aggerholm A, Andrikovics H, Akiki S, Barbany G, Boeckx N, Bench A, Catherwood M, Cayuela JM, Chudleigh S, Clench T, Colomer D, Daraio F, Dulucq S, Farrugia J, Fletcher L, Foroni L, Ganderton R, Gerrard G, Gineikienė E, Hayette S, El Housni H, Izzo B, Jansson M, Johnels P, Jurcek T, Kairisto V, Kizilors A, Kim DW, Lange T, Lion T, Polakova KM, Martinelli G, McCarron S, Merle PA, Milner B, Mitterbauer-Hohendanner G, Nagar M, Nickless G, Nomdedéu J, Nymoen DA, Oppliger Leibundgut E, Ozbek U, Pajič T, Pfeifer H, Preudhomme C, Raudsepp K, Romeo G, Sacha T, Talmaci R, Touloumenidou T, Van der Velden VH, Waits P, Wang L, Wilkinson E, Wilson G, Wren D, Zadro R, Ziermann J, Zoi K, Müller MC, Hochhaus A, Schimmel H, Cross NC, Emons H. A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR.
      Leukemia. 2015 Feb;29(2):369-76
    • Frey PM, Méan M, Limacher A, Jaeger K, Beer HJ, Frauchiger B, Aschwanden M, Rodondi N, Righini M, Egloff M, Osterwalder J, Kucher N, Angelillo-Scherrer A, Husmann M, Banyai M, Matter CM, Aujesky D. Physical activity and risk of bleeding in elderly patients taking anticoagulants.
      J Thromb Haemost. 2015 Feb;13(2):197-205
    • Edgar CE, Terrell DR, Vesely SK, Wren JD, Dozmorov IM, Niewold TB, Brown M, Zhou F, Frank MB, Merrill JT, Kremer Hovinga JA, Lämmle B, James JA, George JN, Farris AD. Ribosomal and Immune Transcripts Associate with Relapse in Acquired ADAMTS13-Deficient Thrombotic Thrombocytopenic Purpura.
      PLoS One. 2015 Feb 11;10(2):e0117614
    • von Auer C, von Krogh AS, Kremer Hovinga JA, Lämmle B. Current insights into thrombotic microangiopathies: Thrombotic thrombocytopenic purpura and pregnancy.
      Thromb Res. 2015 Feb;135 Suppl 1:S30-3
    • Wetzel D, Mueller BU, Mansouri Taleghani B, Baerlocher GM, Seipel K, Leibundgut K, Pabst T. Delayed Haematological recovery after autologous stem cell transplantation is associated with favourable outcome in acute myeloid leukaemia.
      Br J Haematol. 2015 Jan;168(2):268-73
    • Leiss W, Méan M, Limacher A, Righini M, Jaeger K, Beer HJ, Osterwalder J, Frauchiger B, Matter CM, Kucher N, Angelillo-Scherrer A, Cornuz J, Banyai M, Lämmle B, Husmann M, Egloff M, Aschwanden M, Rodondi N, Aujesky D. Polypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolism.
      J Gen Intern Med. 2015 Jan;30(1):17-24
    • Raval JS, Padmanabhan A, Kremer Hovinga JA, Kiss JE. Development of a clinically significant ADAMTS13 inhibitor in a patient with hereditary thrombotic thrombocytopenic purpura.
      Am J Hematol. 2015 Jan;90(1):E22

    2014

    • Jenny L, Ajjan R, King R, Thiel S, Schroeder V. Plasma Levels of MASP-1 and MASP-2 are Elevated in Type 1 Diabetes and Correlate with Glycaemic Control.
      Clin Exp Immunol. 2014 Dec 23
    • Gotta V, Widmer N, Decosterd LA, Chalandon Y, Heim D, Gregor M, Benz R, Leoncini-Franscini L, Baerlocher GM, Duchosal MA, Csajka C, Buclin T. Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trial.
      Cancer Chemother Pharmacol. 2014 Dec;74(6):1307-19
    • Nagler M, Angelillo-Scherrer A. Diagnostic value of the 4Ts score for heparin-induced thrombocytopenia in the critically ill.
      J Crit Care. 2014 Dec;29(6):1126-7
    • Adler M, Kremer Hovinga JA, Lämmle B. Le purpura thrombotique thrombocytopénique - un diagnostic méconnu.
      Rev Med Suisse 2014;10:2280-2284
    • Schaller M, Vogel M, Kentouche K, Lämmle B, Kremer Hovinga JA. The splenic autoimmune response to ADAMTS13 in thrombotic thrombocytopenic purpura contains recurrent antigen-binding CDR3 motifs.
      Blood. 2014 Nov 27;124(23):3469-79
    • Stroka D, Keogh A, Vu D, Fort A, Stoffel MH, Kühni-Boghenbor K, Furer C, Banz V, Demarmels Biasiutti F, Lämmle B, Candinas D, Neerman-Arbez M. In vitro rescue of FGA deletion by lentiviral transduction of an afibrinogenemic patient's hepatocytes.
      J Thromb Haemost. 2014 Nov;12(11):1874-9
    • Daskalakis M, Colucci G, Keller P, Rochat S, Silzle T, Demarmels Biasiutti F, Barizzi G, Alberio L. Decreased generation of procoagulant platelets detected by flow cytometric analysis in patients with bleeding diathesis.
      Cytometry B Clin Cytom. 2014 Nov;86(6):397-409
    • Nagler M, Ten Cate H. Thromboelastometry changes in myeloproliferative neoplasms-surrogate for a procoagulant haemostatic imbalance or a consequence of technical reasons? : Comment on A. Tripodi et al. Ann Hematol (2013) 92:1633-1639.
      Ann Hematol. 2014 Oct;93(10):1781-2
    • Dobó J, Schroeder V, Jenny L, Cervenak L, Závodszky P, Gál P. Multiple roles of complement MASP-1 at the interface of innate immune response and coagulation.
      Mol Immunol. 2014 Oct;61(2):69-78
    • Hanfstein B, Shlyakhto V, Lauseker M, Hehlmann R, Saussele S, Dietz C, Erben P, Fabarius A, Proetel U, Schnittger S, Krause SW, Schubert J, Einsele H, Hänel M, Dengler J, Falge C, Kanz L, Neubauer A, Kneba M, Stegelmann F, Pfreundschuh M, Waller CF, Spiekermann K, Baerlocher GM, Pfirrmann M, Hasford J, Hofmann WK, Hochhaus A, Müller MC; SAKK and the German CML Study Group. Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib.
      Leukemia. 2014 Oct;28(10):1988-92
    • Hanfstein B, Lauseker M, Hehlmann R, Saussele S, Erben P, Dietz C, Fabarius A, Proetel U, Schnittger S, Haferlach C, Krause SW, Schubert J, Einsele H, Hänel M, Dengler J, Falge C, Kanz L, Neubauer A, Kneba M, Stegelmann F, Pfreundschuh M, Waller CF, Spiekermann K, Baerlocher GM, Pfirrmann M, Hasford J, Hofmann WK, Hochhaus A, Müller MC; SAKK and the German CML Study Group. Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib.
      Haematologica. 2014 Sep;99(9):1441-7
    • Hess K, Alzahrani SH, Price JF, Strachan MW, Oxley N, King R, Gamlen T, Schroeder V, Baxter PD, Ajjan RA. Hypofibrinolysis in type 2 diabetes: the role of the inflammatory pathway and complement C3.
    • Falter T, Kremer Hovinga JA, Lackner K, Füllemann HG, Lämmle B, Scharrer I. Late onset and pregnancy-induced congenital thrombotic thrombocytopenic purpura.
      Hamostaseologie. 2014 Aug 5;34(3):244-8
    • Proetel U, Pletsch N, Lauseker M, Müller MC, Hanfstein B, Krause SW, Kalmanti L, Schreiber A, Heim D, Baerlocher GM, Hofmann WK, Lange E, Einsele H, Wernli M, Kremers S, Schlag R, Müller L, Hänel M, Link H, Hertenstein B, Pfirrman M, Hochhaus A, Hasford J, Hehlmann R, Saußele S; German Chronic Myeloid Leukemia Study Group; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung (SAKK). Older patients with chronic myeloid leukemia (>=65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV.
      Ann Hematol. 2014 Jul;93(7):1167-76
    • de Witt SM, Swieringa F, Cavill R, Lamers MM, van Kruchten R, Mastenbroek T, Baaten C, Coort S, Pugh N, Schulz A, Scharrer I, Jurk K, Zieger B, Clemetson KJ, Farndale RW, Heemskerk JW, Cosemans JM. Identification of platelet function defects by multi-parameter assessment of thrombus formation.
      Nat Commun. 2014 Jul 16;5:4257
    • Bart T, Volken T, Fischer Y, Mansouri Taleghani B. Giving blood and enrolling on the stem cell donor registry: ranking of obstacles and motives in Switzerland.
      Transfus Med Hemother. 2014 Jul;41(4):264-72
    • Stuck AK, Méan M, Limacher A, Righini M, Jaeger K, Beer HJ, Osterwalder J, Frauchiger B, Matter CM, Kucher N, Egloff M, Aschwanden M, Husmann M, Angelillo-Scherrer A, Rodondi N, Aujesky D. The adherence to initial processes of care in elderly patients with acute venous thromboembolism.
      PLoS One. 2014 Jul 1;9(7):e100164
    • Borhany M, Handrkova H, Cairo A, Schroeder V, Fatima N, Naz A, Amanat S, Shamsi T, Peyvandi F, Kohler HP. Congenital factor XIII deficiency in Pakistan: characterization of seven families and identification of four novel mutations.
      Haemophilia. 2014 Jul;20(4):568-74
    • Fontana S, de la Cuadra C, Müller U, Schmid P, Perler M, Luginbühl M, Mansouri Taleghani B. A Simple Guideline Reduces the Need for Red Blood Cell Transfusions in Swiss Hospitals: A Prospective, Multicentre, Before-and-After Study in Elective Hip and Knee Replacement.
      Transfus Med Hemother. 2014 Jun;41(3):182-8
    • Mansouri Taleghani B, Heuft HG. Hemovigilance.
      Transfus Med Hemother. 2014 Jun;41(3):170-1
    • von Krogh AS, Kremer Hovinga JA, Tjønnfjord GE, Ringen IM, Lämmle B, Waage A, Quist-Paulsen P. The impact of congenital thrombotic thrombocytopenic purpura on pregnancy complications.
      Thromb Haemost. 2014 Jun;111(6):1180-3
    • Julmy F, Ammann RA, Fontana S, Mansouri Taleghani B, Hirt A, Leibundgut K. Transfusion efficacy of apheresis platelet concentrates irradiated at the day of transfusion is significantly superior compared to platelets irradiated in advance.
      Transfus Med Hemother. 2014 Jun;41(3):176-81
    • Abetel G, Angelillo-Scherrer A. Thrombophilie: quand y penser?
      Rev Med Suisse 2014;10:1028-33
    • Nagler M, Keller P, Siegrist D, Alberio L. A case of EDTA-dependent pseudothrombocytopenia: simple recognition of an underdiagnosed and misleading phenomenon.
      BMC Clin Pathol. 2014 May 1;14:19
    • Ferrari S, Palavra K, Gruber B, Kremer Hovinga JA, Knöbl P, Caron C, Cromwell C, Aledort L, Plaimauer B, Turecek PL, Rottensteiner H, Scheiflinger F. Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura.
    • Crottet SL, Henny C, Meyer S, Still F, Stolz M, Gottschalk J, Neuenschwander K, Mansouri Taleghani B, Gowland P, Frey BM, Fontana S, Hustinx H, Niederhauser C, Gassner C. Implementation of a mandatory donor RHD screening in Switzerland.
      Transfus Apher Sci. 2014 Apr;50(2):169-74
    • Jandus C, Boligan KF, Chijioke O, Liu H, Dahlhaus M, Démoulins T, Schneider C, Wehrli M, Hunger RE, Baerlocher GM, Simon HU, Romero P, Münz C, von Gunten S. Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance.
      J Clin Invest. 2014 Apr;124(4):1810-20
    • Ferrari S, Palavra K, Gruber B, Kremer Hovinga JA, Knöbl P, Caron C, Cromwell C, Aledort L, Plaimauer B, Turecek PL, Rottensteiner H, Scheiflinger F. Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura.
      Haematologica. 2014 Apr;99(4):779-87
    • Nagler M, Bachmann LM, Schmid P, Raddatz Müller P, Wuillemin WA. Patient self-management of oral anticoagulation with vitamin k antagonists in everyday practice: efficacy and safety in a nationwide long-term prospective cohort study.
      PLoS One. 2014 Apr 18;9(4):e95761
    • Navdaev A, Subramanian H, Petunin A, Clemetson KJ, Gambaryan S, Walter U. Echicetin coated polystyrene beads: a novel tool to investigate GPIb-specific platelet activation and aggregation.
      PLoS One. 2014 Apr 4;9(4):e93569
    • Mendez A, Nagler M. Neue orale Antikoagulantien.
      Pipette-Swiss Laboratory Medicine 2014 April;2:12-13
    • Colucci G, Stutz M, Rochat S, Conte T, Pavicic M, Reusser M, Giabbani E, Huynh A, Thürlemann C, Keller P, Alberio L. The effect of desmopressin on platelet function: a selective enhancement of procoagulant COAT-platelets in patients with primary platelet function defects.
      Blood. 2014 Mar 20;123(12):1905-16
    • Jiang Y, McIntosh JJ, Reese JA, Deford CC, Kremer Hovinga JA, Lämmle B, Terrell DR, Vesely SK, Knudtson EJ, George JN. Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura.
      Blood. 2014 Mar 13;123(11):1674-80
    • Rank CU, Kremer Hovinga JA, Mansouri Taleghani M, Lämmle B, Gøtze JP, Nielsen OJ. Congenital thrombotic thrombocytopenic purpura caused by new compound heterozygous mutations of the ADAMTS13 gene.
      Eur J Haematol. 2014 Feb;92(2):168-71
    • de Wreede LC, Watson M, van Os M, Milligan D, van Gelder M, Michallet M, Dreger P, Dearden CE, Homewood J, Dupuis J, Leporrier M, Karas M, Corront B, Baerlocher GM, Herr W, Choquet S, Niederwieser DW, Sutton L, Kröger N, de Witte TM, Schetelig On Behalf Of The Chronic Malignancies Working Party Of The Ebmt And The Uk Medical Research Council J. Improved relapse-free survival after autologous stem cell transplantation does not translate into better quality of life in chronic lymphocytic leukemia: lessons from the randomized European Society for Blood and Marrow Transplantation-Intergroup study.
      Am J Hematol. 2014 Feb;89(2):174-80
    • Hehlmann R, Müller MC, Lauseker M, Hanfstein B, Fabarius A, Schreiber A, Proetel U, Pletsch N, Pfirrmann M, Haferlach C, Schnittger S, Einsele H, Dengler J, Falge C, Kanz L, Neubauer A, Kneba M, Stegelmann F, Pfreundschuh M, Waller CF, Spiekermann K, Baerlocher GM, Ehninger G, Heim D, Heimpel H, Nerl C, Krause SW, Hossfeld DK, Kolb HJ, Hasford J, Saußele S, Hochhaus A. Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV.
      J Clin Oncol. 2014 Feb 10;32(5):415-23
    • Nagler M, Ten Cate H, Kathriner S, Casutt M, Bachmann LM, Wuillemin WA. Consistency of thromboelastometry analysis under scrutiny: Results of a systematic evaluation within and between analysers.
      Thromb Haemost. 2014 Jan 30;111(6)
    • Simeon L, Nagler M, Wuillemin WA. Neue orale Antikoagulanzien - Einfluss auf Gerinnungstests.
      Dtsch Med Wochenschr 2014;1390:94-98

    2013

    • Oppliger Leibundgut E, Baerlocher GM. Molekulare Diagnostik: der Schlüssel zur zielgerichteten Therapie
      Schweiz Med Forum 2013;13(0102):8-10
    • Méan M, Righini M, Jaeger K, Beer HJ, Frauchiger B, Osterwalder J, Kucher N, Lämmle B, Cornuz J, Angelillo-Scherrer A, Rodondi N, Limacher A, Trelle S, Matter CM, Husmann M, Banyai M, Aschwanden M, Egloff M, Mazzolai L, Hugli O, Bounameaux H, Aujesky D. The Swiss cohort of elderly patients with venous thromboembolism (SWITCO65+): rationale and methodology.
      J Thromb Thrombolysis 2013 Nov;36(4):475-83
    • Méan M, Aujesky D, Lämmle B, Gerschheimer C, Trelle S, Angelillo-Scherrer A. Design and establishment of a biobank in a multicenter prospective cohort study of elderly patients with venous thromboembolism (SWITCO65+).
      J Thromb Thrombolysis. 2013 Nov;36(4):484-91
    • Diaz JA, Fuchs TA, Jackson TO, Kremer Hovinga JA, Lämmle B, Henke PK, Myers DD Jr, Wagner DD, Wakefield TW. Plasma DNA is Elevated in Patients with Deep Vein Thrombosis.
      J Vasc Surg Venous Lymphat Disord. 2013 Oct 1;1:341-348.e1
    • Reese JA, Muthurajah DS, Kremer Hovinga JA, Vesely SK, Terrell DR, George JN. Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features.
      Pediatr Blood Cancer. 2013 Oct;60(10):1676-82
    • Jovanovic JV, Ivey A, Vannucchi AM, Lippert E, Oppliger Leibundgut E, Cassinat B, Pallisgaard N, Maroc N, Hermouet S, Nickless G, Guglielmelli P, van der Reijden BA, Jansen JH, Alpermann T, Schnittger S, Bench A, Tobal K, Wilkins B, Cuthill K, McLornan D, Yeoman K, Akiki S, Bryon J, Jeffries S, Jones A, Percy MJ, Schwemmers S, Gruender A, Kelley TW, Reading S, Pancrazzi A, McMullin MF, Pahl HL, Cross NC, Harrison CN, Prchal JT, Chomienne C, Kiladjian JJ, Barbui T, Grimwade D. Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study.
      Leukemia. 2013 Oct;27(10):2032-2039
    • Deford CC, Reese JA, Schwartz LH, Perdue JJ, Kremer Hovinga JA, Lämmle B, Terrell DR, Vesely SK, George JN. Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura.
      Blood. 2013 Sep 19;122(12):2023-9
    • Schroeder V, Kohler HP. Factor XIII Deficiency: An Update.
      Semin Thromb Hemost. 2013 Sep;39(6):632-41
    • Deal T, Kremer Hovinga JA, Marques MB, Adamski J. Novel ADAMTS13 mutations in an obstetric patient with Upshaw-Schulman syndrome.
      J Clin Apher. 2013 Aug;28(4):311-6
    • Oppliger Leibundgut E, Porret NA, Abbal C, Darbellay R, Goede JS, Kalberer C, Lehmann T, Baerlocher GM. Molekulares BCR-ABL1-Monitoring bei CML gemäss neuen ELN-Empfehlungen. Internationale Skala in der Schweiz etabliert.
      Leading Opinions Hämatologie & Onkologie 2013;4/13:42-45
    • Frauenknecht V, Thiel S, Storm L, Meier N, Arnold M, Schmid JP, Saner H, Schroeder V. Plasma levels of mannan-binding lectin (MBL)-associated serine proteases (MASPs) and MBL-associated protein in cardio- and cerebrovascular diseases.
      Clin Exp Immunol. 2013 Jul;173(1):112-20
    • Demarmels Biasiutti F. Stellenwert von Gerinnungsstörungen bei habituellen Aborten.
      Gynäkologische Endokrinologie 2013;11:95-99
    • Wuillemin WA, Alberio LA, Angelillo-Scherrer A, Asmis LM, Boehlen F, Fontana P, Huber A, Korte W, Mendez A, Reber G, Stricker H, Studt JD, Tsakiris DA. Questions et réponses sur l'utilisation du rivaroxaban (Xarelto) dans la pratique.
      Rev Med Suisse. 2013 Jun 26;9(392):1375-85
    • Alberio L. My patient is thrombocytopenic! Is (s)he? Why? And what shall I do? A practical approach to thrombocytopenia.
      Hamostaseologie. 2013 May 29;33(2):83-94
    • Mansouri Taleghani M, von Krogh AS, Fujimura Y, George JN, Hrachovinová I, Knöbl PN, Quist-Paulsen P, Schneppenheim R, Lämmle B, Kremer Hovinga JA. Hereditary thrombotic thrombocytopenic purpura and the hereditary TTP registry
      Hamostaseologie. 2013 May 29;33(2):138-43
    • Kremer Hovinga JA. Thrombotic microangiopathies.
      Hamostaseologie. 2013 May 29;33(2):81
    • Schaller M, Studt JD, Voorberg J, Kremer Hovinga JA. Acquired thrombotic thrombocytopenic purpura. Development of an autoimmune response.
      Hämostaseologie 2013 May 29;33(2):121-30
    • Lane J, McLaren PJ, Dorrell L, Shianna KV, Stemke A, Pelak K, Moore S, Oldenburg J, Alvarez-Roman MT, Angelillo-Scherrer A, Boehlen F, Bolton-Maggs PH, Brand B, Brown D, Chiang E, Cid-Haro AR, Clotet B, Collins P, Colombo S, Dalmau J, Fogarty P, Giangrande P, Gringeri A, Iyer R, Katsarou O, Kempton C, Kuriakose P, Lin J, Makris M, Manco-Johnson M, Tsakiris DA, Martinez-Picado J, Mauser-Bunschoten E, Neff A, Oka S, Oyesiku L, Parra R, Peter-Salonen K, Powell J, Recht M, Shapiro A, Stine K, Talks K, Telenti A, Wilde J, Yee TT, Wolinsky SM, Martinson J, Hussain SK, Bream JH, Jacobson LP, Carrington M, Goedert JJ, Haynes BF, McMichael AJ, Goldstein DB, Fellay J; for the NIAID Center for HIV/AIDS Vaccine Immunology (CHAVI). A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A.
      Hum Mol Genet. 2013 May 1;22(9):1903-10
    • Kappelmayer J, Beke Debreceni I, Vida A, Antal-Szalmás P, Clemetson KJ, Nagy B Jr. Distinct effects of Re- and S-forms of LPS on modulating platelet activation.
      J Thromb Haemost. 2013 Apr;11(4):775-8
    • Hausammann S, Vogel M, Kremer Hovinga JA, Lacroix-Desmazes S, Stadler BM, Horn MP. Designed ankyrin repeat proteins: a new approach to mimic complex antigens for diagnostic purposes?
      PLoS One. 2013 Apr 23;8(4):e60688
    • Scherz N, Méan M, Limacher A, Righini M, Jaeger K, Beer HJ, Frauchiger B, Osterwalder J, Kucher N, Matter CM, Banyai M, Angelillo-Scherrer A, Lämmle B, Husmann M, Egloff M, Aschwanden M, Bounameaux H, Cornuz J, Rodondi N, Aujesky D. Prospective, multicenter validation of prediction scores for major bleeding in elderly patients with venous thromboembolism.
      J Thromb Haemost. 2013 Mar;11(3):435-43
    • Boehlen F, Casini A, Chizzolini C, Mansouri B, Kohler HP, Schroeder V, Reber G, de Moerloose P. Acquired factor XIII deficiency: a therapeutic challenge.
      Thromb Haemost. 2013 Mar;109(3):479-87
    • Nagler M, Bachmann LM, Alberio L, Angelillo-Scherrer A, Asmis LM, Korte W, Mendez A, Reber G, Stricker H, Tsakiris DA, Wuillemin WA. Variability between laboratories performing coagulation tests with identical platforms: a nationwide evaluation study.
      Thromb J 2013 Mar 7;11(1):6
    • Nagler M, Kathriner S, Bachmann LM, Wuillemin WA. Impact of changes in haematocrit level and platelet count on thromboelastometry parameters.
      Thromb Res. 2013 Mar;131(3):249-53
    • Helbling D, Bodoky G, Gautschi O, Sun H, Bosman F, Gloor B, Burkhard R, Winterhalder R, Madlung A, Rauch D, Saletti P, Widmer L, Borner M, Baertschi D, Yan P, Benhattar J, Oppliger Leibundgut E, Bougel S, Koeberle D. Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07.
      Ann Oncol. 2013 Mar;24(3):718-25
    • Labarinas S, Gumy-Pause F, Rougemont AL, Baerlocher GMOppliger Leibundgut E, Porret N, Schäppi MG, Barazzone-Argiroffo C, Passweg J, Merlini L, Ozsahin H, Ansari M. Is Acute Fibrinous and Organizing Pneumonia the Expression of Immune Dysregulation?
      J Pediatr Hematol Oncol. 2013 Mar;35(2):139-43
    • Federzoni EA, Humbert M, Valk PJ, Behre G, Leibundgut EO, Torbett BE, Fey MF, Tschan MP. The actin-binding protein CORO1A is a novel PU.1 (SPI1)- and CEBPA-regulated gene with significantly lower expression in APL and CEBPA-mutated AML patients.
      Br J Haematol. 2013 Mar;160(6):855-9
    • Colucci G, Alberio L. Pneumatic tube transport and Rotem analysis.
      Br. J. Anaesth 2013; epub February 1, 2013
    • Schroeder V, Kohler HP. New developments in the area of factor XIII.
      J Thromb Haemost. 2013 Feb;11(2):234-44
    • Jutzi M, Rüesch M, Mansouri B. Einführung der Pathogeninaktivierung für Thrombozytenkonzentrate in der Schweiz.
      Schweiz Med Forum 2013:13(11):222-226
    • Richardson VR, Schroeder V, Grant PJ, Standeven KF, Carter AM. Complement C3 is a substrate for activated factor XIII that is cross-linked to fibrin during clot formation.
      Br J Haematol. 2013 Jan;160(1):116-9
    • Oppliger Leibundgut E, Porret NA, Bienz Muggli M, Baumgartner H, Dahlhaus M, Baerlocher GM. Rapid and highly specific screening for NPM1 mutations in acute myeloid leukemia.
      Ann Hematol. 2013 Jan;92(2):173-7
    • Nagler M, Raddatz Müller P, Schmid P, Bachmann LM Wuillemin WA. Accuracy of the point-of-care coagulometer coaguchek xs in the hands of patients.
      J Thromb Haemost 2013 Jan;11(1):197-9

    2012

    • Alter BP, Rosenberg PS, Giri N, Baerlocher GM, Lansdorp PM, Savage SA. Telomere length is associated with disease severity and declines with age in dyskeratosis congenita.
      Haematologica 2012;97(3):353-9
    • Castaman G, Giacomelli SH, Schroeder V, Sanna S, Valdrè L, Morfini M, Banov L, Kohler HP, Rodeghiero F. Further evidence of heterogeneity of gene defects in Italian families with factor XIII deficiency.
      Haemophilia. 2012 Jan;18(1):e6-8
    • Hess K, Alzahrani SH, Mathai M, Schroeder V, Carter AM, Howell G, Koko T, Strachan MW, Price JF, Smith KA, Grant PJ, Ajjan RA. A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3.
      Diabetologia 2012;55(4):1103-13
    • Howes JM, Richardson VR, Smith KA, Schroeder V, Somani R, Shore A, Hess K, Ajjan R, Pease RJ, Keen JN, Standeven KF, Carter AM. Complement C3 is a novel plasma clot component with anti-fibrinolytic properties.
      Diab Vasc Dis Res 2012;9(3):216-25
    • Pasquier E, De Saint Martin L, Kohler HP, Schroeder V. Factor XIII plasma levels in women with unexplained recurrent pregnancy loss.
      J Thromb Haemost 2012;10(4):723-5
    • Frauenknecht V, Schroeder V. [Complement--a phylogenetically old system as a new player in the development of atherosclerosis].
      Hämostaseologie 2012;32(4):276-85
    • Hess K, Ajjan R, Phoenix F, Dobó J, Gál P, Schroeder V. Effects of MASP-1 of the complement system on activation of coagulation factors and plasma clot formation.
      PLoS One. 2012;7(4):e35690
    • Stricker H, Tosi Bianda F, Guidicelli-Nicolosi S, Limoni C, Colucci G. Effect of a single, oral, high-dose vitamin D supplementation on endothelial function in patients with peripheral arterial disease: a randomised controlled pilot study.
      Eur J Vasc Endovasc Surg 2012;44(3):307-12
    • Amann G, Zehnter C, Marti F, Colucci G. Effect of acceleration forces during transport through a pneumatic tube system on ROTEM analysis.
      Clin Chem Lab Med 2012;50(8):1335-42
    • Kremer Hovinga JA, Lämmle B. Role of ADAMTS13 in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura.
      Hematology Am Soc Hematol Educ Program 2012;610-6
    • Nagler M, Wuillemin W. Laboratory diagnostic with regard to new anticoagulans - monitoring and influence on coagulation tests.
      Ther Umsch 2012;69(11):650-6
    • Zappa F, Droege C, Betticher D, von Moos R, Bubendorf L, Ochsenbein A, Gautschi O, Oppliger Leibundgut E, Froesch P, Stahel R, Hess T, Rauch D, Schmid P, Mayer M, Crowe S, Brauchli P, Ribi K, Pless M; on behalf of the Swiss Group for Clinical Cancer Research (SAKK). Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: A multicenter phase II trial (SAKK 19/05).
      Lung Cancer 2012;78(3):239-44
    • Zwierzina D, Limacher A, Méan M, Righini M, Jaeger K, Beer HJ, Frauchiger B, Osterwalder J, Kucher N, Matter CM, Banyai M, Angelillo-Scherrer A, Lämmle B, Egloff M, Aschwanden M, Mazzolai L, Hugli O, Husmann M, Bounameaux H, Cornuz J, Rodondi N, Aujesky D. Prospective comparison of clinical prognostic scores in elderly patients with pulmonary embolsim.
      J Thromb Haemost 2012 Nov;10(11):2270-6
    • Mansouri B, Strasser E. Therapeutic Hemapheresis.
      Transfus Med Hemother 2012;39(4):232-233
    • Theocharides A, Jin L, Cheng P, Prasolava T, Malko A, Ho J, Poeppl A, Rooijen N, Minden M, Danska J, Dick J, Wang J. Disruption of SIRP-alpha signaling in macrophages eliminates human acute myeloid leukemia stem cells in xenografts.
      JEM 2012;209(10):1883-99
    • Du VX, van Os G, Kremer Hovinga JA, Dienava-Verdoold I, Wollersheim J, Ruggeri ZM, Fijnheer R, de Groot PG, de Laat B. Indications for a protective function of beta2-glycoprotein I in thrombotic thrombocytopenic purpura.
      Br J Haematol 2012;109(1):94-103
    • Fuchs TA, Kremer Hovinga JA, Schatzberg D, Wagner DD, Lämmle B. Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies.
      Blood 2012;120(6):1157-64
    • von Grünigen I, Raschle J, Rüsges-Wolter I, Mansouri B, Müller B, Pabst T. The relapse risk of AML patients undergoing autologous transplantation correlates with the stem cell mobilizing potential.
      Leuk Res 2012;36(11):1325-9
    • Oppliger Leibundgut E, Rogenmoser-Dissler D, de Beer D, Porret NA, Zibellini S, Dürig J, Röth A, Klinbiel D, Baerlocher GM. CLLU1 expression distinguishes chronic lymphocytic leukemia from other mature B-cell neoplasms.
      Leuk Res 2012;36(9):1204-7
    • Nagler M, Feller S, Beyeler C. Retrospective adjustment of self-assessed medical competencies - noteworthy in the evaluation of postgraduate practical training courses.
      GMS Z Med Ausbildung 2012;29(3):doc45
    • Aubert G, Baerlocher GM, Vulto I, Poon SS, Lansdorp PM. Collapse of telomere homeostasis in hematopoietic cells caused by heterozygous mutations in telomerase genes.
      PLoS Genet 2012;8(5):e1002696
    • Urwyler N, Theiler L, Hirschberg M, Kleine-Brueggner M, Colucci G, Greif R. Standard vs point-of-care measurement of fibrinogen: potential impact on clinical decisions.
      Minvera Anestesiol 2012;78(5):550-5
    • Meierhofer S, Colucci G, Steiner S. Coumarin-Induced necrotic purpura of the skin - case report and review of the literature.
      Praxis 2012;101(9):609-13
    • Colucci G, Jahns M, Silzle T, Alberio L. Catastrophic Complications of Intravenous Line Flushing with Unfractionated Heparin.
      Int J Clin Med 2012;3:36-39
    • von Känel R, Vökt F, Demarmels Biasiutti F, Stauber S, Wuillemin WA, Lukas PS. Relation of psychological distress to the INR in Patients with venous thromboembolism with  and without oral anticoagulant therapy.
      J Thromb Haemost 2012;10(8):1547-55
    • Lukas P, Neugebauer A, Schnyder S, Demarmels Biasiutti F, Krummenacher R, Gander Ferrari ML, von Känel R. Depressive symptoms, perceived social support, and prothrombotic measures in patients with venous thromboembolism.
      Thrombosis Research 2012;130(3):374-80
    • Som S, Deford CC, Kaiser ML, Terrell DR, Kremer Hovinga JA, Lämmle B, George JN, Vesely SK. Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011.
      Transfusion 2012;52(12):2525-32
    • Kremer Hovinga JA, Voorberg J. Improving on nature: redesigning ADAMTS13.
      Blood 2012;119(16):3654-5
    • Hanfstein B, Müller MC, Baerlocher GM et al. Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML).
      Leukemia 2012;26(9):2096-102
    • Anderson B, Kasher PR, Mayer J, Oppliger Leibundgut E, Baerlocher GM et al. Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus
      Nat Genet 2012;44(3):338-42
    • Nagler M, Haslauer M, Wuillemin WA. Fondaparinux - data on efficacy and safety in special situations.
      Thromb Res 2012;129:407-417
    • Nagler M, Fabbor T, Wuillemin WA. Prospective Evaluation of the Inter-Observer Reliability of the 4T's Score in Patients with Suspected HIT
      J Thromb Haemost 2012;10:151-2
    • Cataland SR, Peyvandi F, Mannucci PM, Lämmle B, Kremer Hovinga JA, Macchin SJ, Scully M, Rock G, Gilbert JC, Yang S, Wu H, Jilma B, Knoebl P. Initial experience from a double-blind, placebo-controlled, clinical outcome study of ARC1779 in patients with thrombotic thrombocytopenic purpura.
      Am J Hematol 2012;87(4):430-2
    • George JN, Terrell DR, Vesely SK, Kremer Hovinga JA, Lämmle B. Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer.
      Presse Med 2012;41:e177-88
    • Froehlich-Zahnd R, George JN, Vesely SK, Terrell DR, Aboulfatova K, Dong JF, Luken BM, Voorberg J, Budde U, Sulzer I, Lämmle B, Kremer Hovinga JA. Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura.
      Haematologica 2012;97(2):297-303
    • Colucci G, Silzle T, Solenthaler M. Pyrazinamide-induced sideroblastic anemia.
      Am J Hematol 2012;87(3):305
    • Nellen V, Sulzer I, Barizzi G, Lämmle B, Alberio L. Rapid exclusion or confirmation of heparin-induced thrombocytopenie: a single-centre experience with 1291 patients.
      Haematologica 2012;97(1):89-97

    2011

    • Fabarius A, Leitner A, Baerlocher GM et al. Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: longterm observation of 1151 patients from the randomized CML Study IV.
      Blood 2011;118(26):6760-8
    • De Marchis GM, Jung S, Colucci G, Meier N, Fischer U, Weck A, Mono ML, Galimanis A, Mattle HP, Schroth G, Gralla J, Arnold M, Brekenfeld C. Intracranial hemorrhage, outcome and mortality after intra-arterial therapy for acute ischemic stroke in patients under oral anticoagulants.
      Stroke 2011;42:3061-3066
    • Pabinger I, Alt-Epping B, Demarmels Biasiutti F, Langer F, Wörman B, Riess H. Venöse Thromboembolien bei Tumorpatienten.
      Hämostaseologie 2011;31(4):281-90
    • Alberio L. Proteins influencing the blood coagulation.
      Ther Umsch 2011;68(11):631-40
    • Terrell DR, Motto DG, Kremer Hovinga JA, Lämmle B, George JN, Vesely SK. Blood group O and black race are independent risk factors for thrombotic thrombocytoppenic purpura associated with severe ADAMTS13 deficiency.
      Transfusion 2011;51:2237-2243
    • Asmis LM, Alberio L, Angelillo-Scherrer A, Korte W, Mendez A, Reber G. Seifert B, Stricker H, Tsakiris DA, Wuillemin WA. Rivaroxaban: Quantification by anti-FXa assay and influence on coagulation tests, a study in 9 Swiss laboratories.
      Thromb Res 2011;129(4):492-8
    • Alberio L, Lämmle B. On the Dosing of Lepirudin (letter to the Editor).
      Br J Clin Pharmacol 2011;72(4):717
    • Jung S, Mono ML, Fischer U, Galimanis A, Findling O, De Marchis GM, Weck A, Nedeltchev K, Colucci G, Mordasini P, Brekenfeld C, El-Koussy M, Grall J, Schroth G, Mattle HP, Arnold M. Three-month and long-term outcomes and their predictors in acute basilar artery occlusion treated with intra-arterial thrombolysis.
      Stroke 2011;42(7):1946-51
    • Ackermann KA, Z'Graggen WJ, El-Koussy M, Caversaccio M, Vajtai I, Colucci G. Blindness in a patient with chronic lymphocytic leukemia.
      Am J Hematol 2011;86(9):783-4 
    • Fontana S, Keller P, Mansouri B. Platelet Recruitment during Mulitple Donor Platelet Apheresis Differs between Cell Separators.
      Transfus Med Hemother 2011;38(3):195-198
    • Jahns M, Friess D, Demarmels F, Kremer Hovinga JA, Alberio L, Oldenburg J, Lämmle B, Colucci G. Massive muscle haematoma three months after starting vitamin K antagonist therapy for deep vein thrombosis in an antithrombin deficient patient: Another case of factor IX propeptide mutation.
      Thromb Haemost 2011;106(2):381-2
    • Heimgartner B, Oestmann A, Keller P, Rüsges-Wolter I. Spontaneous Hematomas and Isolated Prolongation of aPTT.
      Praxis 2011;100(10):603-606
    • Pos W, Luken BM, Sorvillo N, Kremer Hovinga JA, Voorberg J. Humoral immune response to ADAMTS13 in acquired TTP.
      J Thromb Haemost 2011;9(7):1285-91
    • Krummenacher R, Lukas P, Demarmels F, Begré S, Znoj H, von Känel R. Relationship Between Psychological Distress and Endogenous Anticoagulants in Patients With a Previous Thromboeembolic Event.
      Clin Appl Thromb Hemost 2011;17(2):171-80
    • Birri N, Baumgartner D, Conte T, Huynh A, Weller K, Pavicic M, Reusser M, Siegenthaler I, Barizzi G, Alberio L. Stability of low molecular weight heparin anti-factor Xa acitivity in citrated whole blood and plasma.
      Br J Haematol 2011;155(5):629-31
    • Schmid P, Mordasini A, Luginbühl M, Regli B, Kohler H-P, Zimmermann H, Inderbitzin D, Hirt A, Lämmle B, Alberio L. Low-dose recombinant activated factor VII for massive bleeding: A single centre observational cohort study with 73 patients.
      Swiss Med Wkly 2011;7:141
    • Humbert M, Halter V, Shan D, Laedrach J, Oppliger EBaerlocher GTobler A, Fey M, Tschan MP. Deregulated expression of Kruppel-like factors in acute myeloid leukemia
      Leuk Res 2011;35(7):909-13
    • Fontana S, Rados L, Schmid P, Oppliger EMansouri B. Recruitment of platelets, white blood cells, and hematopoietic progenitor cells during high-yield plateletpheresis.
      Transfusion 2011;51(9):2034-43
    • Colucci G, Giabbani E, Barizzi G, Urwyler N, Alberio L. Laboratory-based ROTEM analysis: implementing pneumatic tube transport and real-time graphic transmission
      Int J Lab Hematol 2011;3(4):441-6
    • Poller L, Ibrahim S, Keown M, Pattison A, Jespersen J, European Action on Anticoagulation (Lämmle B, Alberio L). The prothrombin time/international normalized ratio (PT/INR) Line: derivation of local INR with commercial thromboplastins and coagulometers - two independent studies.
      J Thromb Haemost 2011;9:140-148
    • Plaimauer B, Kremer Hovinga JA, Juno C, Wolfsegger MJ, Skalicky S, Schmidt M, Grillberger L, Hasslacher M, Knöbl P, Ehrlich H, Scheiflinger F. Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitoy antibodies.
      J Thromb Haemost 2011;9(5):936-44
    • Béné MC, Nebe T, Bettelheim P, Buldini B, Bumbea H, Kern W, Lacombe F, Lemez P, Marinov I, Matutes E, Maynadié M, Oelschlagel U, Orfao A, Schabath R, Solenthaler M, Tschurtschenthaler G, Vladareanu AM, Zini G, Faure GC, Porwit A. Immunophenotyping of acute leukemia and lympoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10.
      Leukemia 2011;25(4):567-74
    • Sellmann L, de Beer D, Bartels M, Opalka B, Nückel H,  Dührsen U, Dürig J, Seifert M, Sieber D, Küppers R, Baerlocher GM, Röth A. Telomeres and prognosis in patients with chronic lymphocytic leukaemia.
      Int J Hematol. 2011 Jan;93(1):74-82
    • Brill A, Fuchs TA, Chauhan AK, Yang J, de Meyer SF, Källnberger M, Wakefield TW, Lämmle B, Massberg S, Wagner DD. Von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models.
      Blood 2011;117()4:1400-7

    2010

    • Ivaskevicius V, Biswas A, Bevans C, Schroeder V, Kohler HP, Rott H, Halimeh S, Petrides PE, Lenk H, Krause M, Miterski B, Harbrecht U, Oldenburg J. Identification of eight novel coagulation factor XIII subunit A mutations: implied consequences for structure and function.
      Haematologica 2010;95(6):956-62
    • Ivaskevicius V, Biswas A, Loreth R, Schroeder V, Ohlenforst S, Rott H, Krause M, Kohler HP, Scharrer I, Oldenburg J. Mutations affecting disulphide bonds contribute to a fairly common prevalence of F13B gene defects: results of a genetic study in 14 families with factor XIII B deficiency.
      Haemophilia 2010;16(4):675-82
    • Lämmle B, Demarmels F, Keller P. Das Problem der "Ghost und guest Authors". Leserbrief
      Schweiz Med Forum 2010;10(30-31):516-7Ortner E, Schroeder V, Walser R, Zerbe O, Kohler HP. Sensitive and selective detection of free FXIII activation peptide: a potential marker of acute thrombotic events.
      Blood 2010;115(24):5089-98
    • Schroeder V, Ortner E, Mono ML, Galimanis A, Meier N, Findling O, Fischer U, Brekenfeld C, Arnold M, Mattle HP, Kohler HP. Coagulation factor XIII activation peptide and subunit levels in patients with acute ischaemic stroke: a pilot study
      Thromb Res 2010;126(2):e122-7Schroeder V, Kohler HP. Thrombelastographic studies on factor XIII.
      Thromb Haemost 2010;104(6):1277-9
    • Keller P, Angelillo-Scherrer A, Bargetzi M, Goede J, Hess U, Imbach P, Mach-Pascual S, Mey U, Rüfer A, Schmidt A. Diagnose und Behandlung der primären Immun-Thrombozytopenie.
      Schweiz Med Forum 2010;10(50):875-883Fluri S, Kaczala GW, Leibundgut K, Alberio L. Chickenpox is not always benign: postvaricella purpura fulminanas requires prompt and aggressive treatment.
      Pediatr Emerg Care 2010;26(12):932-4
    • Clemetson KJ. Snaclecs (snake C-type lectins) that inhibit or activate platelets by binding to receptors.
      Toxicon 2010;56:1236-46Terrell DR, Vesely SK, Kremer Hovinga JA, Lämmle B, George JN. Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic-uremic syndromes.
      Am J Hematol 2010;85(11):844-7
    • Regli B, Mansouri Taleghani B. Erythrozytentransfusion heute – intensivmedizinische Aspekte.
      Eckart J, Forst H, Briegel J (Hrsg): Intensivmedizin. Kompendium und Repetitorium zur interdisziplinären Weiter- und Fortbildung. ecomed Medizin, Heidelberg, Deutschland, 2010; 39. Ergänzungslieferung 7/10; III-20.2: 1-4.Luginbühl R, Barizzi G, Sulzer I, Lämmle B, Alberio L. Screening for lupus anticoagulant: Improving the performance of the lupus-sensitive PTT-LA.
      Int J Lab Hematol 2010;33(2):168-75
    • Baerlocher GM, Oppliger Leibundgut E. Molecular analyses for (early) recognition of hematologic diseases - Sense and sensibility for molecular analysis: the art of intelligent decision-making.
      Ther Umsch 2010;67(7):349-58
    • Demarmels Biasiutti F. Anemia of chronic disorder - pathogenesis, clinical presentation and treatment.
      Ther Umsch 2010;67(5):225-8
    • Leupin N, Schuller JC, Solenthaler M, Heim D, Rovo A, Beretta K, Gregor M, Bargetzi MJ, Brauchli P, Himmelmann A, Hanselmann S. Zenhäusern R. Efficacy of rituximab and cladribine in patientes with chronic lymphocytic leukemia and feasiblity of stem cell mobilization: a prospectiv multicenter phase II trail (protocol SAKK 34/02).
      Leuk Lymphoma 2010;51(4):613-9
    • Kremer Hovinga JA, Vesely SK, Terrell D, Lämmle B, George J. Survival and relapse in patients with thrombotic thrombocytopenic purpura.
      Blood 2010;115(8):1500-1511
    • Jenal M, Batliner J, Reddy VA, Haferlach T, Tobler A, Fey MF, Torbett BE, Tschan MP. The anti-apoptotic gene BCL2A1 is a novel transcriptional target of PU.1.
      Leukemia 2010;24(5):1073-6
    • Britschgi A, Simon HU, Tobler A, Fey MF, Tschan MP. Epigallocatechin-3-gallate induces cell death in acute myeloid leukaemia cells and supports all-trans retinoic acid-induced neutrophil differentiation via death-associated protein kinase 2.
      Br J Haematol 2010;149(1):55-64
    • Isenegger J, Meier N, Lämmle B, Alberio L, Fischer U, Nedeltchev K, Gralla J, Kohler HP, Mattle HP, Arnold M. D-Dimers Predict Stroke Subtype when Assessed Early.
      Cerebrovasc Dis 2010;29(1):82-6
    • Tschan MP, Shan D, Lädrach J, Eyholzer M, Oppliger Leibundgut E, Baerlocher GM, Tobler A, Stroka D, Fey MF. NDRG1/2 expression is inhibited in primary acute myeloid leukemia.
      Leuk Res 2010;34(3):393-8
    • Dubach P, Mantokoudis G, Lämmle B. Rumpel-Leede sign in thrombocytopenia due to Epstein-Barr virus-induced mononucleosis.
      Br J Haematol 2010;148(1):2
    • Röth A, Harley CB, Baerlocher GM. Imetelstat (GRN163L) - Telomerase-Based Cancer Therapy.
      Recent Results Cancer Res 2010;184:221-34

    2009

    • Fontana S, Weingand T, Maier A, Mansouri Taleghani B. Prospective, Paired Crossover Comparison of the in vitro Quality of Red Blood Cells Collected by the Automate for Blood Collection Device or by a Conventional Method.
    • Colucci G, Alberio L, Jahns M, Keller P, Steiner S, Rüsges-Wolter I, Lämmle B. Effective therapy with tranexamic acid in a case of chronic disseminated intravascular coagulation with acquired alpha2-antiplasmin deficiency associated with AL amyloidosis.
      Thromb Haemost 2009;102(6):1285-7
    • Lukas PS, Krummenacher R, Demarmels Biasiutti F, Begre S, Znoj H, von Känel R. Association of fatigue and psychological distress with quality of life in patients with a  previous venous thromboembolic envent.
      Thromb Haemost 2009:102(6):1219-26
    • Colucci G, Domenighetti G, Della Bruna R, Bonilla J, Limoni C, Matthay MA, Martin TR. Comparison of two non-bronchoscopic methods for evaluating inflammation in patients with acute hypoeaemic respiratory failure.
      Crit Care 2009;13(4) Epub
    • Urwyler N. Trelle S, Theiler L, Juni P, Staub LP, Luyet C, Alberio L, Stricker K, Greif R. Does point of care prothrombin time measurement reduce the transfusion of fresh frozen plasma in patients undergoing major surgery? The POC-OP randomized-controlled trial.
      Trials 2009;10:107
    • Ferrari S, Mudde GC, Rieger M, Veyradier A, Kremer Hovinga A, Scheiflinger F. IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura.
      J Thromb Haemost 2009;7:1703-10
    • Krummenacher R, Lukas PS, Demarmels Biasiutti F, Begré S, Znoj H, von Känel R. Independent association of sleep quality, fatigue, and vital exhaustion with platelet count in patients with a previous venous thromboembolic event.
      Platelets 2009;20(8):566-74
    • Urwyler N, Staub LP, Beran D, Deplazes M, Lord SJ, Alberio L, Theiler L, Greif R. Is perioperative point-of-care prothrombin time testing accurate compared to the standard laboratory test?
      Thromb Haemost 2009;102:779-86
    • Zenhäusern R, Schmitz SF, Solenthaler M. Heim D, Meyer-Monard S, Hess U, Leoncini L, Bargetzi M, Rufener B, Tobler A. Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98).
      Leuk Lymphoma 2009;4:1-11
    • Jenal M, Trinh E, Britschgi C, Britschgi A, Roh V, vorburger SA, Tobler A, Leprince D, Fey MF, Helin K, Tschan MP. The Tumor Suppressor Gene Hypermethylated in Cancer 1 Is Transcriptionally Regulatet by E2F1.
      Mol Cancer Res 2009;7(6):916-22
    • Wampfler J, Tschan MP, Shan D, Laemmle A, Oppliger E, Baerlocher GM, Stroka D, Fey MF, Britschgy C. SIRT 1 is downregulated during neutrophil differentiation of acute promyelocytic leukaemia cells.
      Br J Haematol 2009;146(3)337-41
    • Mumprecht S, Schürch C, Schwaller J, Solenthaler M, Ochsenbein AF. PD-1 signaling on chronic myeloid leukemia-specific T cells results in T cell exhaustion and disease prgression.
      Blood 2009;114(8):1528-36
    • Baerlocher GM, Rovo A, Müller A, Matthey S, Stern M, Halter J, Heim D, Rischewski J, Gratwohl A, Tichelli A. Cellular senescence of white blood cells in very long-term survivors after allogeneic hematopoietic stem cell transplantation: the role of chronich GVHD and a female donor gender.
      Blood 2009;114(1):219-22
    • Heimpel H, Dührsen U, Hofbauer P, Rigamonti Wermelinger V, Kreuser ED, Schwarz K, Solenthaler M, Pauls S. Bulky extramedullary hematopoiesis is not a rare complication of congenital dyserythropoietic anemia.
      Ann Hematol 2009;88(10):937-41
    • Colucci G, Lämmle B, Alberio L. Variability of anti-PF4/heparin antibody results obtained by the rapid testing system ID-H/PF4-PaGIA: reply to a rebuttal.
      J Thromb Haemost 2009;7:1755-6
    • Schneiter S, Colucci G, Sulzer I, Barizzi G, Lämmle B, Alberio L. Variability of anti-PF4/heparin antibody results obtained by the rapid testing system ID-H/PF4-PaGIA.
      J Thromb Haemost 2009;7:1649-55
    • Amrein K, Schmid P, Mansouri B. Delayed haemolytic transfusion reaction initially presenting as serum sickness like syndrome.
      Eur J Intern Med 2009;20(5)122-3
    • Benjamin M, Terrell DR, Vesely SK, Voskuhl GW, Dezube BJ, Kremer Hovinga JA, Lämmle B, George JN. Frequency and Significance of HIV Infection among Patients Diagnosed with Thrombotic Thrombocytopenic Purpura.
      Clin Infect Dis 2009;48(8):1129-37
    • Gabutti L, Lucchini B, Marone C, Alberio L, Burnier M. Citrate- vs. acetate-based dialysate in bicarbonate haemodialysis: consequences on haemodynamics, coagulation, acid-base status, and electrolytes.
      BMC Nephrol 2009;10:7
    • Pos W, Luken BM, Kremer Hovinga JA, Turenhout EAM, Scheiflinger F, Dong JF, Fijnheer R, Voorberg J. VH1-69 germline encoded antibodies directed towards ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.
      J Thromb Haemost 2009;7(3):421-8
    • Kennedy AS, Lewis QF, Scott JG, Kremer Hovinga JA, Lämmle B, Terrell DR, Vesely SK, George JN. Cognitive deficits after recovery from thrombotic thrombocytopenic purpura.
      Transfusion 2009;49:1092-1101
    • Julmy F, Ammann RA, Mansouri B, Fontana S, Hirt A, Leibundgut K. Transfusion efficacy of ABO major-mismatched platelets (PLTs) in children is inferior to that of ABO-identical PLTs.
      Transfusion 2009;49:21-33
    • Zenhausern R, von Rohr A, Rufibach K, Solenthaler M, Meyer-Monard S, Gratwohl A, Hess U, Bargetzi MJ, Kovacsovic T, Leoncini L, Tobler A. Low dose 2-chlorodeoxyadenosine given as a single subcutaneous injection in hairy cell leukemia - a multicentre trial SAKK 32/95.
      Leuk Lymphoma 2009; 50(1):133-6
    • Thuerlemann C, Haeberli A, Alberio L. Monitoring Thrombin Generation by Electrochemistry: Development of an Amperometric Biosensor Screening Test for Plasma and Whole Blood.
      Clin Chem 2009;55(3):505-12
    • Swisher KK, Terrell DR, Vesely SK, Kremer Hovinga JA, Lämmle B, George JN. Clinical outcomes following after platelet transfusions in patients with thrombotic thrombocytopenic purpura.
      Transfusion 2009;49(5):873-87
    • Tiede A, Huth-Kühne A, Oldenburg J, Grossmann R, Geisen U, Krause M, Brand B, Alberio L, Klamroth R, Spannagl M, Knöbl P. Immunosuppressive treatment for acquired haemophilia: current practice and future directions in Germany, Austria and Switzerland.
      Ann Hematol 2009;88(4):365-70
    • Chtioui H, Millius C, Lämmle B, Lauterburg B. Concomitant treatment with lamivudine renders cladribine inactive by inhibition of its phosphorylation.
      Br J Haematol 2009;144:136-137
    • Tschudi M, Lämmle B, Alberio L. Dosing lepirudin in patients with heparin-induced thrombocytopenia and normal or impaired renal function: A single-centre experience with 68 patients.
      Blood 2009;113(11):240-9

    2008

    • Tiede A, Huth-Kühne A, Oldenburg J, Grossmann R, Geisen U, Krause M, Brand B, Alberio L, Klamroth R, Spannagl M, Knöbl P. Erhebung zur immunsuppressiven Therapie der erworbenen Hämophilie in Deutschland, Österreich und der Schweiz.
      Hämostaseologie 2008;28(Suppl 1):S29-S30.
    • Bergmann IP, Kremer Hovinga JA, Lämmle B, Peter HJ, Schiemann U. Acute pancreatitis and thrombotic thrombocytopenic purpura.
      Eur J Med Res 2008;13(10):481-2
    • Tripodi A, Peyvandi F, Chantarangkul V, Palla R, Afrasiabi A, Canciani M, Chung DW, Ferrari S, Fujimura Y, Karimi M. Kokame K, Kremer Hovinga JA, Lämmle B, De Meyer F, Plaimauer B, Vanhoorelbeke K., Varadi K. Mannucci PM. Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS-13).
      J Thromb Haemost 2008;6:1534-1541
    • Röth A, de Beer D, Nückel H, Sellmann L, Dührsen U, Dürig J, Baerlocher GM. Significantly shorter telomerexs in T-Cells of patients with ZAP-70(+)/CD38(+) chronic lymphocytic leukaemia.
      Br J Haemtol 2008;143(3):383-6
    • Warncke C, Alberio L, Savolainen H, von Allmen R, Baumgartner I, Husmann M. HIT on Trousseau Double trouble: acquired coagulopathy with femoral artery thrombosis.
    • Kremer Hovinga JA, Meyer S. Current management of thrombotic thrombocytopenic purpura.
      Curr Opin Hematol 2008;15:445-450
    • Alberio L. Heparin-induced thrombocytopenia: some working hypotheses on pathogenesis, diagnostic strategies and treatment.
      Curr Opin Hematol 2008;15:456-464
    • Britschgi A, Trinh E, Rizzi M, Jenal M, Ress A, Tobler A, Fey MF, Helin K, Tschan MP. DAPK2 is a novel E2F1/KLF6 target gene involved in their proapoptotic function.
      Oncogene 2008:27(43):5706-16
    • Alberio L, Lämmle B. Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature: only a part of the story. Reply to E. J. Favaloro.
      Thromb Haemost 2008: 99(6):1123
    • Meyer SC, Jeddi R, Meddeb B, Gouider E, Lämmle B, Kremer Hovinga JA. A first case of congenital TTP on the Afircan continent due to a new homozygous mutation in the catalytic domain of ADMATS13.
      Ann Hematol 2008;87(8);663-6
    • Jutzi M, Levy G, Mansouri B. Swiss Haemovigilance Data and Implementation of Measures for the Prevention of Transfusion Associated Acute Lung Injury (TRALI).
      Transfus Med Hemother 2008;35:98-101
    • Baerlocher GM, Röth A. Telomerbiologie im hämatologischen und onkologischen Alltag. Die Enden der Chromosomen - Schlüssel zur (Un)Sterblichkeit.
      Forschung und Praxis 2008;1:19-23
    • Röth A, Baerlocher GM. Dyskeratosis congenita.
      Br J Haematol 2008;141(4):412
    • Niederhauser C, Mansouri B, Graziani M, Stolz M, Tinguely C, Schneider P. Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus?
      Swiss Med Wkly 2008;138(9-10):134-41
    • Asmis L, Asmis R, Sulzer I, Furlan M, Lämmle B. Contact system activation in human sepsis - 47kD HK, a marker of sepsis severity?
      Swiss Med Wkly 2008;138(9-10):142-9
    • Britschgi C, Jenal M, Rizzi M, Mueller BU, Torbett BE, Andres AC, Tobler A, Fey MF, Tschan MP. HIC1 tumour suppressor gene is suppressed in acute myeloid leuaemia and in granulocytic differentiation.
      Br J Haematol 2008;141(2):179-87
    • Larson RA, Druker BJ, Guilhot F, O'Brien SG, Riviere GJ, Krahnke T, Gathmann I, Wang Y; IRIS (International Randomized Interferon vs STI571) Study Group. Collaborator Solenthaler M. Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study.
      Blood 2008;111(8):4022-8
    • Savage SA, Giri N, Baerlocher GM, Orr N, Lansdorp PM, Alter BP. TINF2, a component of the shelterin telomere protection complex, is mutated in congenita.
      Am J Hum Genet 2008;82(2):501-9
    • Zürcher M, Sulzer I, Barizzi G, Lämmle B, Alberio L. Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature.
      Thromb Haemost 2008;99(2):416-426
    • Lämmle B, Kremer Hovinga JA, George JN. Acquired thrombotic thrombocytopenic purpura: ADAMTS13 activity, anti-ADAMTS13 autoantibodies and risk of recurrent disease.
      Haematologica 2008;93(2):172-177
    • George JN, Kremer Hovinga JA, Terrel DR, Vesely SK, Lämmle B. The Oklahoma thrombotic thrombocytopenic purpura - hemolytic uremic syndrome registry: The Swiss connection.
      Eur J Haematol 2008;80(4):277-86
    • Karpac CA, Li X, Terrell DR, Kremer Hovinga JA, Lämmle B, Vesely SK, George JN. Sporadic bloody diarrhea-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults in Oklahoma, 1989-2006.
      Br J Haematol 2008;141(5):696-707
    • Julmy F, Ammann RA, Mansouri B, Fontana S, Hirt A, Leibundgut K. Effects of high-yield thrombocytapheresis on the quality of platelet products.
      Transfusion 2008;48:442-450

    2007

    • Schmid P, Fischer AG, Wuillemin WA: Prevalence of impaired renal function in medical inpatients.
      Swiss Med Wkly 2007;137:514
    • Mansouri B. Plasmaaustauschbehandlung (Plasmapherese und Immunadsorption) Gold R, Toyka KV (Hrsg): Immuntherapie neurologischer Erkrankungen.
      Uni-Med, Bremen, Deutschland 2007: 65-72.
    • Barizzi G, Alberio L. Quantitative assessment of elevated D-Dimers.
      Int J Hematol 2007;86:459-60
    • Kalicki R, Aregger F, Alberio L, Lämmle B, Frey F, Uehlinger D. Use of the pentasaccharide fondaparinux as an anticoagulant during haemodialysis.
      Thromb Haemost 2007;98:1200-1207
    • O'Meara AC, Demarmels Biasiutti F, Heizmann M. Fondaparinux as an alternative therapy in heparin-induced delayed-type hypersensitivity skin lesions. 
      Thromb Haemost 2007;98:1389-1391
    • Tschan MP, Gullberg U, Shan D, Torbett BE, Fey MF, Tobler A. The hDMP1 tumor suppressor is a new WT 1 target in myeloid leukemias.
      Leukemia. 2007 Nov 1 (Epub ahead of print)
    • Rüfer A, Brodmann D, Gregor M, Kremer Hovinga JA, Lämmle B, Wuillemin WA. Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura - a case report and concise review of the literature.
      Swiss Medical Weekly 2007;137:518-24
    • Kremer Hovinga JA, Zeerleder S, Kessler P, Romani de wit T, van Mourik JA, Hack CE, Ten Cate H, Reitsma PH, Wuillemin WA, Lämmle B. ADAMTS-13, von Willebrand factor and related parameters in severe sepsis and septic shock.
      J Thromb Haemost 2007;5(11):2284-90
    • Röth A, Dürig J, Himmelreich H, Bug S, Siebert R, Dührsen U, Lansdorp PM, Baerlocher GM. Short telomeres and high telomerase activity in T-cell prolymphocytic leukemia.
      Leukemia 2007;21(12):2456-62
    • Baerlocher GM, Sloand EM, Young NS, Lansdorp PM. Telomere length in paroxysmal nocturnal hemoglobinuria correlates with clone size.
      Exp Hematol 2007;35(12):1777-81
    • Hehlmann R,  Berger U, Pfirrmann M, Heimpel H,  Hochhaus A, Hasford J,  Kolb H-J, Lahaye T, Maywald O, Reiter A,  Hossfeld D, Huber C,  Löffler H, Pralle H, Queisser W, Tobler A, Nerl C, Solenthaler M, Goebeler M, Griesshammer M, Fischer T, Kremers S, Eimermacher H, Pfreundschuh M,  Hirschmann W, Lechner K, Wassmann B, Falge C,  Kirchner H, Gratwohl A, for the Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung (SAKK) and the German CML Study Group. Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia.
      Blood 2007;109:4686-4692
    • Meier N, Lipp E, Solenthaler M. Panzytopenie und Hämolyse - Diagnose, Differenzialdiagnose und Therapie der perniziösen Anämie.
      Dtsch Med Wochenschr 2007;29;132(27):1469-74
    • Fritschi J, Raddatz-Muller P, Schmid P, Wuillemin W. Patient self-management of long-term oral anticoagulation in Switzerland.
      Swiss Med Wkly 2007;137(17-18):252-258
    • Swisher K, Doan J, Vesely S, Kwaan H, Kim B, Lämmle B, Kremer Hovinga JA, George J. Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports.
      Haematologica 2007;92:936-943
    • Alter BP, Baerlocher GM, Savage SA, Chanock SJ, Weksler BB, Willner JP, Peters JA, Giri N, Lansdorp PM. Very short telomere length by flow FISH identifies patients with Dyskeratosis Congenita.
      Blood 2007;110(5):1439-47
    • Meyer SC, Sulzer I, Lämmle B, Kremer Hovinga JA. Hyperbilirubinemia interferes with ADAMTS-13 activity measurement by FRETS-VWF73 assay: diagnostic relevance in patients suffering from acute thrombotic microangiopathies.
      J Thromb Haemost 2007;5:866-7
    • Wendel S, Biagini S, Trigo F, Fontao-Wendel R, Taaning E, Jorgensen J, Riisom K, Krusius T, Koskinen S, Kretschmer V, Karger R, Lawlor E, Okazaki H, Charlewood R, Brand A, Solheim BG, Flesland O, Letowska M, Zupaska B, Muniz-Diaz E, Noques N, Senn M, Mansouri B, Chapman CE, MAssey E, Navarrette C, Stinsby D, Win N, Williamson LM, Kleinman S, Kopko PM, Silva M, Shulman I, Holness L, Epstein JS. Measures to prevent TRALI.
      Vox Sang 2007;92(3):258-77
    • Roth A, Schneider L, Himmelreich H, Baerlocher GM, Duhrsen U. Impact of culture conditions on the proliferative lifespan of human T cells in vitro.
      Cytotherapie 2007;9(1):91-8
    • Rizzi M, Tschan MP, Britschgi C, Britschgi A, Hugli B, Grob TJ, Leupin N, Mueller BU, Simon HU, Ziemiecki A, Torbett BE, Fey MF, Tobler A. The death-associated protein kinase 2 (DAPK2) is up-regulated during normale myeloid differentiation and enhances neutrophil maturation in myeloid leukemic cells.
      J Leukoc Biol 2007;81(6):1599-608
    • Voves C, Wolter I, Gregor M, Tsakiris D, Wuillemin W. Schwere Thrombozytopenie und sieben problemlose Geburten.
      Schweiz Med Forum 2007;7:212-214
    • Ouyang Q, Baerlocher GM, Vulto I, Landsdorp PM. Telomere Length in Human Natural Killer Cell Subsets.
      Ann N Y Acad Sci 2007;1106:240-52
    • Baerlocher GM, Rice K, Vulto I, Lansdorp PM. Longitudinal data on telomere length in leukocytes from newborn baboons support a marked drop in stem cell turnover around 1 year of age.
      Aging Cell 2007;6:121-3
    • Gratwohl A, Heim D, Bargetz M, Baerlocher GM, Chalandon Y, Durchosal M, Gregor M, Hess U, Oppliger Leibundgut E, Passweg J, Schanz U, Dirnhofer S. Behandlung der chronischen myeloischen Leukämie 2007. Empfehlung der Schweizerischen Arbeitsgruppe CML.
      Schweiz Med Forum 2007;7:934-40
    • Zeerleder S, Schroeder V, Lämmle B, Wuillemin WA, Hack CE, Kohler HP. Factor XIII in severe sepsis and septic shock.
      Thrombosis Research 2007;119:311-318
    • Ruutu T, Barosi G, Benjamin RJ, Clark RE,. George JN, Gratwohl A, Holler E, Iacobelli M, Kentouche K, Lämmle B, Moake JL, Richardson P, Socié G,  Zeigler Z, Niederwieser D, Barbui T. Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group.
      Haematologica/THJ 2007;92:95-100
    • Wolter I, Baerlocher GM. Chronische myeloische Leukämie: Epidemiologie, Pathogenese, Symptomatik, Diagnostik, und Therapie der CML.
      Onkologie 2007;1:14-19
    • Schmidt A, Solenthaler M. Chronische lymphatische Leukämie: Einteilung, Verlauf, Therapie und Prognose der CLL.
      Onkologie 2007;1:20-29

    2006

    • Vassina EM, Yousefi S, Simon D, Zwicky C, Conus S, Simon HU. cIAP-2 and survivin contribute to cytokine-mediated delayed eosinophil apoptosis.
      Eur J Immunol 2006; 36(7):1975-84
    • Baerlocher GM, Vulto I, de Jong G, Lansdorp PM. Flow cytometry and FISH to measure the average length of telomeres (flow FISH).
      Nat Protoc 2006;1(5):2365-76
    • Voves C, Wuillemin WA, Zeerleder S. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in spesis patients.
      Blood Coagul Fibrinolysis 2006; 17:445-451
    • Kickuth R, Anderson S, Peter-Salonen K, Lämmle B, Eggli S, Triller J. Hemophilia complicating total knee arthroplasty: Embolization: A cost-reducing alternative to medical therapy.
      Cardiovasc Intervent Radiol 2006; 29:1132-1135
    • Mansouri Taleghani B: Plasmaaustauschbehandlung (Plasmapherese und Immunadsorption). In: Gold R, Toyka KV (Hrsg): Immuntherapie neurologischer  Erkrankungen. Uni-Med, Bremen, Deutschland, 2006, (Buchbeitrag).Levy G, Byland C, Niederhauser C, Schwabe R, Senn M, Mansouri Taleghani B. Transfusion medicine in Switzerland.
      Transfus Med Hemother 2006; 33:393-400.
    • Fontana S, Lersch F, Nohl F, Mansouri Taleghani B. Pica, peanuts and plasma exchange.
      Transfusion 2006;46:1853-1854.
    • Flegel WA, Eicher NI, Doescher A, Hustinx H, Mansouri Taleghani B, Petershofen EK, Bauerfeind U, Ernst M, Zabern I, Schrezenmeier H, Wagner FF. In-frame triplet deletions in RHD alter the D antigen phenotype.
      Transfusion 2006; 46:2156-61.
    • Fontana S, Mordasini L, Keller P, Mansouri Taleghani B. Prospective, paired crossover comparison of multiple platelet aphereses with two different single-needle cell separators.
      Transfusion 2006; 46:2004-2010.
    • Fontana S, Groebli R, Leibundgut K, Pabst T, Zwicky C, Mansouri Taleghani B. Progenitor cell recruitment during individualized high-flow, very large volume apheresis for autologous transplantation improves collection efficiency.
      Transfusion 2006; 46:1408-1416
    • Fontana S, Kremer Hovinga JA, Lämmle B. Mansouri Taleghani B. Treatment of thrombotic thrombocytopenic purpura.
      Vox Sanguinis 2006;90:245-254
    • George JN, Vesely SK, Lämmle B. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. In: Hemostasis and Thrombisis. Basic principles and clinical practice (R.W. colman et al., editors).
      Lippincott, Williams and Wilkins, 2006 (5th edition), pp. 1613-1620
    • Kremer Hovinga JA, Mottini M, Lämmle B. Measurement of ADAMTS-13 activity in plasma by the FRETS-VWF73 assay: comparison with other assay methods.
      J Thromb Haemost 2006;4:1146-1148
    • Lämmle B, Kremer Hovinga JA. A new tool to further explore the role of ADAMTS-13 in health and disease.
      J Thromb Haemost 2006;4:952-954
    • Luken BM, Kaijen PHP, Turenhout EAM, Kremer Hovinga JA, Van Mourik JA, Fijnheer R, Voorberg J. Multipble B-cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type-1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura.
      J Thromb Haemost 2006;4:2355-2364
    • Mueller BU, Buerger AU, Solenthaler M, Garamvoelgyi EM, Oppliger Leibundgut E, Fey MF, Pabst T. Pleural tumors as sole primary manifestation of acute promyelocytic leukemia.
      Ann Oncol 2006;17:722-723
    • Oppliger Leibundgut E, Horn M, Brunold C, Pfanner B, Marti D, Hirsiger H, Tobler A, Zwicky C. Hematopoietic and endothelial progenitor cell trafficking in patients with myeloproliferative diseases.
      Haematologica 2006;91:1467-1474
    • Poole J, Warke N, Hustinx H, Mansouri Taleghani B, Martin P, Finning K, Karamatic Crew V, Green C, Bromilow I, Daniels G. A KEL gene encoding serine at position 193 of the Kell glycoprotein results in expression of KEL1 antigen.
      Transfusion 2006;46:1879-1885
    • Schneppenheim R, Kremer Hovinga JA, Becker T, Budde U, Karpman D, Brockhaus W, Hrachovinova I, Korczowski B, Oyen F, Rittich S, von Rosen J, Tjonnfjord GE, Pimanda JE, Wienker TF, Lämmle B. A common origin of the 4143insA ADAMTS13 mutation.
      Thromb Haemost 2006;96:3-6
    • Schnog JJB, Kremer Hovinga JA, Krieg S, Akin S, Lämmle B, Brandjes DPM, Mac Gillavry MR, Muskiet FD, Duits AJ. ADAMTS13 Activity in Sickle Cell Disease.
      Am J Hematol 2006;81:492-498
    • Stricker H, Colucci G, Alberio L, Mombelli G. Variation in coagulation inhibitors during prolonged sitting: possible pathogenetic mechanisms for travel-associated thrombosis.
      J Thromb Haemost 2006;4:900-902
    • Stricker H, Colucci G, Mombelli G. Acute effect of smoking and of 2 weeks of folate substitution on hemostasis and homocysteine in healthy chronic smokers.
      J Thromb Haemost 2006;4:2500-2503
    • Savage SA, Stewart BJ, Weksler BB, Baerlocher GM, Landsdorp PM, Chanock SJ, Alter BP. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.
      Blood Cells Mol Dis 2006; 37: 134-6

    2005

    • Alberio L, Clemetson KJ. Platelet inhibition and activation. Mechanisms and clinical implications.
      Herz 2005;30:176-80
    • Alberio L, Lämmle B. More on: thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia.
      J Thromb Haemost 2005;3:1549
    • Beyer V, Muhlematter D, Parlier V, Cabrol C, Bougeon-Mamin S, Solenthaler M, Tobler A, Pugin P, Gregor M, Hitz F, Hess U, Chapuis B, Laurencet F, Schanz U, Schmidt PM, van Melle G, Jotterand M.Polysomy 8 defines a clinico-cytogenetic entity representing a subset of myeloid hematologic malignancies associated with a poor prognosis: report on a cohort of 12 patients and review of 105 published cases.
      Cancer Genet Cytogenet 2005;160:97-119
    • Bienz M, Ludwig M, Leibundgut EO, Mueller BU, Ratschiller D, Solenthaler M, Fey MF, Pabst T. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
      Clin Cancer Res 2005;11:1416-24. Erratum in: Clin Cancer Res. 2005;11:5659
    • Brander L, Reil A, Bux J, Mansouri Taleghani B, Regli B, Takala J: Near-fatal transfusion-related acute lung injury (TRALI).
      Anesth Analg 2005;101:499-501
    • Fontana S, Gadola S, Mansouri Taleghani B, Nydegger UE: Klinische Bedeutung von Immunkomplexen. Teil 2 von 2.
      Swiss Medical Forum 2005;5:355-361
    • Klein CL, Marky-Zay J, Corbisier P,  Gancberg D, Cooper S, Gemmati D, Halbmayer WM, Kitchen S, Melegh B, Neumaier M, Oldenburg J, Oppliger Leibundgut E, Reitsma PH, Rieger S, Schimmel HG, Sapnnagl M, Tordai A, Tosetto A, Visvikis S, Zadro R, Mannhalter C. Reference materials (RMs) for analysis of the human factor II (prothrombin) gene G20210A mutation.
      Clin Chem Lab Med 2005;43:862-868
    • Krieg S, Studt JD, Sulzer I, Lämmle B, Kremer JA. Is factor V Leiden a risk factor for thrombotic microangiopathies without severe ADAMTS13 deficiency?
      Thromb Haemost 2005;94:1186-1189
    • Lämmle B, Kremer JA, Alberio L. Thrombotic thrombocytopenic purpura.
      J Thromb Haemost 2005;3:1663-1675
    • Ly H, Calado RT, Allard P, Baerlocher GM, Lansdorp PM, Young NS, Parslow TG. Functional characterization of telomerase RNA variants found in patients with hematologic disorders.
      Blood 2005;105:2332-2339
    • Mansouri Taleghani B, Fontana S, Meyer O, Ahrens N, Novak U, Borner M, Salama A.  Oxaliplatin-induced immune pancytopenia.
      Transfusion 2005;45:704-708
    • Oppliger Leibundgut E, Brunold C, Marti D, Horn MP, Seiler C, Schroeder V, Schmid JP, Tobler A, Zwicky C. Progenitor cell trafficking in physiologic conditions and in myeloproliferative diseases: quantification of CD34+ cells by polymerase chain reaction.
      Haematologica 2005;90:875-80
    • Rieger M, Mannucci PM, Kremer JA, Herzog A, Gerstenbauer G, Konetschny Ch, Zimmermann K, Scharrer I, Peyvandi F, Galbusera M, Remuzzi G, Böhm M, Plaimauer B, Lämmle B, Scheiflinger F. ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases.
      Blood 2005;106:1262-1267
    • Rittersma SZ, Kremer Hovinga JA, Koch KT, Boekholt SM, van Aken BE, Scheepmaker A, Bax M, Schotborgh CE, Piek JJ, Tijssen JG, Reitsma PH, de Winter RJ. Relation between in vitro lipopolysaccharide-induced cytokine response in whole blood, angiographic in-stent restenosis and Toll-like receptor 4 gene polymorphisms.
      Clinical Chemistry 2005;51:516-21
    • Roth A, Baerlocher GM, Schertzer M, Chavez E, Duhrsen U, Lansdorp PM. Telomere loss, senescence, and genetic instability in CD4+ T lymphocytes overexpressing hTERT.
      Blood 2005;106:43-50
    • Studt JD, Kremer Hovinga JA, Antoine G, Hermann M, Rieger M, Scheiflinger F, Lämmle B. Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS-13 inhibitor: in vitro inhibition of ADAMTS-13 activity by hemoglobin.
      Blood 2005;105:542-544
    • Terrell DR, Williams LA, Vesely SK, Lämmle B, Kremer Hovinga JA, George JN. The incidence of thrombotic thrombocytopenic purpura - hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency.
      J Thromb Haemost 2005;3:1432-1436 
    • Wuillemin WA, Korte W, Waser G, Lämmle B. Usefulness of the D-dimer/fibrinogen ratio to predict deep venous thrombosis.
      J Thromb Haemost 2005;3:385-387
    • Yamaguchi H, Calado RT, Ly H, Kajigaya S, Baerlocher GM, Chanock SJ, Lansdorp PM, Young NS. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia.
      N Engl J Med. 2005;352:1413-24

    2004

    • Arpagaus M, Oppliger Leibundgut E, Zbären K, Brunold C, Ischi E, Tobler A, Zwicky C. Real-time process/quality control for HPC processing. Cytotherapy 2004;6:505-513
    • Baerlocher GM, Lansdorp PM. Telomere length measurements using fluorescence in situ hybridization and flow cytometry. Methods Cell Biol 2004;75:719-50
    • Chilver-Stainer L, Lämmle B, Alberio L. Titer of anti-Heparin/PF4-antibodies and extent of in vivo activation of the coagulation and fibrinolytic systems.
      Thromb Haemost 2004;91:276-282
    • Fontana S, Kremer Hovinga JA, Studt J-D, Alberio L, Lämmle B, Mansouri Taleghani B. Plasma therapy in TTP: Review of the literature and the Berne experience in a subgroup of patients with severe acquired ADAMTS-13 deficiency.
      Sem Hematol 2004;41:48-59
    • Furlan M. Proteolytic cleavage of von Willebrand factor by ADAMTS-13 prevents uninvited clumping of blood platelets.
      J Thromb and Haemost 2004;2,9:1505-1509
    • Gerdes VEA, Kremer Hovinga JA, ten Cate H, Brandjes DPM, Büller HR on behalf of the Amsterdam Vascular Medicine Group. Soluble thrombomodulin in patients with established atherosclerosis.
      J Thromb Haemostas 2004;2:200-1
    • Gowland P, Fontana S, Niederhauser C, Mansouri Taleghani B. Molecular tracing of a transfusion-transmitted hepatitis A.
      Transfusion 2004;44:1555-1561
    • Klaus Ch, Plaimauer B, Studt JD, Dorner F, Lämmle B, Mannucci PM, Scheiflinger F. Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura.
      Blood 2004;103:4514-4519
    • Kremer Hovinga JA, Studt JD, Alberio L, Lämmle B. Von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: The Swiss experience.
      Sem Hematol 2004;41,1:75-82
    • Kremer Hovinga JA, Studt JD, Demarmels Biasiutti F, Solenthaler M, Alberio L, Zwicky C, Fontana S, Mansouri Taleghani B, Tobler A, Lämmle B. Splenectomy in relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpura.
      Haematologica 2004;89:320-4
    • Kremer Hovinga JA, Studt JD, Lämmle B. The von Willebrand factor-cleaving protease (ADAMTS-13) and the diagnosis of thrombotic thrombocytopenic purpura (TTP).
      Pathophysiol Haemostasis Thromb 2003/2004;33:417-421
    • Kremer Hovinga JA, Colucci G, Alberio L, Lämmle B. Die Folgen einer ungenügenden “Proteinschere”.
      Unipress 2004;123:19-21
    • Lämmle B, George JN. Thrombotic thrombocytopenic purpura: Advances in pathophysiology, diagnosis and treatment. Introduction.
      Sem Hematol 2004;41,1:1-3
    • Lämmle B, Kremer Hovinga JA, Studt JD, Mansouri Taleghani B, Alberio L. Thrombotic thrombocytopenic purpura.
      The Hematology Journal 2004;5:S6-S11
    • Ochsenbein AF, Riddell SR, Brown M, Corey L, Baerlocher GM, Lansdorp PM, Greenberg PD. CD27 expression promotes long-term survival of functional effector-memory CD8+ cytotoxic T lymphocytes in HIV-infected patients.
      J Exp Med 2004;200:1407-17
    • Solenthaler M, Tobler A. Myelodysplastische Syndrome – gar nicht so selten.
      Ther Umsch 2004;61:117-124
    • Studt JD, Kremer Hovinga JA, Radonic R, Gasparovic V, Ivanovic D, Merkler M, Wirthmueller U, Dahinden C, Furlan M, Lämmle B. Familial acquired thrombotic thrombocytopenic purpura: ADAMTS-13 inhibitory autoantibodies in identical twins.
      Blood 2004;103:4195-4197
    • Tripodi A, Chantarangkul V, Böhm M, Budde U, Dong JF, Friedman KD, Galbusera M, Girma JP, Moake J, Rick ME, Studt JD, Turecek PL, Mannucci PM. Measurement of von Willebrand factor cleaving protease (ADAMTS-13): results of an international collaborative study involving 11 methods testing the same set of coded plasmas.
      J Thrombosis Haemost 2004;2,9:1601-1609
    • Tobler A, Solenthaler M. Chronische myeloische Leukämie – Update.
      Ther Umsch 2004;61:143-150
    • Zahnd D, Leibundgut K, Zenhäusern R, Pabst T, Fontana S, Schneider R, Tobler A, Zwicky C. Implementation of the JACIE standards for a haematopoietic pregenitor cell transplantation programme: a cost analysis.
      Bone Marrow Transpl 2004;34:847-853
    • Zbaeren J, Solenthaler M, Schaper M, Zbaeren-Colbourn D, Haeberli A. A new fixative allowing accurate immunostaining of kappa and lambda immunoglobulin light chain expressing B-cells without antigen retrieval in paraffin-embedded tissue.
      J of Histotechn 2004;27:87-92
    • Zwicky C, Schneider R. Planung und Organisation einer komplexen Zertifizierung. Das Stammzell-Transplantations-Programm im Inselspital Bern.
      Qualitas 10-11/04

    2003

    • Aegerter Ch, Friess D, Alberio L. Menorrhagia caused by severe hereditary factor VII deficiency. Case 1.
      Hämostaseologie 2003;23:99-102
    • Aegerter Ch, Fontana S, Fux Ch, Demarmels Biasiutti F. Life threatening bleeding under adequate oral anticoagulation.
      Hämostaseologie 2003;23:113-116
    • Alberio L. Die orale Antikoagulation mit Vitamin K-Antagonisten.
      Ther Umsch 2003;60:5-9
    • Alberio L, Kimmerle S, Baumann A, Mansouri Taleghani B, Demarmels Biasiutti F, Lämmle B. Rapid determination of anti-heparin/Platelet factor 4 antibody titers in the diagnosis of heparin-induced thrombocytopenia.
      Am J Med 2003;114:528-536
    • Antoine G, Zimmermann K, Plaimauer B, Grillowitzer M, Studt JD, Lämmle B, F. Scheiflinger B. ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13.
      Br J Haematol 2003;120:821-824
    • Baerlocher GM, Roth A, Lansdorp PM. Telomeres in hematopoietic stem cells.
      Ann N Y Acad Sci, 2003;996:44-8
    • Baerlocher GM, Lansdorp PM. Telomere length measurements in leukocyte subsets by automated multicolor flow-FISH.
      Cytometry. 2003;55A:1-6
    • Baerlocher GM, Mak J, Roth A, Rice KS, Lansdorp PM. Telomere shortening in leukocyte subpopulations from baboons.
      J Leukoc Biol 2003;73:289-96
    • Baud P, Tobler A, Lämmle B, Alberio L. Acquired von Willebrand syndrome in myeloproliferative disorder.
      Hämostaseologie 2003;23:121-124
    • Bösiger J, Demarmels Biasiutti F. Recurrent thrombosis despite anticoagulation in a man with monocystosis.
      Hämostaseologie 2003;23:131-134
    • Caspari G, Cassens U, Hebart H, Klüter H, Mansouri Taleghani B, Wüllenweber J. Aktuelle Aspekte zur Vermeidung von transfusionsassoziierten CMV-Übertragungen. Stellungnahme der Sektionen „Sicherheit in der Hämotherapie“ und „Transplantation und Zelltherapie“ der DGTI. Transfus Med Hemother 2003;30:195-198
    • Demarmels Biasiutti F, Kremer Hovinga Strebel J. Antikoagulation und Antiaggregation in der Schwangerschaft.
      Ther Umschau 2003,60:54-58
    • Demarmels Biasiutti F, Berger D, Mattle HP, Lämmle B, Wuillemin WA. Hemostatic risk factors in ischemic stroke.
      Thromb Haemost 2003;90:1094-1099
    • Demarmels Biasiutti F. Thrombophilie und Schwangerschaft.
      Der Gynäkologe 2003,36:974-979
    • Fogarty PF, Yamaguchi H, Wiestner A, Baerlocher GM, Sloand E, Zeng WS, Read EJ, Lansdorp PM, Young NS. Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA.
      Lancet 2003;362:1628-30
    • Friess D, Lämmle B, Alberio L. Qualitative platelet defect and thrombohemorrhagic complications in a patient with polycythemia vera.
      Hämostaseologie 2003;23:138-143
    • Furlan M. Deficient activity of von Willebrand factor-Cleaving protease in thrombotic thrombocytopenic purpura.
      Expert Rev Cardiovasc Ther 2003;1:243-255
    • Furlan M. Deficiency of ADAMTS-13 in thrombotic and thrombocytopenic purpura.
      J Thromb Haemost 2003;1:2044-45
    • Kremer Hovinga J A, Solenthaler M, Dufour J-D. Congenital dyserythropoietic anaemia type II (HEMPAS) and haemochromatosis: a report of two cases.
      Eur J Gastroenterol Hepatol 2003;5:1141-1147
    • Kucher N, Kohler HP, Dornhöfer T, Wallmann D, Lämmle B. Accuracy of D-dimer/fibrinogen ratio to predict pulmonary embolism: A prospective diagnostic study.
      J Thromb Haemost 2003;1:708-713
    • Lämmle B. Praktische Probleme mit der oralen Antikoagulation: 3 Fallbeispiele.
      Therap Umschau 2003;60:63-66
    • Lämmle B, Strohm O, Tobler A. Organisationsentwicklung in Hämatologie: Arbeitspsychologie in Krankenhaus und Arztpraxis (E. Ulich, Herausgeber).
      Hans Huber, Bern 2003;341-360
    • Lämmle B, Demarmels Biasiutti F, Redondo M, Wuillemin WA. Prospective cross-sectional study of haemostatic factors in patients with and without coronary artery disease by R. Zahn et al. Letter to the Editor.
      Blood Coagul Fibrinolysis 2003;14:313
    • Lämmle B, Kremer Hovinga J A, Studt J-D, Alberio L. Deficiency of ADAMTS-13 in thrombotic and thrombocytopenic purpura. Invited Correspondence.
      J Thromb Haemost 2003;1:2042-2044
    • Leibundgut K, Hirt A, Zwicky C, Wuillemin WA. A 7-year-old boy with cerebral sinovenous thrombosis while on asparaginase treatment for acute lymphoblastic leukemia.
      Hämostaseologie 2003;23:99-148
    • Mansouri Taleghani B, Fontana S, Nydegger UE. Leucodepletion of red cells: current techniques and improvement of whole blood storage quality. In: Rossi U, de Villaescusa (eds.) Universal leucodepletion: the European experience.
      Edizione SIMTI, Milano, Italy, 2003:73-81
    • Mengis C, Demarmels Biasiutti F. Venous thrombosis and multiple prothrombotic gene defects.
      Hämostaseologie 2003;23:117-120
    • Mohaupt G, Krueger T, Girardi V, Mansouri Taleghani. Stroke after high-dose intravenous immunoglobulins.
      Transfus Med Hemother 2003;30:186-188
    • Schmidt E, Klinker E, Opitz A, Herzog S, Sitaru C, Goebeler M, Mansouri Taleghani B, Bröcker E-B, Zillikens D. Protein A immunoadsorption: a novel and effective adjuvant treatment of severe pemphigus.
      Br J Dermatol 2003;148:1222-1229
    • Studt JD, Kremer Hovinga JA, Furlan M, Lämmle B. Discrepant activity levels of von Willebrand factor-cleaving protease (ADAMTS-13) in congenital thrombotic thrombocytopenic purpura. Letter to the editor.
      Blood 2003;102:1148
    • Studt J-D, Kremer Hovinga J A, Alberio L, Bianchi V, Lämmle B (with contributions by P. Hénon, E. Siebke, M. Hermann). Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies: Diagnostic experience 2001/2002 of a single research laboratory.
      Swiss Med Weekly 2003;133:325-332
    • Studt J-D, Böhm M, Budde U, Girma J-P, Varadi K, Lämmle B. Measurement of von Willebrand factor-cleaving protease (ADAMTS-13) activity in plasma: A multicenter comparison of different assay methods.
      J Thromb Haemost 2003;1:1882-1887
    • Van Ziffle JA, Baerlocher GM, Lansdorp PM. Telomere length in subpopulations of human hematopoietic cells.
      Stem Cells 2003;21:654-60
    • Vesely SK, George JN, Lämmle B, Studt JD, Alberio L, El-Harake MA, Raskob GE. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Relation to presenting features and clinical outcomes in a prospective cohort of 142 patients.
      Blood 2003;102:60-68
    • Von der Weid N, Mansouri Taleghani B, Wuillemin WA. Severe nose bleeding after intake of acetylsalicylic acid: von Willebrand disease type 2A.
      Hämostaseologie 2003;23:135-137
    • Winkler A, Kremer Hovinga J A, Bianchi V, Studt J-D, Lämmle B. Schistocytic anaemia, severe thrombocytopenia and renal dysfunction: thrombotic microangiopathy due to severe acquired ADAMTS-13 deficiency.
      Hämostaseologie 2003;23:103-108
    • Yamaguchi H, Baerlocher GM, Lansdorp PM, Chanock SJ, Nunez O, Sloand E, Young NS. Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome.
      Blood 2003;102:916-8
    • Zeerleder S, Zwart B, Wuillemin WA, Aarden LA, Groeneveld ABJ, Caliezi C, van Niewenhuijze AEM, van Mierlo GJ, Eerenberg AJM, Lämmle B, Hack CE. Elevated nucleosome levels in systemic inflammation.
      Crit Care Med 2003;31:1947-1951
    • Zeerleder S, Zürcher Zenklusen R, Hack CE, Wuillemin W A. Disseminated intravascular coagulation in meningococcal sepsis.
      Hämostaseologie 2003;23:125-130
    • Zenhäusern R, Zwicky C, Solenthaler M, Fey MF, Tobler A. Akute Leukämien beim Erwachsenen.
      Schweiz Med Forum 2003 Nr. 29/30
    • Zenhäusern R, Solenthaler M, Tobler A. Chronische Leukämien beim Erwachsenen: Chronische Lymphatische Leukämie und Haarzeel-Leukämie.
      Schweiz Med Forum 2003, Nr. 31

    2002

    • Alberio L, Friese P, Clemetson KJ, Dale GL. Collagen response and glycoprotein VI function decline progressively as canine platelets age in vivo.
      Thromb Haemost 2002;88:510-6
    • Asmis LM, Sulzer I, Furlan M, Lämmle B. Prekallikrein deficiency: The characteristic normalization of the severely prolonged aPTT following increased preincubation time is due to autoactivation of factor XII.
      Thromb Res 2002;105:463-470
    • Awaya N, Baerlocher GM, Manley TJ, Sanders JE, Mielcarek M, Torok-Storb B, Lansdorp PM. Telomere shortening in hematopoietic stem cell transplantation: a potential mechanism for late graft failure?
      Biol Blood Marrow Transplant. 2002;8:597-600
    • Baerlocher GM, Mak J, Tien T, Lansdorp PM. Telomere length measurement by fluorescence in situ hybridization and flow cytometry: tips and pitfalls.
      Cytometry 2002;47:89-99
    • Bianchi V, Robles R, Alberio L, Furlan M, Lämmle B. Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura.
      Blood 2002;100:710-713
    • Brandenberg JB, Demarmels Biasiutti F, Lutz HU, Wuillemin WA. Hereditary spherocytosis and hemochromatosis.
      Ann Hematol 2002;81:202-9
    • Brummendorf TH, Mak J, Sabo KM, Baerlocher GM, Dietz K, Abkowitz JL, Lansdorp PM. Longitudinal studies of telomere length in feline blood cells: implications for hematopoietic stem cell turnover in vivo.
      Exp Hematol 2002;30:1147-52
    • Calderoni A, von Briel C, Aebi S, Solenthaler M, Betticher DC. Intensive chemotherapy with whole blood stem-cell support and concurrent chest radiotherapy in small cell lung cancer: a phase I/II trial.
      Lung Cancer 2002;36:321-326
    • Caliezi C, Zeerleder S, Redondo M, Regli B, Rothen HU, Zürcher-Zenklusen R, Rieben R, Devay J, Hack CE, Lämmle B, Wuillemin WA. C1-inhibitor in patients with severe sepsis and septic shock: Beneficial effect on renal dysfunction.
      Crit Care Med 2002;30:1722-1728
    • Dale GL, Friese P, Batar P, Hamilton SF, Reed GL, Jackson KW, Clemetson KJ, Alberio L. Dual-agonist stimulated platelets utilize serotonin conjugation of procoagulant proteins to enhance their retention on the cell surface.
      Nature 2002;415:175-9
    • Furlan M. Sticky and promiscuous plasma proteins maintain the equilibrium between bleeding and thrombosis.
      Swiss Med Wkly 2002;132:181-189
    • Furlan M. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome (in "Platelets in thrombotic and notn-thrombotic disorders"). Pathophysiology, Pharmacology and Therapeutics (P. Gresche, C. Page, V. Fuster, J. Vermylen Eds).
      Cambridge, University Press 2002
    • Furlan M. Deficiency of ADAMTS-13 is involved in the etiology of thrombotic thrombocytopenic purpura.
      The circulation frontier Vol 8, No 3:26-34
    • Furlan M, Lämmle B. Assays of von Willebrand factor-cleaving protease: A test for diagnosis of familial and acquired thrombotic thrombocytopenic purpura.
      Sem Thromb Hemost 2002;28:167-172
    • George JN, Sadler JE, Lämmle B. Thrombotic Thrombocytopenic Purpura.
      Hematology 2002;315-334
    • Grob T, Fey M, Tobler A. The two faces of p73.
      Cell Death Differ 2002;9:229-230
    • Heizmann M, Baerlocher GM, Steinmann F, Horber FF, Wuillemin W. Anti-Xa activity in obese patients after double standard dose of nadroparin for prophylaxis.
      Thromb Res 2002;106:179-81
    • Lämmle B, Bianchi V, Alberio L, Furlan M. ADAMTS13 and thrombotic thrombocytopenic purpura: Letter to the Editor.
      Blood 2002;100:3840-3842
    • Lämmle B, Hunt BJ, Haycock GB, Furlan M. Reply to Rebuttal. von Willebrand factor-cleaving protease in childhood diarrhoea-associated haemolytic uraemic syndrome. Letter to the Editor.
      Thromb Haemost 2002;87:549-550
    • Mansouri Taleghani B. The quality of leucodepleted whole blood and clinical indications of its use. In: Kretschmer V, Walterová L, Novak VL, Rossi U (eds.) Blood-sparing medicine and surgery: the absolute need of safe autologous and homologous blood donation.
      Proceedings of the ESTM residential course, Lviv (Ukraine), 19.-21. September 2002;185-190.
    • Merlo C, Wuillemin WA, Redondo M, Furlan M, Sulzer I, Kremer Hovinga J, Binder BR, Lämmle B. Elevated levels of plasma prekallikrein, high molecular weight kininogen and factor XI in coronary heart disease.
      Atherosclerosis 2002;161:261-267
    • Novak U, Oppliger Leibundgut E, Hager J, Mühlematter D, Jotterand M, Besse C, Papp J, Kearsey G, Aebi S, Jaggi R, Lüthi JM, Meyer-Monard S, Lathrop M, Tobler A, Fey MF. A high-resolution allelotype of B-cell chronic lymphocytic leukaemia (B-CLL).
      Blood 2002;100:1787-1794
    • Plaimauer B, Zimmermann K, Völkel D, Antoine G, Kerschbaumer R, Jenab P, Furlan M, Gerritsen H, Lämmle B, Schwarz HP, Scheiflinger F. Cloning, expression and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13).
      Blood 2002;100:3626-3632
    • Solenthaler M, Matutes E, Brito-Babapulle V, Morilla R, Catovsky D. p53 and mdm2 in mantle cell lymphoma in leukemic phase.
      Haematologica 2002;87:1141-1150
    • von Rohr A, Schmitz S, Tichelli A, Hess U, Piguet D, Wernli M, Frickhofen N, Konwalinka G, Zulian G, Ghielmini M, Rufener B, Racine C, Fey MF, Cerny T, Betticher D, Tobler A. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection : a phase II study.
      Ann Oncol 2002;13:1641-1649
    • Wuillemin WA, Gasser KM, Zeerleder S, Lämmle B. Evaluation of a platelet function analyser (PFA-100) in patients with a bleeding tendency.
      Swiss Med Weekly 2002;132:443-448
    • Zeerleder S, Mauron T, Lämmle B, Wuillemin WA. Effect of low-molecular weight dextran sulfate on coagulation and platelet function tests.
      Thromb Res 2002;105:441-446
    • Zwicky C, Theiler L, Zbären K, Ischi E, Tobler A. The predictive value of clonogenic stem cell assays for the diagnosis of polycythemia vera.
      Br J Hematol 2002;117:598-604
    • Zwicky C, Zenhäusern R, Tobler A. Traitement des leucémies aiguës.
      Médecine et Hygiène, April 2002;60:852-57

    2001

    • Alberio L, Lämmle B, Esmon CT. Protein C replacement in severe meningococcemia: Rationale and clinical experience.
      Clin Infect Dis 2001;32:1338-1346
    • Barbot J, Costa E, Guerra M, Barreirinho MS, Isvarlal P, Robles R, Gerritsen HE, Lämmle B, Furlan M. Ten years of prophylactic treatment with fresh-frozen plasma in a child with chronic relapsing thrombotic thrombocytopenic purpura as a result of a congenital deficiency of von Willebrand factor-cleaving protease.
      Br J Haematol 2001;113:649-651
    • Fontana S, Gerritsen HE, Kremer Hovinga J, Furlan M, Lämmle B. Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor-cleaving protease.
      Br J Haematol 2001;113:100-102
    • Fünfsinn N, Caliezi C, Demarmels Biasiutti F, Korte W, Z`Brun A, Baumgartner I, Ulrich M, Cottier C, Lämmle B, Wuillemin WA. Rapid D-dimer testing and pre-test clinical probability in the exclusion of deep venous thrombosis in symptomatic outpatients.
      Blood Coagul Fibrinolysis 2001;12:165-170
    • Furlan M, Lämmle B. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
      Best Pract Res Clin Haematol 2001;14:437-454
    • Gerritsen HE, Robles R, Lämmle B, Furlan M. Partial amino acid sequence of purified von Willebrand factor-cleaving protease.
      Blood 2001;98:1654-1661
    • Güngör T, Furlan M, Lämmle B, Kuhn F, Seger RA: Acquired deficiency of von Willebrand factor-cleaving protease in a patient suffering from acute systemic lupus erythematosus.
      Rheumatology 2001;40:940-942
    • Grob T, Novak U, Maisse C, Barcaroli D, Lüthi A, Pirnia F, Hügli B, Graber H, De Laurenzi V, Fey M, Melino G, Tobler A. Human (Np73 regulates a dominant negative feedback loop for Tap73 and p53.
      Cell Death Differ 2001; 8:1213 - 1223
    • Hunt BJ, Lämmle B, Nevard CHF, Haycock GB, Furlan M. Von Willebrand factor-cleaving protease in childhood diarrhoea-associated haemolytic uraemic syndrome.
      Thromb Haemost 2001;85:975-978
    • Kobelt K, Demarmels Biasiutti F, Mattle HP, Lämmle B, Wuillemin WA. Protein Z in ischaemic stroke.
      Br J Haematol 2001;114:169-173.
    • Kremer Hovinga JA, Otten JMM, Levi MM, ten Cate H. Disease specific mechanisms of disseminated intravascular coagulation. In: ten Cate H, Levi M, eds. Molecular Mechanisms of Disseminated Intravascular Coagulation.
      Landes Biosciences, Georgetown, TX, USA 2001 (ISBN 1-58706-058-2)
    • Mansouri Taleghani B, Langer R, Grossmann R, Opitz A, Halbsguth U, Buchheister A, Schuler S, Bachthaler R, Wiebecke D. Verbesserung der biochemischen und rheologischen Qualität von Vollblut und Erythrozytenkonzentraten durch Leukozytendepletion vor Lagerung.
      Anästhesiol Intensivmed Notfallmed Schmerzth 2001,36 (Suppl1):11-19
    • Mansouri Taleghani B, Grossmann R. Treatment of patients with factor VIII autoantibodies by staphylococcal protein a-based immunoadsorption and immunosuppression.
      Br J Haematol 2001,114:954-62 (scientific letter).
    • Mansouri Taleghani B. Plasmaaustauschbehandlung (Plasmapherese und Immunadsorption). In: Gold R, Toyka KV (Hrsg): Immuntherapie neurologischer Erkrankungen.
      Uni-Med, Bremen, 2001:62-67
    • Novak U, Grob TJ, Baskaynak G, Peters UR, Aebi S, Zwahlen D, Tschan MP, Kreuzer KA, Oppliger Leibundgut E, Cajot JF, Tobler A, Fey MF. Overexpression of the p73 gene is a novel finding in high-risk B-cell chronic lymphocytic leukaemia.
      Annals of Oncology 2001;12:981-986
    • Oldenburg J, Kriz K, Wuillemin WA, Maly FE, von Felten A, Siegemund A, Keeling DM, Baker P, Chu K, Konkle BA, Lämmle B, Albert T. Genetic predisposition to bleeding durging oral anticoagulant therapy: Evidence for common founder mutations (FIX Val -10 and FIX Thr -10) and an independent CpG hotspot mutation (FIX Thr -10).
      Thromb Haemost 2001;85:454-457
    • Redondo M, Carroll VA, Mauron T, Demarmels Biasiutti F, Binder BR, Lämmle B, Wuillemin WA. Hemostatic and fibrinolytic parameters in survivors of myocardial infarction: A low plasma level of plasmin-(2-antiplasmin complex is an independent predictor of coronary re-events.
      Blood Coag Fibrinol 2001;12:17-24
    • Redondo M, Caliezi C, Demarmels Biasiutti F, Lämmle B, Wuillemin WA. Increased fibrin monomer plasma concentration in stable coronary artery disease in patients without oral anticoagulation.
      Atherosclerosis 2001;157:417-422
    • Schambeck CM, Hinney K, Haubitz I, Mansouri Taleghani B, Wahler D, Keller F. Familial clustering of high factor VIII levels in patients with venous thrombo-embolism.
      Arterioscler Thromb Vasc Biol 2001,21:289-292
    • Tschan MP, Vonlanthen S, Cajot JF, Peters UR, Oppliger E, Betticher D, Yarbrough WG, Fey MF, Tobler A. Different p16INK4a and p14ARF Expression Patterns in Acute Myeloblastic Leukemia and Normal Blood Leukocytes1.
      Leukemia and Lymphoma 2001;42:1077-1087
    • Wuillemin WA, Demarmels Biasiutti F, Mattle HP, Lämmle B. Frequency of protein Z deficiency in patients with ischaemic stroke. Letter to the editor.
      Lancet 2001;358:840-841

    2000

    • Alberio L, Safa O, Clemetson KJ, Esmon CT, Dale GL. Surface expression and functional characterization of alpha-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen and convulxin.
      Blood 2000;95:1694-1702
    • Balga I, Solenthaler M, Furlan M. Should red cell volume be measured or calculated?
      Blood Cells Mol Dis 2000;26:25-31
    • Bolliger-Stucki B, Baillod P, Furlan M. Functional properties of the fibrinogen component of a fibrin glue before and after severe dry heat treatment.
      J Biomed Mat Res 2000;53:577-583
    • Borberg H, Löliger C, Mansouri Taleghani B, Ullrich H, Wiesneth M: Empfehlungen der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie (DGTI) für therapeutische Hämapheresen.
      www.dgti.de/sektion/haemaph/Empfehlungen_01.doc, Mai 2000
    • Caliezi C, Reber G, Lämmle B, de Moerloose P, Wuillemin WA: Agreement of D-dimer results measured by a rapid ELISA (VIDAS) before and after storage during 24 hours or transportation of the original whole blood samples.
      Thromb Haemost 2000;83:177-178
    • Caliezi C, Wuillemin WA, Zeerleder S, Redondo M, Eisele B, Hack CE. C1-esterase inhibitor: an anti-inflammatory agent and ist potential use in the treatment of diseases other than hereditary angioedema.
      Pharmacol Rev 2000;52:91-112
    • Caliezi C, Waber M, Pfiffner D, Lämmle B, Saner H, Wuillemin WA. Patienten-Selbstkontrolle der oralen Antikoagulation CoaguChek.
      Schweiz Med Wschr 2000;130:916-923
    • Chiappini D, Wuillemin WA, Gardi M, Jeanneret C, Tobler A. Vergleichbarkeit des Blutstatus zwischen dem QBC-Autoread-System und einem elektronischen Zellzählgerät (Coulter Counter STKS).
      Schweiz Med Wschr 2000;130:545-550
    • Cines DB, Konkle BA, Furlan M. Thrombotic thrombocytopenic purpura: a paradigm shift?
      Thromb Haemost 2000;84:528-535
    • Demarmels Biasiutti F. Thrombophilieabklärung.
      Hämostaseologie 2000;1:17-21
    • Furlan M. Rôle de la protéase clivant le facteur von Willebrand dans le purpura thrombotique thrombocytopénique (PTT) et le syndrome hémolytique et urémique (SHU).
      In Actualités Néphrologiques Jean Hamburger, Flammarion, Paris; May 2000:189-197
    • Furlan M. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura (TTP) and the hemolytic uremic syndrome (HUS).
      Adv in Nephr 2000;30:71-81
    • Furlan M, Lämmle B. Splenectomy in thrombotic thrombocytopenic purpura.
      Am J Hematol 2000;64:79, Letter to the Editor.
    • Furlan M, Lämmle B. Haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura - new insights into underlying biochemical mechanisms. Editorial comment.
      Nephrol Dial Transplant. 2000;15:1112-1114
    • Gähler A, Stallmach T, Schwaller J, Fey MF, Tobler A. Interleukin-8 Expression by Fetal and Neonatal Pulmonary Cells in Hyaline Disease and Amniotic Infection.
      Pediatr Res 2000;48:299-303
    • Gasser KM, Wuillemin WA. Der PFA-100: Eine neue Methode für die in vitro-Messung der primären Hämostase. LABOLIFE 2000; 4:13-15
    • Krebs T, Zimmerli S, Bodmer B, Lämmle B. Mycobacterium genavense infection in a patient with long-standing chronic lymphocytic leukaemia.
      J Int Med 2000;248:343-348
    • Lämmle B, Tobler A, Fey MF, Cerny T, Nydegger U: Krankheiten des Blutes und der blutbildenden Organe.
      In: Hadorn Therapie-Handbuch (T. Hess, Herausgeber), 9. Auflage, 2000 Verlag Hans Huber, Bern, S.275-340
    • te Loo DMWM., Levtchenko E, Furlan M, Roosendaal GPM, van den Heuvel LPW. Autosomal recessive inheritance of von Willebrand factor-cleaving protease deficiency.
      Pediatr Nephrol 2000;14:762-765
    • Mansouri Taleghani B, Grossmann R, Reith HB, Wiebecke D, Thiede A: Fremdblutsparende Massnahmen in der operativen Medizin.
      Zentralbl Chir 2000;125:111-122
    • Grossmann R, Mansouri Taleghani B, Rader C, Kramer C, Eulert J, Keller F. Is there any influence of the protein C system on perioperative blood loss in total knee or hip arthroplasty?
      Thromb Res 2000,99:473-475
    • Mauron T, Lämmle B, Wuillemin WA. High molecular weight kininogen is cleaved by FXIa at three sites: Arg409-Arg410, Lys502-Thr503 and Lys325-Lys326.
      Thromb Haemost 2000;83:709-714
    • Medinger P, Schneider P, Nicoloso de Faveri G, Zwicky C, Tissot JD. Autogreffe de cellules souches hématopoïétiques périphériques dans le cadre du traitement d'hémopathies malignes. Partie II : détermination des cellules CD34+ et des colonies de progéniteurs.
      Schweiz Med Wochenschr 2000;130:510-5
    • Medinger P, Tissot JD, Nicoloso de Faveri G, Kovacsovics TJ, Perey L, Schneider Ph, Zwicky C. Autogreffe de cellules souches hématopoïétiques périphériques dans le cadre du traitement d'hémopathies malignes. Partie I : paramètres cliniques.
      Schweiz Med Wochenschr 2000;130:478-84
    • Moshfegh K, Redondo M, Julmy F, Wuillemin WA, Gebauer MU, Haeberli A, Meyer BJ. Antiplatelet effects of Clopidogrel compared with Aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy.
      J Am Coll Cardiol 2000;36:699-705
    • Niederer A, Wuillemin WA. Therapie der venösen Thromboembolie.
      Praxis 2000
    • Pabst T, Peters UR, Tinguely M, Schwaller J, Tschan M, Aebi S, Vonlanthen S, Borisch B, Betticher DC, Zimmermann A, Tobler A, Fey MF. Divergent Expression of Cyclin-Dependent Kinase Inhibitors (CKI) And p14ARF/p16( in Non-Hodgkin's Lymphomas and Chronic Lymphocytic Leukemia.
      Leuk Lymphoma 2000;37:639-648
    • Tschan MP, GrobTJ, Peters UR, De Laurenzi V, Huegli B, Kreuzer KA, Schmidt CA, Melino G, Fey MF, Tobler A, Cajot JF. Enhanced p73 expression during myeloid differentiation and complex p73 isoform pattern in myeloid leukemia.
      Biochem Biophys Res Commun 2000;14;277:62-5
    • Wuillemin WA."Point-of-care Testing / Vollblutmethoden in der Hämostasediagnostik.
      Hämostaseologie 2000;20:13-16.
    • Zenhäusern R, Tobler A, Leoncini L, Hess OM, Ferrari P. Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure.
      Ann Hematol 2000;79:523-6
    • Zwahlen D, Tschan MP, Grob TJ, Peters UR, Fink D, Haenggi W, Altermatt HJ, Cajot JF, Tobler A, Fey MF, Aebi S. Differential Expression of p73 Splice Variants and Protein in Benign and Malignant Ovarian Tumours.
      Int J Cancer 2000;1;88:66-70
    • Zwicky C, Gerber S, Gasparini G, Forestier F, Hohlfeld P, Tissot JD, Schneider P. Preparation and analysis of fetal liver extracts.
      Bone Marrow Transplant 2000;26:667-72

    1999

    • Alberio L, Safa O, Clemetson KJ, Esmon CT, Dale GL. High level surface expression of functional alpha-granule factor V on COAT-platelets, a subpopulation of platelets activated by thrombin and collagen.
      Blood 1999;94(Supplement 1):220a
    • Alberio L, Hirt A. Zweijähriger Knabe mit rezidivierenden muko-kutanen Blutungen: Thrombasthenie Glanzmann. Die Rolle des Fibrinogenrezeptors (Glycoprotein IIb-IIIa) in der Thrombozyten-funktion.
      Therapeutische Umschau 1999;56:495-8
    • Alberio L, Fiori G, Domenighetti G. An unusual cause of shock in a woman with chest pain.
      Hosp Pract 1999:34(4):155-61
    • Alberio L, Dale GL. Platelet-collagen interactions: membrane receptors and intracellular signaling pathways.
      Eur J Clin Invest 1999;29:1066-76
    • Aus der Au C, Wuillemin WA. D-Dimer Test bei Verdacht auf venöse Thromboembolie.
      Ars Medici 1999;11:751-753
    • Baerlocher GM, Leoncini-Franscini L, Wuillemin WA, Furlan M. Patientin mit rezidivierenden gastrointestinalen Blutungen bei aquiriertem Morbus von Willebrand.
      Therapeutische Umschau 1999;9:487-490
    • Beris Ph, Solenthaler M, Deutsch S, Darbellay R, Tobler A, Bochaton-Pialat ML, Gabbiani G. Severe inclusion body (-thalassaemia with haemolysis in a patient double heterozygous for (o-thalassaemia and quadruplicated (-globin gene arrangement of the anti 4.2 type.
      Br J Haematol 1999:105,1074-1080
    • Bohler, Redondo M, Lämmle B. Verlängerte Thrombinzeit bei einem Patienten mit multiplem Myelom.
      Therap Umschau 1999;56:491-494
    • Bohler, Lämmle B. Verminderter Quickprozentwert, akquirierter Faktor X-Mangel, Gelenksblutung und Hautblutungen: Amyloidose.
      Therap Umschau 1999;56:523-525
    • Bolliger-Stucki, Bucciarelli B, Lämmle B, Furlan M. Fibrinogen Milano XIII (A( 19 Arg ® Gly): A dysfunctional variant with an amino acid substitution in the N-terminal polymerization site. Thromb Res 1999;96:399-405
    • Bounameaux H, Beer J, Blättler W, Do DD, Eichlisberger R, Franzeck UK, Hayoz D, Jäger K, Koppensteiner R, de Moerloose P, Stricker H, Vogel J, Wuillemin WA. Die ambulante Behandlung von Patienten mit tiefer Venenthrombose: Stellungnahme eines Expertenkomitees.
      Schw Aerztezeitung 1999;80:405-408
    • Caliezi C, Holtz D, Wuillemin WA. D-Dimer-Bestimmung bei Verdacht auf tiefe Venenthrombose oder Lungenembolie.
      Therapeutische Umschau 1999;9:529-532
    • Caliezi C, Fünfsinn N, Mauron T, Baumgartner I, Sulzer I, Ulrich M, Cottier C, Demarmels Biasiutti F, Lämmle B, Wuillemin WA. Performance of a new fibrin monomer assay to exclude deep vein thrombosis in symptomatic outpatients.
      Thromb Haemost 1999;81:50-53
    • Escher R, Demarmels Biasiutti F. A 26-year-old woman with splanchnic vein thrombosis as the initial manifestation of polycythemia vera.
      Ther Umsch 1999;56:505-8
    • Fontana S, Zeerleder S, Lämmle B. Entgleiste orale Antikoagulation mit sehr hohen INR-Werten und schlechtem Ansprechen auf perorales Vitamin K - Cholestase als mögliche Ursache.
      Therap Umschau 1999;56:477-480
    • Fontana S, Lämmle B. Chronische, blutungsbedingte Eisenmangelanämie bei Morbus Osler.
      Therap Umschau 1999;56:526-528
    • Furlan M, Lämmle B. Von Willebrand factor in thrombotic thrombocytopenic purpura. State of the art.
      Thromb Haemost 1999;82:592-600
    • Furlan M, Robles R, Morselli B, Sandoz P, Lämmle B. Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura.
      Thromb Haemost 1999;81:8-13
    • Furlan M. von Willebrand factor proteolysis in thrombotic thrombocytopenic purpura.
      Blood 1999;4:3611-3612 (Correspondence)
    • Gerritsen HE, Turecek PL, Schwarz HP, Lämmle B, Furlan M. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: A tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
      Thromb Haemost 1999;82:1386-1389
    • Grossmann R, Mansouri Taleghani B: Diagnostik und Therapie erworbener Faktoreninhibitoren.
      D Med Wochenschr 1999;124:740-745
    • Häberle J, Kehrel B, Ritter J, Jürgens H, Lämmle B, Furlan M. New strategies in diagnosis and treatment of thrombotic thrombocytopenic purpura: Case report and review.
      Eur J Pediatr 1999;158:883-887
    • Hasse U, Tinguely M, Oppliger Leibundgut E, Cajot JF, Garvin AM, Tobler A, Borisch B, Fey MF. Clonal loss of heterozygosity in microdissected Hodgkin/Reed-Sternberg cells.
      Int J Cancer 1999;91:1581-1583, 1999
    • Hehlmann R, Hochhaus A, Kolb HJ, Hasford J, Gratwohl A, Heimpel H, Siegert W, Finke J, Ehninger Holler E, Berger U, Pfirrmann M, Muth A, Zander A, Fauser AA, Heyll A, Nerl Ch, Hossfeld DK, Löffler H, Pralle H, Queisser W, Tobler: A for the German CML-Study Group and the SAKK: Interferon ( prior to allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure.
      Blood 1999;94:3668-2677
    • Herren S, Lämmle B. APC-Resistenz - häufigste familiäre Thrombophilie.
      Therap Umschau 1999;56:499-501
    • Kremer Hovinga JA, Wuillemin WA. Rezidivierende Hepatitis unter oraler Antikoagulation: Coumarin induzierte Hepatitis.
      Therapeutische Umschau 1999;9:513-515.
    • Kremer Hovinga JA, Baerlocher GM, Wuillemin WA, Solenthaler M. Tiefe Beinvenenthrombose bei erworbener Thrombophilie - Hyperhomozysteinämie als Folge einer nicht bekannten Zoeliakie.
      Therapeutische Umschau 1999; 9:519-522
    • Kriz-Kozak K, Lämmle B. 46-jährige Frau mit multiplen Hämatomen und Zungengrundblutung: Phenprocoumon-Intoxikation.
      Therap Umschau 1999;56:541-543
    • Lämmle B, Furlan M. New insights into the pathogenesis of thrombotic thrombocytopenic purpura.
      Hematology 1999;243-248
    • Lankhof H., Damas C., Schiphorst M.E., Ijsseldijk M.J.W., Bracke M., Furlan M., de Groot P.G., Sixma J.J., Vink T: Recombinant vWF type 2A mutants R834Q and R834W show a defect in mediating platelet adhesion to collagen, independent of enhanced sensitivity to a plasma protease.
      Thrombosis and Haemostasis 1999;81:876-883
    • Lehmann T, Lämmle B. IFN( treatment in systemic mastocytosis. Letter to the Editor.
      Ann Hematol 1999;78:483-484
    • Leibundgut K, Zbären K, Ischi E, Tobler A. Purity and recovery of the CD34+ Cell fraction, obtained by the CEPRATER selection system from PBSC collections, can be augmented by meticulous washing steps.
      Cytotherapy 1999;1:5-6
    • Leibundgut K, Schmitz N, Tobler A, Ridolfi Lüthy A, Hirt A.: In Childhood Acute Lymphoblastic Leukemia the Hypophosphorylated Retinoblastoma Protein, p110 RB, Is Diminished, as Compared with Normal CD34( Peripheral Blood Progenitor Cells.
      Pediatric Research 1999;45:692-696
    • Lübbert M, Tobler A, Daskalakis. Phagocyte differentiation is associated with cytosine demethylation of the gene for proteinase-3/myeloblastin primary granule protein.
      Leukemia 1999;13:1420-1427
    • Mansouri Taleghani B, Reith HB, Wiebecke D, Thiede A: Hämotherapie in der operativen Medizin (Teil 1).
      Zentralbl Chir 1999;124:W19-26.
    • Mansouri Taleghani B, Reith HB, Wiebecke D, Thiede A: Hämotherpaie in der operativen Medizin (Teil 2).
      Zentralbl Chir 1999;124:W27-41.
    • Mansouri Taleghani B: Gewinnung hämatopoetischer Vorläuferzellen mittels Leukapherese.
      In: Weissinger F, (Hrsg): Grundlagen der autologen peripheren Stammzelltransplantation. Uni-Med, Bremen:1999:52-63.
    • Moshfegh K, Wuillemin WA, Redondo M, Lämmle B, Beer JH, Liechti-Gallati S, Meyer BJ. Association of two silent polymorphisms of platelet glycoprotein Ia/IIa receptor with risk of moycardial infarction: a case-control study.
      Lancet 1999;353:351-354
    • Oppliger Leibundgut E, Jotterand M, Rigamonti V, Parlier, V, Mühlematter D, Tobler A, Solenthaler M. A novel BCR-ABL transcript e2a2 in a chronic myelogenous leukaemia patient with a duplicated Ph-chromosome and monosomy 7.
      Br J Haematol 1999;106:1041-1044
    • Peter K, Furlan M, Lämmle B. Lebenslängliche hämorrhagische Diathes bei einem jungen Mann mit ungerinnbaren Globaltesten der Gerinnung - kongenitale Afibrinogenämie.
      Therap Umschau 1999;56:516-518
    • Peters UR, Tschan MP, Kreuzer KA, Baskaynak G, Lass U, Tobler A, Fey MF, Schmidt CA.Distinct expression patterns of the p53-homologue p73 in malignant and normal hematopoiesis assessed by a novel real-time RT-PCR assay and protein analysis.
      Cancer Res.1999; 59:4233-4236
    • Peters UR, Hasse U, Oppliger E, Tschan M, Tiong Ong S, Rassool FV, Borisch B, Tobler A, Fey MF. Aberrant FHIT mRNA transcripts are present in malignant and normal haematopoiesis, but absence of FHIT protein is restricted to leukaemia.
      Oncogene 1999;18,79-85
    • Redondo M, Solenthaler M, Zeerleder S, Wuillemin WA. Isoliert verlängerte aPTT mit anamnestisch hämorrhagischer Diathese - schwerer FXI-Mangel.
      Therapeutische Umschau 1999; 9:502-504.
    • Redondo M, Watzke HH, Stucki B, Sulzer I, Demarmels Biasiutti F, Binder BR, Furlan M, Lämmle B, Wuillemin WA. Coagulation factors II, V, VII, and X, prothrombin gene 20210 G-A transition and factor V Leiden in coronary artery disease: high factor V clotting activity is an independent risk factor for myocardial infarction.
      Arterioscler Thromb Vasc Biol 1999;19:1020-1025
    • Rigamonti Wermelinger V, Demarmels Biasiutti F. 2-year old patient with systemic lupus erythematosus, thrombocytopenia, ischemic cerebrovascular insult and antiphospholipid antibodies.
      Ther Umsch 1999;56:537-40
    • Solenthaler M, Krauss JK, Boehlen F, Koller R, Hug M, Lämmle B. Fatal fresh frozen plasma infusion containing HPA-1a alloantibodies. Letter to the Editor.
      Br J Haematol 1999;106:258-259
    • Solenthaler M, Lämmle B. Schwere Blutungen, Lymphozytose und leukoerythroblastäres Blutbild - disseminierte intravasale Gerinnung bei metastasierendem Prostatakarzinom und chronisch lymphatischer Leukämie.
      Therap Umschau 1999;56:533-536
    • Stucki B, Schmutz P, Schmid L, Haeberli A, Lämmle B, Furlan M. Fibrinogen St. Gallen I (( 292 Gly ® Val): Evidence for structural alterations causing defective polymerization and fibrinogenolysis.
      Thromb Haemost 1999;81:268-274
    • Stucki, R. Zenhäusern, B. Biedermann, F. Baudo, R. Redaelli, B. Lämmle, M. Furlan. Fibrinogens Bern IV, Bern V and Milano XI: Three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the A(-chain.
      Blood Coag Fibrinol 1999;10:93-99
    • Tschan MP, Peters UR, Cajot JF, Betticher DC, Fey MF, Tobler A. The cylin-dependent kinase inhibitors p18INK4c and p19INK4d are highly expressed in CD34( progenitor and acute myeloid leukaemic cells but not in normal differentiated myeloid cells.
      Br J HaematoL 1999;106:644-651
    • von der Weid N, Furlan M, Siegenthaler I, Lämmle B. Ein Kleinkind mit Nabelschnur- und intrakranieller Blutung - Schwerer Faktor XIII-Mangel.
      Therap Umschau 1999;56:544-546
    • Wuillemin WA, Solenthaler M. Hyperhomozysteinämie: Risikofaktor für arterielle und venöse thrombotische Erkrankungen.
      VASA 1999;28:151-155
    • Wuillemin WA, Zeerleder S, Caliezi C, Hack CE. Treatment of severe sepsis with C1-inhibitor.
      In: Hämostaseologie IV Sepsis und Gerinnung. Martin E, Nawroth P, (eds). Springer-Verlag Berlin, Heidelberg 1999:75-91
    • Wuillemin WA, Hannes FM. Quick-Messung aus Kapilllar-Blut.
      PRAXIS-ARENA 1999;5:8-12
    • Zeerleder S, Schloesser M, Redondo M, Wuillemin WA, Engel W, Furlan M, Lämmle B. Reevaluation of the incidence of thromboembolic complications in congenital factor XII deficiency: a study on 73 subjects from 14 Swiss families.
      Thromb Haemostas 1999;82:1240-1246
    • Zeerleder S, Caliezi C, Redondo M, Wuillemin WA. Aktivierung der plasmatischen Kaskadensysteme bei Sepsis: Rolle von C1-Inhibitor.
      SMW 1999;129:1410-1417
    • Zeerleder S, Asmis L, Redondo M, Sulzer I, Lämmle B. Eine Patientin mit isolierter Verlängerung der aPTT ohne Anamnese einer hämorrhagischen Diathese: schwerer hereditärer Faktor XII-Mangel.
      Therap Umschau 1999;56:509-512
    • Züger M, Demarmels Biasiutti F. Recurrent thromboembolisms despite oral anticoagulation in a 76-year-old patient: Trousseau syndrome.
      Ther Umsch 1999; 56:481-3
    • Zwicky C, Tissot JD, Tefiani Mazouni Z, Schneider Ph, Burnand B. Prévention de l'infection à cytomégalovirus post-transfusionnelle: Recommandations pour la pratique clinique.
      Schweiz Med Wochenschr 1999;129:1061-6

    1998

    • Alberio L, Friese P, Dale GL. Effect of cell age on collagen-induced activation of platelets.
      Blood 1998;92 (Supplement 1):68b
    • Alberio L, Dale GL. Flow cytometric analysis of platelet activation by different collagen types present in the vessel wall.
      Br J Haematol 1998;102:1212-8.
    • Alberio L, Lämmle B. Capnocytophaga canimorsus sepsis. Images in Clinical Medicine.
      N Engl J Med 1998;339:1827
    • Alberio L, Ballmer PE. A 64-year-old woman with long-standing anorexia, chronic diarrhea and three recent episodes of subileus.
      Eur J Int Med 1998;9:27-30
    • Alberio L. Von Willebrand disease: a review.
      Eur J Int Med 1998;9:225-38
    • Betticher DC, Ratschiller D, Hsu Schmitz SF, von Rohr A, Hess U, Zulian G, Wernli M, Tichelli A, Tobler A, Fey MF, Cerny T. Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia.
      Annals of Oncology 1998;9:721-726
    • Briellmann RS, Nydegger UE, Sturzenegger M, Fierz L, Hess CW, Hauser SP. Long-term treatment of chronic relapsing inflammatory demylinating polyradiculoneuropathy: combination of corticosteroids, plasmaexchange, and intravenous immunoglobulins.
      European Neurology 1998;39:190-191
    • Burri S, Demarmels Biasiutti F, Lämmle B, Wuillemin WA. Vergleich der Quick-/INR-Werte aus kapillärem Vollblut (CoaguChek Plus) und venösem Citratplasma bei Patienten mit und ohne orale Antikoagulation.
      Schweiz med Wschr 1998;128:1723-1729
    • Dale GL, Alberio L. Is there a correlation between raised erythropoietin and thrombotic events in sickle cell anemia?
      Lancet 1998;352:566-7
    • Demarmels Biasiutti F, Sulzer I, Stucki B, Wuillemin WA, Furlan M, Lämmle B. Is plasminogen deficiency a thrombotic risk factor? - A study on 23 thrombophilic patients and their family members.
      Thromb Haemostas 1998;80:167-170.
    • Fey MF, Blaser M, Wernli M, Jotterand M, Maibach R, Gratwohl A, Tobler A for the Swiss Group for Clinical Cancer Research (SAKK): Sampling bias and logistical problems of molecular analysis in a clinical leukaemia trial.
      British Journal of Haematology 1998;103:582-588
    • Furlan M, Robles R, Solenthaler M, Lämmle B. Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura.
      Blood 1998;91:2839-2846
    • Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lämmle B. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
      N Engl J Med 1998;339:1578-1584
    • Furlan M, Lämmle B. Deficiency of von Willebrand factor-cleaving protease in familial and acquired thrombotic thrombocytopenic purpura.
      Baillière's Clinical Haematology 1998;11:509-514
    • Hari Y, von Allmen EC, Boss GM, Naiem A, Gittermann M, Nydegger UE. The complement-acitvating capacity of maternal IgG Antibodies to blood group A in paired mother/child serum samples.
      Vox Sanguinis 1998;74:95-100
    • Mandinov L, Kaufmann P, Walpoth BH, Brunner F, Hess OM. Groupe d'étude de l'anémie: Beris Ph, Brunner F, Donat M, Furrer J, Hess OM, Lauener PA, Litschgi M, Rimle M, Tobler A, Walpoth BH: Anémie et fonction cardiaque.
      Méd et Hyg 1998;56, 681-685
    • Mauron T, Wuillemin WA. Niedermolekulare Heparine sind die Therapie der Wahl bei der tiefen Beinvenenthrombose.
      Der informierte Arzt/Gazette Médical 1998;19:316-318
    • Mauron T, Baumgartner I, Z'Brun A, Dermarmels Biasiutti F, Redondo M, Do DD, Lämmle B, Wuillemin WA: SimpliRED D-dimer assay: Comparability of capillary and citrated venous whole blood, between-assay, and performance of the test for exclusion of deep vein thrombosis in symptomatic outpatients.
      Thromb Haemostis 1998; 79:1217-1219
    • Mauron T, Lämmle B, Wuillemin WA. Influence of low molecular weight heparin and low molecular weight dextran sulfate on the inhibition of coagulation factor XIa by serpins.
      Thromb Haemostis 1998;80:82-86
    • Minnema MC, Pajkrt D, Wuillemin WA, Roem D, Blekker WK, Levi M, van Deventer SJH, Hack CE, ten Cate H. Detection of activated clotting factor XI by a novel enzyme capture assay, without evidence of contact activation in experimental human endotoxemia.
      Blood 1998;92:3294-3301
    • Nydegger UE. Immune complexes.
      In: Encyclopedia of Immunology, (Delves PJ, Roitt IM, Eds.) Academic Press, London. 2nd edition, 1998;1220-122
    • Ravi S, Mauron T, Lämmle B, Wuillemin WA. Protien Z in healthy human individuals and in patients with a bleeding tendency.
      Br J Haematol 1998,102:1219-1223
    • Ruan J, Peyruchaud O, Alberio L, Valles G, Clemetson KJ, Bourre F, Nurden AT. Double heterozygosity of the GPIIb gene in a Swiss patient with Glanzmann's thrombasthenia.
      Br J Haematol 1998;102:918-25
    • Scharrer I, Krause M, Vigh T, Furlan M. Diagnose- und Therapieansätze bei der thrombotisch-thrombozytopenischen Purpura (Moschcowitz-Syndrom).
      In Hämostase und Entzündung (Anders O., Jacob J., Eds.), Weller Verlag, Neckargemünd 1998;102-109
    • Tobler A. Pharmacovigilance et facteurs de croissance hématopoiétiques.
      Méd et Hyg 1998;56, 997-1001
    • Uetz-von Allmen E, Sturzenegger M, Rieben R, Rihs F, Frauenfelder A, Nydegger UE. Antiganglioside GM1 antibodies and their complement activating capacity in central and peripheral nervous system disorders and in controls.
      European Neurology 1998;39:103-110
    • Vonlanthen S, Heighway J, Tschan MP, Borner MM, Altermatt HJ, Kappeler A, Tobler A, Fey MF, Thatcher N, Yarbrough WG, Betticher DC. Expression of p16INK4a/p16( and p19ARF/p16( is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
      Oncogene 1998;17:2779-2785.
    • Walpoth B, Nydegger, U, Auckenthaler-Kuhn E, Beris Ph. Traitement de l'anémie péri-opératoire.
      Médecine et Hygiène 1998;56:1521-1526
    • Woermann U, Montandon M, Tobler A. HemoSurf - ein interaktiver Hämatologie-Atlas im World Wide Web.
      Schweiz Med Wschr 1998;128:1605-7
    • Wuillemin WA, Demarmels Biasiutti F. Lämmle B. Therapie der akuten tiefen Beinvenenthrombose mit niedermolekularen Heparinen.
      Hämostaseologie 1998;18:27-30
    • Wuillemin WA, Demarmels Biasiutti F. Ambulante Therapie der akuten tiefen Beinvenenthrombose.
      Therapeutische Umschau 1998;9:546-547

    1997

    • Alberio L, Dale GL. Platelet biotinylation for monitoring in vivo survival and cellular function.
      Platelets 1997;8:373-8
    • Baerlocher GM, Schlappritzi E, Tobler A, Reinhart WH. The influence of tumor necrosis factor-( on phagocytosis of human erythrocytes by autologous monocytes/macrophages.
      Eur J Haematol 1997;58:357-369
    • Beris P, Tobler A. Differentialdiagnose der Anämie.
      PRAXIS, Schweiz Rundschau für Med1997;86:1684-1686
    • Beris P, Tobler A. Im Namen der Anemia Study Group: P. Beris, F. Brunner, J. Furrer, O.M. Hess, P.A. Lauener, M. Litschgi, A. Tobler: Differentialdiagnose der Anämie.
      Praxis 1997;86:1684-1686
    • Beris P, Tobler A. Au nom du groupe d'étude de l'anémie: P. Beris, F. Brunner, J. Furrer, O.M. Hess, P.A. Lauener, M. Litschgi, A. Tobler: Diagnostic de L'Anémie.
      Méd et Hyg 1997;55:1812-1816
    • Borisch B, Tinguely M, Schwaller J, Pabst T, Fey MF, Tobler A. Unterschiedliche Expression Zyklin-abhängiger Kinase Inhibitoren (CKI) in Non-Hodgkin-Lymphom (NHL).
      Verh Dtsch Ges Path 1997;81:377
    • Brand B, Hartmann K, Kuhn M, Nydegger U. Hämovigilanz: Beitrag des Anwenders zur Sicherheit von Blutprodukten/Contribution à la Sécurité des Produits Sanguins.
      Schweizerische Ärztezeitung 1997; 45:1681-1685
    • Brunnerbolliger S, Kiefel V, Horber V, Nydegger UE, Berchtold P. Antibody studies in a patient with acute thrombocytopenia following infusion of plasma containing anti-PlA1.
      American Journal of Hematology 1997;56:119-121
    • Carroll VA, Griffiths MR, Geiger M, Merlo C, Furlan M, Lämmle B, Binder BR. Plasma protein C inhibitor is elevated in survivors of myocardial infarction.
      Arterioscler Thromb Vasc Biol. 1997;17:114-118
    • Citarella F, Wuillemin WA, Lubbers YTP, Hack CE. Initiation of contact system activation in plasma is dependent on factor XII autoactivation and not on enhanced susceptibility of factor XII for kallikrein cleavage.
      Br J Haematol 1997;99:197-205
    • Demarmels Biasiutti F, Stucki B, Solenthaler M, Tobler A, Furlan M, Lämmle B. Venous thrombosis after Caesarean section in a young woman with homozygous APC resistance and type I protein S deficiency.
      Eur J Haematol 1997;58:127-129
    • Fey MF, Tobler A. Haematopoietic myeloid growth factors in the treatment of acute myelogenous leukaemia: players on or off stage?
      Onkologie 1997;20:372-377
    • Fopp M, Fey MF, Bacchi M, Gmür J, Gratwohl A, Jacky E, Schmid L, Tichelli A, Tobler A, Tschopp L, von Fliedner V, Cavalli F for the Swiss Group for Clinical Cancer Research (SAKK): Post-remission therapy of adult acute myeloid leukaemia: One cycle of high-dose versus standard-dose cytarabine.
      Ann Oncol 1997;8:251-257
    • Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P, Lämmle B. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura.
      Blood 1997;89:3097-3103
    • Hehlmann R, Willer A, Heimpel H, Hasford J, Kolb HJ, Pralle H, Hossfeld DK, Queisser W, Löffler H, Hochhaus A, Tobler A, Lengfelder E, Berger U, Leib-Mösch C and the German CML Study Group. Randomized studies with Interferon in chronic myelogenous leukemia (CML) and comparative molecular aspects.
      Leukemia Suppl 1997;3: 506-511
    • Hirt A, Antic V, Wang E, Ridolfi Lüthy A, Leibundgut K, von der Weid N, Tobler A, Wagner HP. Acute lymphoblastic leukaemia in childhood: cell proliferation without rest.
      Br J Haematol 1997;96:366-368
    • Kopp P, Jaggi R, Tobler A, Borisch B,Oestreicher M, Sabacan L, Jameson JL, Fey MF. Clonal X-inactivation analysis of human tumors using the human androgen receptor gene (HUMARA) polymorphism: a non-radioactive and semiquantitative strategy applicable to fresh and archival tissue.
      Mol Cell Probes 1997:11;217-228
    • Lämmle B. Qualität der hämostaseologischen Diagnostik.
      Editorial. Labolife 1997; Nr. 3/97
    • Lämmle B, Demarmels Biasiutti F, Wuillemin WA, Stucki B, Furlan M. Bedeutung der APC-Resistenz für die Praxis.
      Praxis, 1997;86:154-61
    • Lankhof H., Damas C., Schiphorst M.E., Ijsseldijk M.J.W., Bracke M., Furlan M., Tsai H.-M., de Groot P.G., Sixma J.J., Vink T. Von Willebrand factor without the A2 domain is resistant to proteolysis.
      Thrombosis and Heamostasis 1997;77:1008-1013
    • Leibundgut K, Hauser SP, Ridolfi-Lüthy A, von der Weid N, Tobler A, Hirt A. Peripheral blood progenitor cell collections in children with low platelet counts are safe.
      Bone Marrow Transplantation 1997;20:345-346
    • Mandinov L, Kaufmann Ph, Brunner F, Hess OM. In the name of the Anemia Study Group: P. Beris, F. Brunner, J. Furrer, O.M. Hess, P.A. Lauener, M. Litschgi, A. Tobler. Anämie und Herzfunktion.
      Praxis 1997;86:1687-1692
    • Nydegger UE, Moerenhout M, Mohacsi P, Hauser SP. Immunomodulatory treatment of autoimmune diseases (AuID).
      Japanese Journal of Apheresis 1997;16:11-16.
    • Nydegger U, Rieben R, Lämmle B. Biocompatibility in transfusion Medicine.
      Transfusion Science 1997;17:481-488
    • Nydegger UE. Sepsis and polyspecific intravenous immunoglobulins.
      Journal of Clinical Apheresis 1997;12:93-99
    • Nydegger U, Schneider Ph. Production of platelet concentrates in Switzerland.
      Transfusion Science 1997;18:19-20
    • Schloesser M, Zeerleder S, Lutze G, Halbmayer WM, Hofferbert S, Hinney B, Koestering H, Lämmle B, Pindur G, Thies K, Köhler M, Engel W. Mutations in the human factor XII gene. Blood 1997;90:3967-3977
    • Schwaller J, Pabst Th, Koeffler HP, Niklaus G, Loetscher P, Fey MF, Tobler A. Expression and regulation of G1 cell-cycle inhibitors (p16INK4A, p15 INK4B, p18INK4C, p19INK4D) in human acute myeloid leukemia and normal myeloid cells.
      Leukemia 1997:11,54-63
    • Schwaller J, Peters UR, Pabst Th, Niklaus G, Macfarlane DE, Fey MF, Tobler A. Upregulation of p21WAF1 expression in leukaemic myeloid cells is activated by the protein kinase C pathway.
      Br J Cancer 1997;76:1554-1557
    • Schwaller J, Pabst Th, Bickel M, Borisch B, Fey MF, Tobler A. Comparative detection and quantitation of human CDK inhibitor mRNA expression of p15INK4B, p16INK4A, p16(, p18INK4C, p19INK4D, p21WAF1, p27KIP1 and p57KIP2 by RT-PCR using a polycompetitive internal standard.
      Br J Haematol 1997;99:896-900
    • Stampfli R, Schaller M, Schenker T, Frey-Wettstein M, Hauser SP, Nydegger UE. In-process cell counts during preparation of platelet concentrates from buffy coats.
      Transfusion Science 1997;18:495-504
    • Tobler A. Der hämatologische Notfall.
      PRAXIS, Schweiz. Rundschau für Med 1997;86:302-307
    • Wilder-Smith E, Kothbauer-Margreiter I, Lämmle B, Sturzenegger M, Ozdoba C, Hauser SP. Dural puncture and activated protein C resistance: Risk factors for cerebral venous sinus thrombosis.
      J Neurol Neurosurg Psychiatry 1997;63:351-356
    • Wuillemin WA. Coagulation factor XI: Possible solution to a clinical enigma.
      News in Physiological Sciences 1997;12:95-96
    • Wuillemin WA, Zenhäusern R, Bernhard M-C, Lämmle B. Phenprocoumon-induced hepatitis delaying precise diagnosis in a thrombophilic patient with APC-resistance due to Factor V R506Q mutation.
      Am J Med 1997;103:437-439
    • Wuillemin WA, Lämmle B. Activation of the contact system in patients with sepsis and with septic shock.
      Blood 1997;89:3893-3894
    • Wuillemin WA, Burri S, Lämmle B. Quick-Messung aus Kapillar-Blut mittels CoaguChek(r) oder CoaguChekPlus(r).
      LABOLIFE 1997;3: 9-12
    • Wuillemin WA, te Velthuis H, Lubbers YTP, de Ruig CP, Eldering E, Hack CE. Potentiation of C1-Inhibitor by glycosaminoglycans: Dextran sulfate species are effective inhibitors of in vitro complement activation in plasma.
      J Immunol 1997;159:1953-1960
    • Züger M, Demarmels Biasiutti F, Wuillemin WA, Furlan M, Lämmle B. Subcutaneous low-molecular-weight heparin for treatment of Trousseau's syndrome.
      Ann Hematol 1997;75:165-167

    1996

    • Alberio L, Delas G, Moshfegh KJK, Clemetson KJ, Hirt A, Lämmle B, Beer JH. Thrombasthenia Glanzmann mit 20% GPIIb/IIIa und fehlender Funktion. Verdacht auf GPIIb Defekt mit pathologischen komplexspezifischen Bindungseigenschaften.
      Schweiz Med Wochenschrift 1996;126(Suppl.74/I):37S.
    • Alberio L, von Rohr A, Solenthaler M, Ballmer PE. Sind Chemotherapie-assoziierte Mundläsionen durch Herpes simplex verursacht?
      Schweiz Med Wochenschrift 1996;126(Suppl.74/I):44S.
    • Bargetzi MJ, Wortelboer M, Pabst T, Franscini L, Gudat H, Tichelli A, Tobler A, Speck B, Gratwohl A. Severe neutropenia in T-large granular lymphocyte leukaemia corrected by intensive immunosuppression.
      Ann Hematol 1996;73:149-151
    • Bauer C, Wuillemin WA. Blood, Plasma Proteins, Coagulation, Fibrinolysis, and Thrombocyte Function,
      In: Comprehensive Human physiology. From cellular mechanisms to integration. Greger R, Windhorst U (eds). Springer-Verlag Berlin, Heidelberg. 1996:1651 - 1677
    • ten Cate H, Biemond BJ, Levi M, Wuillemin WA, Bauer KA, Barzegar S, Buller HR, Hack CE, ten Cate JW, Rosenberg RD. Factor XIa induced activation of the intrinsic cascade in vivo.
      Thromb Haemost 1996;75:445-9.
    • Demarmels Biasiutti F, Lämmle B. Beitrag des Haemostaselabors bei der Diagnostik der tiefen Venenthrombose.
      Ther Umschau 1996;53:265-71
    • Fey MF, Tobler A. Tumour heterogeneity and clonality - an old theme revisited.
      Ann Oncol 1996;7:121-128
    • Friedli F, Rieben R, Wegmüller E, Moerenhout M, Nydegger UE. Normal levels of allo- but increased levels of potentially autoreactive antibodies against ABO histo-blood group antigens in AIDS patients.
      Clinical Immunology Immunopathology 1996;80:96-100.
    • Furlan M. Von Willebrand factor: molecular size and functional activity.
      Annals of Hematology 1996;72:341-348
    • Furlan M. Too little or too much von Willebrand factor: increased risk for either bleeding tendency or cardiovascular disease.
      Clinical Laboratory 1996;42:1031-1036
    • Furlan M, Robles R, Lämmle B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis.
      Blood 1996;87:4223-4234
    • Furlan M, Steinmann C, Jungo M, Lämmle B. Binding of calcium ions and their effect on clotting of fibrinogen Milano III, a variant with truncated A-chains.
      Blood Coag Fibrinolysis 1996;7:331-335
    • Furlan M, Stucki B, Steinmann C, Jungo M, Lämmle B. Normal binding of calcium to five fibrinogen variants with mutations in the carboxy terminal part of the -chain.
      Thromb Haemost 1996; 76:377-383
    • Furrer Th, Tobler A, Betticher DC, Fey MF, Cerny T, von Rohr A. Multiples Myelom: "Double high-doses"-Therapie mit autologer Transplantation von hämatopoietischen Stammzellen nach konventioneller Induktionstherapie.
      Schweizerisches Krebsbulletin 1996;2:50-52
    • Ghielmini M, Tobler A. Mobilisation und Transplantation von autologen hämatopoetischen Stamm- und Vorläuferzellen aus dem peripheren Blut: Prinzipien und Anwendungsbereiche.
      Schweiz Med Wschr 1996;126:348-356
    • Hardegger TP, von Rohr A, Tobler A, Fey MF. Intensive induction and consolidation chemotherapy in a young female with acute myeloid leukaemia and severe chronic renal failure.
      Ann Hematol 1996;72:327-328
    • Hauser SP, Nydegger UE. Nebenwirkungen durch labile Blutprodukte.
      Schweizerische Medizinische Wochenschrift 1996;126:637-645
    • Hehlmann R, Heimpel H, Hossfeld DK, Hasford J, Kolb HJ, Löffler H, Pralle H, Queisser W, Hochhaus A, Tichelli A, Fett W, Schmitz N, Reiter A, Griesshammer M, Pfeifer W, Bäumler M, Kamp T, Tobler A, Eimermacher H, Kuse R, Berger U, Ansari H and the German CML Study Group: Randomized study of the combination of hydroxyurea and interferon alpha versus Hydroxyurea versus Hydroxyurea monotherapy during the chronic phase of chronic myelogenous leukemia (CML Study II).
      Bone Marrow Transplantation 1996;17:S21-S24
    • Ishiguro A, Spirin KS, Shiohara M, Tobler A, Gombart AF, Israel MA, Norton JD, Koeffler HP. Id2 expression increases with differentiation in human myeloid leukemia cells.
      Blood 1996;87:5225-5231
    • Lehmann T, Beyeler C, Lämmle B, Hunziker T, Vock P, Olah AJ, Dahinden C, Gerber NJ. Severe osteoporosis due to systemic mast cell disease: Successful treatment with interferon alfa-2b.
      Br J Rheumatol 1996;35:898-900
    • Nagel S, Borisch B, von Rohr A, Tobler A, Fey MF. B-cell lymphoma with recurrent spontaneous remissions and evolution into chronic B-cell lymphocytic leukaemia. A case to look at assessment of lymphoma clonality.
      Ann Oncol 1996;7:953-960
    • Nielsen EW, Johansen HT, Hogasen K, Wuillemin WA, Hack CE, Mollnes TE. Activation of the complement, coagulation, fibrinolytic and kallikrein-kinin systems during attacks of hereditary angioedema.
      Scand J Immunol 1996;44:185-192.
    • Nydegger UE. Immunoglobulins in clinical medicine.
      In: Principles of Transfusion Medicine (Rossi EC, Simon TL, Moss GS, Gould SA, Eds.) 2nd Edition. Book Chapter Williams & Wilkins, Baltimore 1996; 453-464.
    • Nydegger U, Hauser SP, Friedli F, Mohacsi P. Perspectives in IVIG therapy.
      Proceedings 4th Interlaken's Meeting on Intravenous Immunoglobulins (Kazatchkine MD, Morell A, eds.) Parthenon Publishing, Casterton Hall, England 1996;103-112
    • Nydegger UE, Walpoth BH, Auckenthaler E, Günter P, Hauser SP. Limitations of preoperative autologous blood donation and the role of r-huEPO.
      Erythropoiesis: New dimensions in the treatment of anaemia 1996; 7:11-17
    • Nydegger UE. Enhanced efficacy of autologous blood donation with epoetin alfa.
      Seminars in Hematology 1996;33:39-42
    • Nydegger UE, Hauser SP. Use of intravenous immunoglobulins in haematological disorders.
      Clinical Immunotherapeutics 1996;5:465-485.
    • Nydegger UE, Rewald E. Anti-D-Rho immunoglobulin: a viewpoint.
      Clinical Immunotherapeutics 1996;5:491.
    • Nydegger UE. Safety and side effects of i.v. immunoglobulin therapy.
      Clinical and Experimental Rheumatology 1996;14 (Suppl 15):S53-S57
    • Pabst T, Schwaller J, Jotterand Bellomo M, Oestreicher M, Mühlematter D, Tichelli A, Tobler A, Fey MF: Frequent clonal loss of heterozygosity, but scarcity of microsatellite instability at chromosomal breakpoint cluster regions in adult leukemias.
      Blood 1996;88:1026-1034
    • Pabst Th, Schwaller J, Tobler A, Fey MF: Detection of microsatellite markers in leukaemia using DNA from archival bone marrow smears.
      Br J Haematol 1996;95:135-137
    • Rieben R, Frauenfelder A and Nydegger UE.Spectrotype analysis of human ABO antibodies: evidence for different clonal heterogeneity of IgM, IgG, and IgA antibody populations.
      Vox Sanguinis 1996;70:104-111
    • von Rohr A, Tobler A. Zytokintherapie.
      In: Klinische Immunologie, 2. Auflage. (Hrsg. PeterHH/Pichler WJ). 1996:179-185
    • Steinmann C, Jungo M, Beck EA, Lämmle B, Furlan M. Fibrinogen Claro - another dysfunctional fibrinogen variant with 275 Arginine ? Histidine substitution.
      Thromb Res 1996;81:145-150
    • Walpoth BH, Galliker B, Spririg P, Haeberli A, Rosenmund A, Althaus U, Nydegger UE. Use of epoietin alfa in autologous blood donation programs for patients scheduled for elective cardiac surgery.
      Seminars in Hematology 1996;33:75-77
    • Wuillemin WA, Mertens K, ten Cate H, Hack CE. Thrombin-mediated activation of endogenous factor XI in plasma in the presence of physiological glycosaminoglycans occurs only with high concentrations of thrombin.
      Br J Haematol 1996;92:466-472.
    • Wuillemin WA, Eldering E, Citarella F, de Ruig CP, ten Cate H, Hack CE. Modulation of contact system proteases by glycosaminoglycans: selective enhancement of the inhibition of factor XIa.
      J Biol Chem 1996;271:12913-12918.
    • Wuillemin WA, Bleeker WK, Agterberg J, Rigter G, ten Cate H, Hack CE. Clearance of human factor XIa-inhibitor complexes in rats.
      Br J Haematol 1996;93:950-954
    • Wuillemin WA, Hack CE, Blekker WK, Biemond BJ, Levi M, ten Cate H.Inactivation of Factor Ia in vivo: studies in chimpanzees and in humans.
      Thromb Haemost 1996;76:549-555.
    • Wuillemin WA, Fijnvandraat K, Derkx BHF, Peters M, Vreede T, ten Cate H, Hack CE. Activation of the intrinsic pathway of coagulation in children with meningococcal septic shock.
      Thromb Haemost 1996;74: 1436-1441
    • Züger M, Demarmels Biasiutti F, Furlan M, Mannhalter Ch, Lämmle B. Plasminogen deficiency: An additional risk factor for thrombosis in a family with factor V R506Q mutation?
      Thromb Haemost 1996;76:475-80

    1995

    • Barella L, Loetscher M, Tobler A, Baggiolini M, Moser BA. Sequence variation of a novel heptahelical leukocyte receptor through alternative transcript formation.
      Biochem J 1995;309:773-779
    • Becker Ch D , Rösler HR, F. Demarmels Biasiutti F, Baer HU. Congestive hypersplenism: Treatment by means of radioembolization of the spleen with Y-90.
      Radiology 1995;195:183-86
    • Bühler R, Kremer Hovinga J, Aebi-Huber I, Furlan M, Lämmle B. Improved detection of proteolytically cleaved high molecular weight kininogen by immunoblotting using an antiserum against its reduced 47 kDa light chain.
      Blood Coag Fibrinol 1995;6:223-232
    • Demarmels Biasiutti F, Merlo C, Furlan M, Sulzer I, Binder BR, Lämmle B. No association of APC resistance with myocardial infarction.
      Blood Coag Fibrinol 1995;6:456-59
    • Furlan M. Molekularer Mechanismus und Klassifizierung des Morbus von Willebrand.
      Haemo 1995;4:2-4
    • Galliker-von Dach B, Lämmle B. Thrombophilieabklärung.
      Labor und Medizin 1995;22:49-52
    • Ishiguro A, Spirin K, Shiohara M, Tobler A, Norton JD, Rigolet M, Shimbo T, Koeffler HP. Expression of Id2 and Id3 mRNA in human lymphocytes.
      Leuk Res 1995;19:989-996
    • Kazatchine MD, Kaveri SS, Nydegger UE, Sultan Y. Variable (V) region-mediated control of autoreactivity fo factor VIII.
      Advances Experimental Medicine Biology 1995; 386:223-228.
    • Leibundgut K, von Rohr A, Brülhart K, Hirt A, Ischi E, Jeanneret C, Muff J, Ridolfi-Lüthy A, Wagner HP, Tobler A. The number of circulating CD34+ blood cells predicts the colony-forming capacity of leukapheresis products in children.
      Bone Marrow Transplant1995;15:25-31
    • Meier RW, Niklaus G, Fey MF, Tobler A. The induction kinetics of IL-8 messenger RNA in HL60 cells demonstrate the participation of negative-acting gene(s).
      Leuk Res 1995;19:449-455
    • Meier RW, Niklaus G, Dewald B, Fey MF, Tobler A. Inhibition of the arachidonic acid pathway prevents induction of IL-8 mRNA by phorbol ester and changes the release of IL-8 from HL 60 cells: Differential inhibition of induced expression of IL-8, TNF-(, IL-1( and IL-1(.
      J Cell Physiol 1995;165:62-70
    • Nagel S, Borisch B, Thein SL, Oestreicher M, Nöthiger F, Birrer S, Tobler A, Fey MF. Somatic mutations detected by mini- and microsatellite DNA markers reveal clonal intratumor heterogeneity in gastrointestinal cancers.
      Cancer Res 1995;55: 2866-2870
    • Nakamaki T, Kawamata N, Schwaller J, Tobler A, Fey M, Pakkala S, Lee YY, Kim BK, Fukuchi K, Tsuruoka N, Kahan J, Miller CW, Koeffler HP. Structural integrity of the cyclin-dependent kinase inhibitor gene, p15, p16 and p18 in myeloid leukemias.
      Br J Haematol 1995;91:139-149
    • Pabst Th, Fey M, Tobler A. Immungenotypisierung bei lymphoproliferativen Syndromen: Neue diagnostische Methoden an der Schwelle zur Routine.
      Labolife 1995;6:13-17
    • Parlier V, van Melle G, Beris Ph, Schmidt PM, Tobler A, Haller E, Jotterand Bellomo M. Prediction of 18 months survival in patients with primary myelodysplastic syndrome: a regression model and scoring system based on the combination of chromosome findings and the Bournemouth score.
      Cancer Genet Cytogenet 1995;81:158-165
    • Rieben R, Korchagina EQ, von Allmen E, Kremer Hovinga J, Lämmle B, Jungi TW, Nydegger UE. In vitro evaluation of the efficacy and biocompatibility of new, synthetic ABO immunoabsorbents.
      Transplantation 1995;60:425-430
    • Rieben R, von Allmen E, Korchagina EY, Oriol R, Nydegger UE, Bovin NV, Cooper DKC. Detection, Immunoabsorption, and inhibition of cytotoxic activity of anti-a ?gal antibodies using newly developed substances with synthetic gal a 1-3 ?gal disaccharide epitopes.
      Xenotransplantation 1995;2:98-106
    • Schloesser M, Hofferbert S, Bartz U, Lutze G, Lämmle B, Engel W. The novel acceptor splice site mutation 11396(G ?A) in the factor XII gene causes a truncated transcript in cross-reacting material negative patients.
      Human Molecular Genetics 1995;4:1235-1237
    • Schwaller J, Koeffler HP, Niklaus G, Loetscher P, Nagel S, Fey MF, Tobler A. Posttranscriptional stabilization underlies p53-independent induction of p21 WAF1/CIP1/SDI1 in differentiating human leukemic cells.
      J Clin Invest 1995;95:973-979
    • Schwaller J, Tobler A, Niklaus G, Hurwitz N, Henning I, Fey MF, Borisch B. Interleukin-12 expression in human lymphomas and nonneoplastic lymphoid disorders.
      Blood 1995;85:2182-2188
    • Spycher MO, Nydegger UE. Participation of the blood platelet in immune reactions due to platelet-complement interaction.
      Infusionstherapie und Transfusionsmedizin 1995;22:36-43
    • Takeuchi S, Bartram CR, Seriu T, Miller CW, Tobler A, Janssen JWG, Reiter A, Ludwig WD, Zimmermann M, Schwaller J, Lee E, Miyoshi I, Koeffler HP:Analysis of a family of cyclin-dependent kinase inhibitors. p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of child hood.
      Blood 1995;86:755-760
    • Wuillemin WA, Gerber AU. Fehlerquellen in der präanalytischen Phase der Blutgasanalyse.
      Schweizerische Rundschau für Medizin, PRAXIS 1995;84:200-203.
    • Wuillemin WA, Minnema M, Meijers JCM, Roem D, Eerenberg AJM, Nuijens JH, ten Cate H, Hack CE. Inactivation of factor XIa in human plasma assessed by measuring factor XIa-protease inhibitor complexes: major role for C1-inhibitor.
      Blood 1995;85:1517-1526.

    1994

    • Balestra B, Quadri P, Demarmels Biasiutti F, Furlan M, Lämmle B. Low molecular weight heparin - induced thrombocytopenia and skin necrosis distant from injection sites.
      Eur J Haematol 1994;53:61-63
    • Bänninger H, Lämmle B, Furlan M. Binding of -thrombin to fibrin depends on the quality of fibrin network.
      Biochem J 1994;298:157-163
    • Betticher DC, Fey MF, von Rohr A, Tobler A, Jenzer H, Gratwohl A, Lohri A, Pugin P, Hess U, Pagani O, Zulian G, Cerny T: High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemias.
      Ann Oncol 1994;5: 57-64
    • Chen T, Meier R, Ziemiecki A, Fey MF, Tobler A. Myeloblastin/Proteinase 3 belongs to the set of negatively regulated primary response genes expressed during in vitro myeloid differentiation.
      Biochem. B17408 -iophys. Res Commmun 1994;200:1130-1135
    • De Cristofaro R, Furlan M, Landolfi R. Fibrinogen Milano IV (Aa 16 Arg 6 His): Characterization of its abnormal interaction with human a-thrombin.
      Biochemical Journal 1994;302:623-624
    • Demarmels Biasiutti F, Lämmle B. Prophylaxe venöser Thromboembolien - bei wem, wann und wie?
      Ther Umschau 1994;51:663-70
    • Fey MF, Liechti-Gallati S, von Rohr A, Borisch B, Theilkäs L, Schneider V, Oestreicher M, Nagel S, Ziemiecki A, Tobler A. Clonality and X-inactivation patterns in haematopoietic cell populations detected by the highly informative M27( DNA probe.
      Blood 1994;83:931-938
    • Fey MF, von Rohr A, Tobler A. Assessment of clonality in haematological malignancies and other proliferations by X-inactivation analysis with the M27.
      Blood (Letter)1994;84:2377-2378
    • Furlan M, Steinmann C, Jungo M, Bögli C, Baudo F, Redaelli R, Fedeli F, Lämmle B. A frameshift mutation in exon V of the A-chain gene leading to truncated A-chains in the homozygous dysfibrinogen Milano III.
      J Biol Chem 1994;269:33129-33134
    • Hehlmann R, Heimpel H, Hasford J, Kolb HJ, Pralle H, Hossfeld DK, Queisser W, Löffler H, Heinze B, Georgii A, Bartram CR, Griesshammer M, Hochhaus A, Bergmann L, Essers U, Falge C, Queisser U, Meyer P, Schmitz N, Eimermacher H, Walther F, Westerhausen M, Kleeberg UR, Weiss J, Käbisch A, Nerl C, Zimmermann R, Meuret G, Tichelli A, Kanz L, Tigges FJ, Schmid L, Brockhaus W, Tobler A, Perker M, Hohnloser J, Verpoort K, Zankovich R, v. Wussow P, Prümmer O, Thiele J, Buhr T, Ansari H, and the German CML Study Group: Randomized comparison of Busulfan and Interferon-alpha in chronic myelogenous leukemia: prolongation of survival by Interferon-alpha.
      Blood 1994;84:4064-4077
    • Kremer Hovinga J, Schaller J, Stricker H, Wuillemin WA, Furlan M, Lämmle B. Coagulation factor XII Locarno: The functional defect is due to the amino acid substitution Arg 353-Pro leading to loss of a kallikrein cleavage site.
      Blood 1994;84:1173-1181
    • Kopp P, Kimura ET, Aeschimann S, Oestreicher M, Tobler A, Fey MF, Studer H. Polyclonal and monoclonal thyroid nodules coexist within human multinodular goiters.
      J Clin Endocrin 1994;79:134-139
    • Lämmle B, Tobler A, Fey MF, Cerny T, Nydegger U. Krankheiten des Blutes und der blutbildenden Organe.
      In: Hadorn / Lehrbuch der Therapie, 8. vollständig überarbeitete Auflage. (Hrsg. T. Hess). Verlag Hans Huber, 1994:239-297
    • Leibundgut K, Muff J, Hirt A, Mitschulat H, Nydegger UN, Ridolfi Lüthy A, Tobler A, Wagner HP: Evaluation of the fresenius cell separator AS 104 for harvesting peripheral blood stem cells in pediatric patients.
      Transfus Sci 1994;15:93-99
    • Leibundgut K, Hirt A, Ridolfi Lüthy A, Tobler A, Wagner HP. Single institution experience with mobilization, harvesting, reinfusion of peripheral blood stem cells in children with solid tumor or leukemia.
      Pediat Hematol Oncol 1994;11:215-221
    • Nydegger U, Hardegger Th, Tobler A, Rieder H,Cerniak A, Lämmle B. Cold agglutinin syndrome and liver transplantation.
      Vox Sanguinis 1994;67:85
    • Nydegger U, Muff J, Walter K, Tobler A, Leibundgut K: Stammzellapherese - Berner Erfahrungen bei Kindern.
      In: Transfusionsmedizin 1993/94 (Hrsg. W. Sibrowski, W. Stangel, S. Wegener). Beitrag Infusionstherapie Transfusionsmediizin. Karger Verlag, Basel, 345-350
    • Nydegger UE. Alte und neue Aspekte der intravenösen Immunglobulintherapie.
      Schweizerische Medizinische Wochenschrift 1994;124:5-25
    • Parlier V, Van Melle G, Beris Ph, Schmidt PM, Tobler A, Haller E, Jotterand Bellomo M. Hematological, clinical and cytogenetic analysis in 109 patients with primary myelodysplastic syndrome. Prognostic significance of morphology and chromosome findings.
      Cancer Genet Cytogenet 1994;78: 219-231
    • Rohrdorf R, Barth A, Nydegger U, Tobler A. Behandlung einer schweren idiopathischen Kälteagglutininkrankheit mit Interferon-? 2b.
      Schweiz Med Wochenschrift 1994;124:56-61
    • Schlaeppi B, Günter P, Nydegger UE. Enhancing the efficacy of preoperative autologous blood donation by erythropoietin.
      Transfusion Science 1994;15:171-177
    • Seitz M, Loetscher P, Fey MF, Tobler A. Constitutive mRNA and protein production of macrophage colony-stimulating factor but not of other cytokines by synovial fibroblasts from rheumatoid arthritis and osteoarthritis patients.
      Br J Rheumatol 1994;33:613-619
    • Stahel RA, Jost LM, Cerny T, Pichert G, Honegger H, Tobler A, Jacky E, Fey M, Platzer E. Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies.
      J Clin Oncol 1994;12:1931-1938
    • Steinmann C, Bögli C, Jungo M, Lämmle B, Heinemann G, Wermuth B, Redaelli R, Baudo F, Furlan M. Fibrinogen Milano V: A congenital dysfibrinogenaemia with a 275 Arg Cys substitution.
      Blood Coag Fibrinolysis 1994;5:463-471
    • Steinmann C, Bögli C, Jungo M, Lämmle B, Heinemann G, Wermuth B, Redaelli R, Baudo F, Furlan M. A new substitution, 358 Ser Cys, in fibrinogen Milano VII causes defective fibrin polymerization.
      Blood 1994;84:1874-1880
    • Tobler A. Haematopoietic Cytokines. Characteristics and role in haematopoiesis.
      Sandoz-Atlas 1994:1-72
    • Von Allmen E, Rieben R, Nydegger UE. Development of a C1q-ABO-ELISA to measure C1q binding by human anti-A alloantibodies.
      Journal of Immunological Methods 1994;171:85-92
    • Wernli M, Tichelli A, von Fliedner V, Brun del Re G, Chapuis B, Fey MF, Fopp M, Gmür J, Grob JP, Jacky E, Pedrazzini A, Schmid L, Senn HJ, Tobler A, Gratwohl A. Intensive induction/consolidation therapy without maintenance in adult acute lymphoblastic leukaemia: A pilot assessment.
      Br J Haematol 1994;87:39-43
    • Zingg K, von Rohr A, Fey MF, Tobler A. Aussagekraft von Knochenmarkuntersuchungen am Tag 8 und am Tag 17 des ersten Induktionstherapie-Zyklus bei akuter myeloischer Leukämie.
      Schweiz med Wschr 1994;124:51-55
    • Zubler, RH, Tucci A, Rieben R, Matthes T, Nydegger UE. Quantification of autoreactive lymphocytes in health and disease.
      Autoimmunity 1994:173-190.
    • Zucca E, Fontana S, Roggero E, Pedrinis E, Pampallona S, Cavalli F: Treatment and prognosis of centrocytic (mantle cell) lymphoma: a retrospective analysis of twenty-six patients treated in one institution.
      Leuk Lymphoma 1994;13:105-110

    1993

    • Aeschimann S, Kopp PA, Kimura ET, Zbaeren J, Tobler A, Fey MF, Studer H: Morphological and functional polymorphism within clonal thyroid nodules.
      J Clin Endocr Metab 1993;77:846-851
    • Auf der Maur Ch, Hodel M, Nydegger UE, Rieben R. Age-dependency of ABO histo-blood group antibodies -reexamination of an old dogma.
      Transfusion 1993;33:915-918
    • Bänninger H, Hardegger T, Tobler A, Barth A, Schüpbach P, Reinhart W, Straub PW, Lämmle B, Furlan M. Fibrin glue in surgery; frequent development of inhibitors of bovine thrombin and human factor V.
      Br J Haematol 1993;85:528-532
    • Barth A, Furlan M, Lämmle B. Unerwartet verlängerte Thrombinzeit.
      Schweiz med Wschr 1993;123:523-529
    • Barth A, Passerini M, Oppliger R, Spycher M, Nydegger U. Wirksamkeit von zwei verschiedenen Leukozytenfiltern für Erythrozytenkonzentrate.
      Schweiz med Wschr 1993;123:1160-1164
    • Bärtsch P, Haeberli A, Nanzer A, Lämmle B, Vock P, Oelz O, Straub PW. High altitude pulmonary edema: Blood coagulation.
      Hypoxia and molecular medicine 1993:252-258.
    • Favre G, Fopp M, Gmür J, Tichelli A, Fey MF, Tobler A, Schatzmann E, Gratwohl A. Factors associated with transfusion requirements during treatment for acute myelogenous leukemia.
      Ann Hemato 1993;67:153-160
    • Fey MF, Zimmermann A, Borisch B, Tobler A. Studying clonal heterogeneity in human cancers.
      Cancer Res 1993;53:921
    • Fey MF, Tobler A. An interleukin-8 (IL-8) cDNA clone identifies a frequent HindIII polymorphism.
      Hum Genet 1993;91:298
    • Furlan M, Robles R, Affolter D, Meyer D, Baillod P, Lämmle B. Triplet structure of von Willebrand factor reflects proteolytic degradation of high molecular weight multimers.
      Proc Natl Acad Sci 1993;90:7503-7507
    • Hehlmann R, Heimpel H, Hasford J, Kolb HJ, Pralle H, Hossfeld DK, Queisser W, Löffler H, Heinze B, Georgii A, v. Wussow P, Bartram C, Griesshammer M, Bergmann L, Essers U, Falge C, Hochhaus A, Queisser U, Sick C, Meyer P, Schmitz N, Verpoort K, Eimermacher H, Walther F, Westerhausen M, Kleeberg UR, Heilein A, Käbisch A, Barz C, Zimmermann R, Meuret G, Tichelli A, Berdel WE, Kanz L, Anger B, Tigges F.J, Schmid L, Brockhaus W, Zankovich R, Schläfer U, Weissenfels I, Mainzer K, Tobler A, Perker M, Hohnloser J, Messener D, Thiele J, Buhr T, Ansari H, and the German CML Study Group: Randomized comparison of Busulfan and Hydroxyurea in chronic myelogenous leukemia: prolongation of survival by Hydroxyurea.
      Blood 1993;82: 398-407
    • Jahns G, Haeffner-Cavaillon N, Nydegger UE, Kazatchkine MD. Complement activation and cytokine production as consequences of immunological bioincompatibility of extracorporeal circuits.
      Clinical Materials 1993;14:303-336
    • Joncourt F, Oberli A, Redmond SMS, Fey MF, Tobler A, Margison GP, Gratwohl A, Buser K, Cerny T: Cytostatic drug resistance: parallel assessment of glutathione-based detoxifying enzymes, O6-alkylguanine-DNA-alkyltransferase and P-glycoprotein in adult patients with leukaemia.
      Br J Haematol. 1993;85:103-111
    • Lämmle B, Hardegger T, Straub PW, Vock P, Furlan M. Die innere Blutung beim oral antikoagulierten Patienten.
      Schweiz med Wschr 1993:123:701-710
    • Lämmle B, Tobler A, Fey MF, Cerny T, Nydegger U. Krankheiten des Blutes und der blutbildenden Organe.
      In: Hadorn Lehrbuch der Therapie (Hess. T Hrsg.) Huber, Bern 1993; pp. 239-297 (Subkapitel "Transfusionsmedizin und Blutprodukte" mit B. Lämmle).
    • Leibundgut K, Hirt A, Ridolfi Lüthy A, Tobler A, Wagner HP: Autotransplants with peripheral blood stem cells and clinical results obtained in children: a review.
      Eur J Pediatr 1993;152: 546-554
    • Nydegger UE. Properties, efficacy and side effects of thereapeutic immunoglobulins.
      In: Blood transfusion Methods and Quality Assurance, II: Methodelogical Advances and Clinical Aspects, (Rock G, Seghatchian MJ, eds.) CRC Press, Boca Raton USA 1993; pp 384-409.
    • Nydegger UE, Rieben R, Kazatchkine MD. Intravenöse Immunglobulintherapie als Beeinflussungsmöglichkeit von autoimmunen Prozessen.
      In: Infektionen und Autoimmunerkrankungen II: Therapie mit Immunglobulinen und deren Derivaten (Salama A, Kurrle R, Hrsg.) Universitätsverlag Jena 1993; pp 15-27.
    • Schwaller J, Chen T, Fey MF, Tobler A. A myeloblastin/proteinase-3 cDNA clone identifies a BglII and a PvuII restriction fragment length polymorphism.
      Hum Genet 1993;92:525
    • Steinmann C, Reber P, Jungo M, Lämmle B, Heinemann G, Wermuth B, Furlan M. Fibrinogen Bern I: Substitution 337 Asn Lys is responsible for defective fibrin monomer polymerization.
      Blood 1993;82:2104-2108
    • Tobler A, Nydegger U: Pathophysiologie des cytokines hématopoietiques.
      Méd Hyg 1993;51:1328-1330
    • Tobler A. Die Bedeutung der Zytokine in der normalen und leukämischen Hämatopoese.
      Schweiz. med. Wschr. 123, 44-52, 1993.
    • Tobler A, Fey MF. Molekulargenetische Diagnostik bei hämatologischen Neoplasien.
      Labolife 1993;1:27-29
    • Tobler A. Der Blutbildnotfall.
      Schweiz med Wschr 1993;123: 711-720
    • Tobler A, Moser B, Dewald B, Geiser T, Studer H, Baggiolini M, Fey MF. Constitutive expression of interleukin-8 and its receptor in human myeloid and lymphoid leukemia.
      Blood 1993;82:2517-2525
    • Walpoth BH, Schwaller J, Hofstetter H, Castelli D, Nydegger UE. Current problems with autologous blood supply.
      Infusionstherapie und Transfusionsmedizin 1993;20:316-326
    • Woermann UJ, Schenk R, Zimmermann A, Tobler A. Increased bone metabolism in a patient undergoing long-term rhG-CSF treatment for idiopathic acquired neutropenia.
      Ann Hematol 1993;66:267-268
    • Wuillemin WA, Vischer MW, Tobler A, Fey MF. Relapse of acute myeloblastic leukaemia presenting as temporal bone chloroma with facial nerve paralysis.
      Ann Oncol 1993;4:339-40
    • Wuillemin WA, Furlan M, von Felten A, Lämmle B. Functional characterization of a variant prekallikrein (PK Zürich).
      Thromb Haemost 1993;70:427-432
    • Zoppi M, Oppliger R, Althaus U, Nydegger U. Reduction of plasma cold agglutinin titers by means of plasmapheresis to prepare a patient for coronary bypass surgery.
      Infusionstherapie und Transfusionsmedizin 1993;20:19-22.

    1992

    • Alberio L, Beretta-Piccoli C, Tanzi F, Koch P, Zehender M. Kardiale Interaktionen zwischen Ketanserin und dem Calcium-Antagonisten Nifedipin.
      Schweiz Med Wochenschrift 1992;122:1723-7
    • Algiman M, Dietrich G, Nydegger UE, Boieldieu P, Sultan Y, Kazatchkine MD. Antibodies to FVIII (anti-hemophilic factor) in healthy individuals.
      Proceedings of the National Academy of Sciences USA 1992; 89:3795-3799.
    • Bögli C, Hofer A, Baudo F, Redaelli R, Furlan M. Fibrinogen Milano IV, another case of congenital dysfibrinogenemia with an abnormal fibrinopeptide A release (Aa 16 Arg 6 His).
      Haemostasis 1992; 22: 7-11
    • Borisch B, Gatter KC, Tobler A, Theilkäs L, Bunch C, Wainscoat JS, Fey MF. Epstein-Barr virus-associated anaplastic large-cell lymphoma in renal transplant patients.
      Am J Clin Path 1992;98:312-318
    • Borradori L, Nydegger U. Déficits en complément et lupus érythémateux.
      Revue Médicale de la Suisse Romande 1992;112:355-362
    • Cerny T, Fey MF, Oppliger R, Castiglione M, Nachbur B, Gertsch M, Gasser A, Joss RA. Thatcher N, Lind M, von Rohr A, Nydegger UE. Prevalence of the rhesus-negative phenotype in caucasian patients with small-cell lung cancer (SCLC).
      International Journal of Cancer 1992;52:504-506
    • Demarmels Biasiutti F, Lämmle B. Thrombophilieabklärung: Indikation und Durchführung.
      Therap Umschau 1992;49:850-58
    • Dietrich G, Algiman M, Sultan Y, Nydegger UE, Kazatchkine MD. Origin of anti-idiotypic activity against anti-factor VIII autoantibodies in pools of normal human immunoglobulin G (IVIg).
      Blood 1992;79:2946-2951
    • Fey MF, Peter HJ, Hinds HL, Zimmermann A, Liechti-Gallati S, Gerber H, Studer H, Tobler A. Clonal analysis of human tumours with M27(, a highly informative polymorphic X-chromosomal probe.
      J Clin Invest 1992;89:1438-1444
    • Furlan M. Fibrinogen.
      In Human Protein Data (Haeberli A., Ed.), VCH Verlagsgesellschaft, Weinheim, 1992
    • Furlan M. Von Willebrand factor.
      In Human Protein Data (Haeberli A., Ed.), VCH Verlagsgesellschaft, Weinheim, 1992
    • Hardegger T, Lämmle B. Thromboembolische Erkrankungen aus hämatologischer Sicht: 13 Fallbeispiele.
      Therap Umschau 1992;49:859-866
    • Hasler CR, Rieben R, Buchs JP, Nydegger UE. Comparison between the levels of anti-A/B IgM/G antibodies in paired mother/child serum samples.
      Transfusion Science 1992,13:113-118
    • Lämmle B. Factor XII.
      In: Human Protein Data (A. Haeberli, Editor), 1st Installment. VCH, Weinheim, 1992.
    • Macherel P, Sulzer I, Furlan M, Lämmle B. Determination of thrombin-antithrombin-III-complex is not a suitable screening test for detecting deficiency of protein C or protein S.
      Thromb Res 1992;66: 775-777
    • Meier RW, Bielke W, Chen T, Niklaus G, Friis RR, Tobler A. Lyn, a src-like tyrosine-specific protein kinase is expressed in HL60 cells induced to monocyte-like or granulocyte-like cells.
      Biochem Biophys Res Comm 1992;185:91-95
    • Meier RW, Chen T, Mathews S, Niklaus G, Tobler A. The differentiation pathway of HL60 cells is a model system for studying the specific regulation of some myeloid genes.
      Cell Growth 1992;3:663-669
    • Nydegger UE. Clinical relevance of optimal versus maximum doses of prophylactic and therapeutic immunoglobulins.
      International Congress and Symposium Series No 189,London 1992; pp 11-25.
    • Nydegger UE, Borradori LE. Immune complexes.
      In: Encyclopedia of Immunology, (Roitt IM, Delves PJ, Eds.) Academic Press, London. Volume 2, 1992; pp 751-755.
    • Nydegger UE. Intravenous immunoglobulin in combination with other prophylactic and therapeutic measures.
      Transfusion 1992;32:72-82
    • Nydegger UE, Rieben RR. Nouveaux aspects immunologiques et cliniques des groupes sanguins ABO. Médecine & Hygiène 1992;50:1334-1337
    • Nydegger UE. Cold agglutinin disease.
      Annales de Médecine Interne 1992;6:361-364
    • Reinhart WH, Lütolf O, Nydegger U, Mahler F, Straub PW. Plasmapheresis for hyperviscosity syndrome in macroglobulinemia Waldenström and multiple myeloma: influence on blood rheology and the microcirculation.
      Journal of Laboratory and Clinical Medicine 1992;119:69-76
    • Rieben R, Frauenfelder A, Nydegger UE. Naturally occurring ABO antibodies - long term stable, individually distinct anti-A IgG spectrotypes.
      European Journal of Immunology 1992;22:2129-2133
    • Rieben R, Tucci A, Nydegger UE, Zubler RH. Self tolerance to human A and B histo-blood group antigens exists at the B cell level and cannot be broken by potent polyclonal B cell activation in vitro.
      European Journal of Immunology 1992; 22:2713-2717
    • Rittmeyer I, Nydegger UE. Influence of the cryoprotective agents glyerol and hydroxyethyl starch on red blood cell adenosine-triphosphate and 2,3-diphosphoglycerate levels.
      Vox Sanguinis 1992;62:141- 145
    • Tobler A, Meier R, Seitz M, Dewald B, Baggiolini M, Fey MF: Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of M-CSF in human fibroblasts. Blood 1992 ;79:45-51
    • Tobler A, Koeffler HP: Differentiation inducers and their potential use in the treatment of acute myelogenous leukemia.
      The Search for New Anticancer Drugs (Series "Cancer Biology and Medicine"):1992:163-181
    • Villiger PM, Fey MF, Kuis W, Tobler A: IgG2 and IgG4 subclass deficiency and Evan's syndrome in an adult patient.
      J Allerg Clin Immunol 1992;90: 693-694
    • Von Känel R, Wuillemin WA, Furlan M, Lämmle B. Factor XII clotting activity and antigen levels in patients with thromboembolic disease.
      Blood Coagulation and Fibrinolysis 1992;3:555-561
    • Wuillemin WA, Furlan M, Stricker H, Lämmle B. Functional characterization of a variant factor XII (F XII Locarno) in a cross reacting material positive F XII deficient plasma.
      Thromb Haemostas 1992;67:219-225.

    1991

    • Borisch B, Fey MF, Tobler A, Bürki K, Gatter KC, Wainscoat JS. Grosszellige anaplastische Lymphome bei Immunsuppression.
      Verh Dtsch Ges Path 1991;75:171-174
    • Borradori L, Born B, Nydegger UE, Schaad UB, Morell A. Phenotypes of spontaneously IL-2 proliferating lymphocytes in HIV infected and normal children.
      Immunology & Infectious Diseases 1991;1:49-53
    • Buchs JP, Nydegger UE. Defining specificity of anti-A/B IgM/G antibodies with different antigens and lectins.
      Vox Sanguinis 1991;60:174-180
    • Buchs JP, Maillard H, Nydegger UE. Anti-A/B IgM/G Immunantwort auf A --> O Fehltransfusion und auf Toxocara canis Infestation.
      Schweizerische Medizinische Wochenschrift 1991;121:347-350
    • Castelli D, Nydegger U. Trombopenia associata ad una infezione da virus HIV.
      Tribuna Medica Ticinese 1991;56:78-80.
    • Dietrich G, Rossi F, Sultan Y, Kaveri S, Nydegger UE, Kazatchkine MD. IVIg and regulation of autoimmunity through the idiotypic network.
      In: Clinical use of i.v.immunoglobulins (Imbach P et al Eds). Academic Press, London.1991;pp. 3-14
    • Fey MF, Kulozik AE, Hansen-Hagge TE, Tobler A: The polymerase chain reaction: a new tool for the detection of minimal residual disease in haematological malignancies.
      Eur J Cancer 1991;27: 89-94
    • Fey MF, Tobler A: Assessment of DNA 'fingerprinting' as a method for validating the identity of cancer cell lines maintained in long-term culture.
      Nucl Acids Res 1991;19:3464
    • Fey MF, Tobler A: Cancer diagnosis by molecular genetic probes: The present and the promise.
      Annals of Oncology 1991;2: 629-633
    • Furlan M, Robles R, Lämmle B, Zimmermann J, Hunziker E. Immunogold labelling of human von Willebrand factor adsorbed to collagen.
      Blood Coagulation and Fibrinolysis 1991;2:441-446
    • Furlan M, Leupin L, Demarmels Biasiutti F, Lämmle B. Fibrinogen Bern III: Ein weiterer Fall der hereditären Fibrinogenvariante mit Substitution A 16 Arg Cys.
      Schweiz. med. Wschr.1991;121:1068-1071
    • Gersbach P, Lämmle B, Schüpbach P, Mühlemann W, Althaus U. Major coagulation disorders when using aprotinin - observations on a case.
      Thorac. Cardiovasc Surgeon 1991;39:196-198
    • Lämmle B, Wuillemin WA, Huber I, Krauskopf K, Zürcher Ch, Pflugshaupt R, Furlan M: Thromboembolism and bleeding tendency in congenital factor XII deficiency. A study on 74 subjects from 14 Swiss families.
      Thromb Haemost 1991;65:117-121
    • Lämmle B, Schneider H. Venöse Thromboembolie in Schwangerschaft und Puerperium: Pathophysiologie, Therapie, Prophylaxe.
      Arch Gynecol Obstet 1991;249 (Suppl.):38-45
    • Meier R, Chen T, Friis RR, Tobler A: Myeloperoxidase is a primary response gene in HL60 cells, directly regulated during hematopoietic differentiation.
      Biochem. Biophys Res Comm 1991;176:1345-1350
    • Nydegger UE. Hypothetic and established action mechanisms of therapy with immunoglobulin G.
      In: Clinical use of i.v. immunoglobulins (Imbach P et al Eds.) Academic Press, London 1991: 27-36.
    • Nydegger UE, Kazatchkine MD, Miescher PA. Immunopathological and clinical features of hemolytic anemia due to cold agglutinins.
      Seminars in Hematology 1991;28:66-77
    • Nydegger U.E., Castelli D. Review on Therapeutic Options in HIV Associated Thrombo-cytopenia with Emphasis on I.V. Immunoglobulin Treatment. Immunological Investigations 1991;20(2):223-229
    • Nydegger UE. Diagnostik von Komplement-Mangelzuständen.
      Diagnose und Labor 1991; 41:124-132
    • Rieben R, Buchs JP, Flückiger E, Nydegger UE. Antibodies to histo-blood group substances A and B: agglutination titers, Ig class, and IgG subclasses in healthy persons of different age categories
      Transfusion 1991;31:607-615.
    • Schifferli J, Leski M, Favre H, Imbach P, Nydegger UE, Davies K. Transient impairment of renal function after high-dose intravenous IgG treatment in patients with kidney disease.
      Lancet 1991;i:457-458.
    • Sultan Y, Kazatchkine MD, Nydegger U, Rossi F, Dietrich G, Algiman M. Intravenous immunoglobulin in the treatment of spontaneously acquired factor VIII:inhibitors.
      American Journal of Medicine 1991:91,Suppl 5A:5A-35S.
    • Tobler A, Koeffler HP. Myeloperoxidase: localization, structure and function.
      Blood Cell Biochemistry 1991;3: 255-288,
    • Tobler A, Schürch E, Altermatt HJ, Im Hof V. Anti-basement membrane antibody disease with severe pulmonary haemorrhage and normal renal function.
      Thorax 1991;46:68-70
    • Tobler A, Marti HP, Gimmi C, Cachelin A, Saurer S, Fey MF: Dexamethasone and 1,25-dihydroxyvitamin D3, but not cyclosporine A inhibit production of granulocyte-macrophage colony-stimulating factor in human fibroblasts.
      Blood 1991;77:1912-1918
    • Walpoth BH, Volken U, Aeschbacher B, Roth F, Althaus U, Nydegger UE. Nutzen und Nebenwirkungen der präoperativen Eigenblutspende bei 11 herzchirurgischen Patienten. Schweizerische Medizinische Wochenschrift 1991;121:1365-1371
    • Wuillemin WA, Furlan M, Huber I, Lämmle B. Purified factor XII has a higher specific activity than the parent molecule in plasma.
      Thromb Haemost 1991;65:169-173.
    • Wuillemin WA, Späth PJ, Uring Lambert B, Straub PW: Clinical manifestations in humans of combined C7 and C4 deficiency associated with low levels of C2, C8, and C9.
      Complement Inflamm 1991;8:70-79
    • Wuillemin WA, Huber I, Furlan M, Lämmle B. Functional characterization of an abnormal factor XII molecule (F XII Bern).
      Blood 1991;78:997-1004
    • Zimmerli M, Lerut J, Müller P, Zimmermann A, Nydegger U. Fluctuation of anti-A and anti-B histo-blood group antibodies in a patient after liver transplantation.
      Infusionstherapie 1991;18:91-95

    1990

    • Bögli C, Cofrancesco E, Cortellaro M, Della Volpe A, Hofer A, Furlan M, Zanussi C. Fibrinogen Milano VI: a heterozygous dysfibrinogenemia (Aa16Arg 6 His) with bleeding tendency.
      European Journal of Haematology 1990;45:26-30
    • Borradori L, Castelli D, Flückiger E, Nydegger UE. Clinical significance of platelet-associated immunoglobulins in narcotic addicts with human immunodeficiency virus infection.
      Clinical Immunology and Immunopathology 1990;54:256-65.
    • Buchs JP, Nydegger UE. Quantitation of anti-A and anti-B IgG antibodies in therapeutic i.v.immunoglobulin by indirect ELISA.
      Transfusion Science 1990;11:113-21.
    • Castelli D, Genetet B, Habibi B, Nydegger U. Transfusion in Europe.(Edited Book).
      Proceedings of the first ISBT Regional Congress, European Region, Lugano. Arnette, Paris 1990.
    • Demarmels F, Lüthy AR, Hirt A, Furlan M, Lämmle B: Inferior vena cava thrombosis in a child with nephroblastoma and combined deficiency of antithrombin III and free protein S.
      Blut 1990;61:295-97
    • Fey MF, Theilkäs L, Tobler A: Bone marrow trephine biopsies as a source of nucleic acids for molecular diagnosis of haematological neoplasms.
      Br J Haematol 1990:74,229-231
    • Fey MF, Tobler A, Stadelmann B, Hirt A, Theilkäs L, Khandjian EW, Ridolfi-Lüthy A, Delaleu B, Weil R, Wagner HP: Immunogenotyping with antigen receptor gene probes as a diagnostic tool in childhood acute lymphoblastic leukaemia.
      Eur J Haematol 1990;45:215-222
    • Furlan M, Bögli C, Hofer A, Bouvier CA, de Moerloose P. Fibrinogen Geneva, a new case of Aa 16 Arg 6 Cys dysfibrinogenemia.
      Blood Coagulation and Fibrinolysis 1990;1:139-144
    • Furlan M, Escher N, Lämmle B. Fractionation of fibrinogen chains and plasmic degradation products by ion exchange high performance liquid chromatography. In: Fibrinogen 4. Current basic and clinical aspects (eds. M. Matsuda, S. Iwanaga, A. Takada, A. Henschen).
      Elsevier Science Publishers, Amsterdam, 1990, pp. 3-8.
    • Huser B, Lämmle B, Landmann J, Tran TH, Oberholzer M, Marbet GA, Thiel G, Mihatsch MJ, Duckert F. Von Willebrand factor and factor VIII in renal transplant recipients under immunosuppression with cyclosporine and steroids. Sequential measurements over 4 months in 17 patients.
      Clinical Nephrology 1990;34:214-222
    • Jungi TW, Brcic M, Kuhnert P, Spycher MO, Li F, Nydegger UE. Effect of IgG for intravenous use on Fc receptor-mediated phagocytosis by human monocytes.
      Clinical Experimental Immunology 1990;82:163-169
    • Jungi TW, Nydegger UE. Plasma exchange and intravenous immunoglobulin infusions: antagonistic effects on mononuclear phagocyte functions with potential implications for therapy.
      Apheresis (Rock G, Ed.) 1990; pp 429-433.
    • Koeffler HP, Bishop JE, Reichel H, Singer F, Nagler A, Tobler A, Walka M, Norman AW: Lymphocyte cell lines from vitamin D-dependent rickets type II show normal functional defects in the 1(,25-dihydroxyvitamin D3 receptor.
      Mol Cell Endocrinol 1990;70:1-11
    • Kremer Hovinga JA, Felix R, Furlan M, Lämmle B. Malondialdehyde formation by blood platelets: A diagnostic test to assess acetylsalicylic acid induced thrombocytopathy?
      Thromb. Res. 1990;59:89-95
    • Macherel P, Sulzer I, Furlan M, Lämmle B. Warning: Simplate II. Lack of standardization in standardized bleeding time devices. Letter to the Editor.
      Thromb Haemost 1990;64: 605
    • Nydegger UE, Rieben R, Jungi TW. Synergy between plasma exchange and i.v.immunoglobulin.
      Current Topics in Hematology and Blood Transfusion 1990; 57:31-50
    • Nydegger UE. Immunoglobulins in clinical medicine.
      In: Principles of Transfusion Medicine (Rossi EC, Simon TL, Moss GS, Eds.) Williams & Wilkins, Baltimore 1990; pp 383-93
    • Nydegger UE, Rieben R, Aeschbacher B. Biocompatibility f apheresis harness.
      Transfusion Science 1990;11:43-54
    • Nydegger UE, Borradori L. Monoklonale Gammopathie.
      Hospitalis 1990; 60:1-6
    • Tobler A, Meier R, Theilkäs L, Viollier AF, Fey MF: A myeloperoxidase cDNA clone identifies an EcoRV RFLP.
      Nucl. Acids Res 1990;18: 6176.
    • Volken U, Walpoth B, Nydegger UE: Qualitative Analyse des Thoraxdrainageblutes.
      Herzmedizin 1990;13:22-7
    • Walpoth BH, Volken U, Pfäffli T, Mühlemann W, Jutzi H, Nydegger U, Althaus U. Quantitative und qualitative Analyse verschiedener Blutsparmassnahmen in der Herzchirurgie.
      Schweizerische Medizinische Wochenschrift. 1990;120:817-822
    • Walpoth BH, Volken U, Nydegger U, Jutzi H, Gersbach P, Leupi F,Schüpbach P, Althaus U: Retransfusion des Thoraxdrainageblutes: qualitative Analyse.
      Helvetica Chirurgica Acta 1990;57:385-8.
    • Wuillemin WA, Furlan M, Lämmle B. A quantitative dot immunobinding assay for coagulation factor XII in plasma.
      J Immunol Methods 1990;130:133-140
    • Zoppi M, Furlan M, Brun del Re G, Wuillemin WA, Lämmle B. Decreased free protein S levels in polycythemia vera.
      Thromb Haemostas 1990;64:177-178
    • Zoppi M, Weiss M, Nydegger UE, Hess T, Späth PJ: Recurrent meningitis in a patient with congenital deficiency of the C9 component of complement. First case of C9 deficiency in Europe.
      Archives of Internal Medicine 1990;150:2395-9

    1989

    • Aeschbacher B, Häberli A, Nydegger UE. Donor safety and plasma quality in automated plasmapheresis; a comparison of two filter materials.
      Vox Sanguinis 1989;57:104-111.
    • Bärtsch, Lämmle B, Huber I, Haeberli A, Vock P, Oelz O, Straub PW. Contact phase of blood coagulation is not activated in edema of high altitude.
      J Appl Physiol 1989:67,1336-1340
    • Blaser K, Burckhardt JJ, Carrel S, Heusser C, Nydegger UE, Riesen W. Möglichkeiten der therapeutischen Anwendung von monoklonalen Antikörpern.
      GIT-Labormedizin 1989;5:191-202;6:275-281;7:328-341.
    • Buchs JP, Nydegger UE. Development of an ABO-ELISA for the quantitation of human blood group anti-A and anti-B IgM and IgG antibodies.
      Journal of Immunological Methods 1989;118:37-46.
    • Furlan M, Felix R, Escher N, Lämmle B. How high is the true fibrinogen content of fibrinogen standards?
      Thromb Res1989; 56:583-592
    • Kazatchine MD, Rossi F, Sultan Y, Nydegger UE. Anti-idiotypes against autoantibodies to procoagulant factor VIII (VIII:C) in intravenous immunoglobulins.
      International Reviews in Immunology 1989;5:147-53.
    • Lämmle B, Furlan M, Sulzer I. Vergleich eines sensitiven Kaninchenhirn-Thromboplastins und eines humanen Plazenta-Thromboplastins zur Thromboplastinzeitbestimmung.
      Schweiz. med. Wschr. 1989;119:178-183
    • Lämmle B. Comments on "Quantification of human high molecular weight kininogen by immunoblotting with a monoclonal anti-light chain antibody" by Reddigari and Kaplan. Letter to the editor.
      J Immunol 1989;125:291-292
    • Nydegger UE, Buchs JP, Borradori L. Relative importance of total versus external platelet associated IgG.
      Blut 1989;59:67-74.
    • Nydegger UE, Lauper M. Donor reactions and complications.
      In: Donor Hemapheresis (Pineda A, Valbonesi M, Sniecinski I, Eds.) Wichtig Editore, Milano 1989; pp 117-24.
    • Nydegger UE, Borradori L. Bedeutung der Idiotypie in der Immunhämatologie.
      Infusionstherapie 1989;24:185-92.
    • Nydegger U, Borradori L. Apport du laboratoire au diagnostic des collagénoses.
      Médecine et Hygiène 1989;47:874-80.
    • Nydegger UE, Sultan Y, Kazatchkine MD. The concept of anti-idiotypic regulation of selected autoimmune diseases by intravenous immunoglobulin.
      Clinical Immunology and Immunopathology 1989;53:572-82.
    • Nydegger U. Das Komplementsystem.
      GIT-Labormedizin 1989;12:553-564.
    • Thommen D, Buhrfeind E, Felix R, Sulzer I, Furlan M, Lämmle B. Hämostaseparameter bei 55 Patienten mit venösen und/oder arteriellen Thromboembolien.
      Schweiz med Wschr 1989:119:493-499
    • Vaudaux P, Huggler E, Lerch P, Morgenthaler JJ, Nydegger UE, Schumacher-Perdreau F, Lew D, Waldvogel FA. Inhibition by immunoglobulins of Staphylococcus aureus adherence to fibronectin-coated foreign surfaces.
      Journal of Investigative Surgery 1989;2/4:397-408
    • Zimmerli W, Huber I, Bouma BN, Lämmle B. Purified human plasma kallikrein does not stimulate but primes neutrophils for superoxide production.
      Thromb Haemostas 1989;62:1121-1125